Last updated: May 09, 2020 - 02:00 BST
| An Expanded Access program of use of Convalescent Plasma for Severe COVID-19 |
Coronavirus disease 19 infection |
convalescent plasma alone |
|
|
OneBlood, University of Miami Health System |
|
|
|
|
|
Phase Not Applicable |
Status not specified |
0 |
|
|
Shweta Anjan |
2020-05-08 |
| Study for the application of novel coronavirus pneumonia (COVID-19) intestinal tract toxicity in diagnosis and its prognostic effect |
Coronavirus disease 19 infection, Viral pneumonia |
probiotic plus rifaximin |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Union Hospital Tongji Medical School Huazhong University Of Science & Technology |
|
China |
2020-05-04 |
2021-12-31 |
ChiCTR2000032686 |
Phase Not Applicable |
Not yet recruiting |
1 |
19 Months |
390 |
Xiaohua Hou, Yu Jin |
2020-05-08 |
| Follow-up study of pregnancy outcomes of novel coronavirus pneumonia (COVID-19) complicated in the first and second trimester |
Coronavirus disease 19 infection |
|
|
Female, Young Adults (18-44 yrs) |
Union Hospital Tongji Medical School Huazhong University Of Science & Technology |
|
China |
2020-04-01 |
2020-12-31 |
ChiCTR2000032666 |
Phase Not Applicable |
Recruiting |
1 |
9 Months |
6 |
Zhao Yin |
2020-05-08 |
| SloLifestyle: Diet, Body Composition, Lifestyle and Cardiovascular Health of Healthy and Active Adults From Slovenia |
Cardiovascular disease, Coronavirus disease 19 infection, Sleep disorder |
dietary intake alone, lifestyle status alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Barbara Jakse sp |
|
Slovenia |
2020-05-10 |
2020-07-01 |
KR4, NCT04379622, SloLifestyle |
Phase Not Applicable |
Not yet recruiting |
1 |
1 Month |
300 |
Boštjan Jakše, Stanislav Pinter, PhD |
2020-05-08 |
| A phase I clinical trial to assess the tolerability and immune response of recombinant MVA vector vaccine fo the prevention of SARS-CoV-2 COVID-19 infection |
Coronavirus disease 19 infection |
recombinant MVA vector vaccine (COVID-19), German Center for Infection Research alone |
COVID19 Spike glycoprotein modulator |
|
German Center for Infection Research (DZIF) |
|
|
|
|
|
Phase 1 Clinical |
Planned |
0 |
|
|
|
2020-05-08 |
| A clinical trial of SARS-CoV-2 therapy for the prevention/treatment of COVID-19 infection |
Coronavirus disease 19 infection |
SARS-CoV-2 therapy (COVID-19), Shionogi/Hokkaido University Research Center alone |
|
|
Hokkaido University, Shionogi & Co Ltd |
|
|
|
|
|
Phase Not Applicable |
Planned |
0 |
|
|
|
2020-05-08 |
| Study for efficacy and safety of Jie-Xing-Jun-Zi granules in the Treatment of convalescent patients of novel coronavious pneumonia (COVID-19) |
Coronavirus disease 19 infection, Viral pneumonia |
Jiexingjunzi granules alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
The Third affiliated Hospital of Beijing Traditional Chinese Medicine University |
|
China |
2020-05-01 |
2020-12-31 |
ChiCTR2000032313, ChiMCTR2000003243 |
Phase 0 Clinical |
Not yet recruiting |
3 |
8 Months |
60 |
Hongsheng Cui, Xinxin Qin |
2020-05-08 |
| A medical records based study for optimization and evaluation of the comprehensive diagnosis and treatment of novel coronavirus pneumonia (COVID-19) and the assessment of risk factors for severe pneumonia |
Coronavirus disease 19 infection, Viral pneumonia |
|
|
|
The First Affiliated Hospital of Nanchang University |
|
China |
2020-01-31 |
2020-07-31 |
ChiCTR2000030095 |
Phase 0 Clinical |
Recruiting |
1 |
6 Months |
94 |
Anjun Chen, Wei Zhang |
2020-05-08 |
| Study for Screening of Chinese Patent Drugs in the Rehabilitation Treatment of Novel Coronavirus Pneumonia (COVID-19) |
Coronavirus disease 19 infection, Viral pneumonia |
Pien Tze Huang capsule plus thymosin enteric capsule |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Hubei province hospital of Traditional Chinese Medicine |
Ministry of Science and Technology of the People´s Republic of China |
China |
2020-04-01 |
2021-03-31 |
ChiCTR2000032635, ChiMCTR2000003279 |
Phase 0 Clinical |
Not yet recruiting |
1 |
12 Months |
60 |
He Shaobin, Zhuo Yana |
2020-05-08 |
| SurgiCovid: Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center |
Coronavirus disease 19 infection |
Computed tomography chest alone, Reverse transcription polymerase chain reaction test alone, Screening test for covid alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hospices Civils De Lyon |
|
France |
2020-03-19 |
2020-04-25 |
CRC_GHN_2020_001, NCT04379232, SurgiCovid |
Phase Not Applicable |
Completed |
1 |
1 Month |
112 |
|
2020-05-08 |
| Social Media and Covid19 Pandemic |
Coronavirus disease 19 infection |
survey alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Acibadem University |
|
Turkey |
2020-05-01 |
2020-05-08 |
ACIBADEMU SOCIAL MEDIA, NCT04378738 |
Phase Not Applicable |
Recruiting |
2 |
|
212 |
|
2020-05-08 |
| A clinical trial to investigate and define the molecular mechanisms of SARS-CoV-2 infection and COVID-19 and identify targets for medicines and vaccines |
Coronavirus disease 19 infection |
|
|
|
Institute For Systems Biology, Merck & Co Inc |
10X Technologies Inc, Adaptive Biotechnologies Corp, Andy Hill CARE Fund, Biomedical Advanced Research and Development Authority (BARDA), Bloodworks Northwest, Isoplexis Corp, M.J. Murdock Charitable Trust, Metabolon Inc, NanoString Technologies Inc, Parker Institute for Cancer Immunotherapy, Scisco Genetics Inc, Stanford University, Swedish Hospital, Wilkes University |
|
|
|
|
Phase Not Applicable |
Status not specified |
0 |
|
200 |
Dr. Jason D. Goldman |
2020-05-08 |
| Efficacy of Liu-zi-jue in patients with 2019 novel Coronavirus pneumonia (COVID-19): a randomized, controlled trial |
Coronavirus disease 19 infection, Viral pneumonia |
Liu-zi-jue alone, conventional treatment alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine |
|
China |
2020-02-19 |
2020-07-31 |
ChiCTR2000032367, ChiMCTR2000003246 |
Phase Not Applicable |
Recruiting |
2 |
5 Months |
186 |
Min Fang, Shuaigpan Zhang |
2020-05-08 |
| Lingnan Fire-Needle Therapy Improves the Quality of Life in General Population Under the Pandemic of Novel Coronavirus Pneumonia (COVID-19): A Prospective, Randomized Controlled Trial |
Coronavirus disease 19 infection, Viral pneumonia |
lingnan fire needle therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
The first affiliated hospital of Guangzhou university of Traditional Chinese medicine |
|
China |
2020-04-27 |
2020-12-31 |
ChiCTR2000032346, ChiMCTR2000003245 |
Phase 0 Clinical |
Recruiting |
1 |
8 Months |
120 |
Guohua Lin, Jingchun Zeng |
2020-05-08 |
| Neurologic Manifestations of COVID 19 in Children |
Coronavirus disease 19 infection |
|
|
Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs) |
University of Pittsburgh |
Johns Hopkins University, University of Utah |
US |
2020-04-29 |
2022-12-31 |
NCT04379089, STUDY20040154 |
Phase Not Applicable |
Recruiting |
0 |
32 Months |
500 |
David Maloney, BS, Ericka L Fink, Ericka L Fink, MD |
2020-05-08 |
| COPING: COVID Pandemic Short Interval National Survey Gauging Psychological Distress |
Acute stress disorder, Coronavirus disease 19 infection |
|
|
|
Nova Scotia Health Authority |
|
Canada |
2020-05-31 |
2022-05-31 |
COPING, NCT04379063, Temporary REB#25470 |
Phase Not Applicable |
Not yet recruiting |
1 |
24 Months |
10000 |
Jonathan Bailey, MD MSc FRCPC |
2020-05-08 |
| CovRep: Effector and Regulatory T-Cell Receptor Repertoire Analysis in Patients Affected by COVID-19 |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Assistance Publique Hopitaux de Paris |
|
France |
2020-05-31 |
2020-11-30 |
2020-A01245-34, APHP200544, CovRep, NCT04379466 |
Phase Not Applicable |
Not yet recruiting |
1 |
6 Months |
60 |
David KLATZMANN, MD, PhD, Roberta LORENZON, MD |
2020-05-08 |
| Rintatolimod and IFN Alpha-2b for the Treatment of Mild or Moderate COVID-19 Infection in Cancer Patients |
Coronavirus disease 19 infection |
Recombinant Interferon Alfa-2b alone, Rintatolimod alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Roswell Park Comprehensive Cancer Center |
|
US |
2020-05-30 |
2021-04-30 |
I 659920, I 659920, NCI-2020-02317, NCT04379518, P30CA016056 |
Phase 1/Phase 2 Clinical |
Not yet recruiting |
0 |
11 Months |
80 |
Brahm H Segal, Brahm H. Segal |
2020-05-08 |
| A phase II study to assess the effect of DW-2008 in the treatment of COVID-19 patients |
Coronavirus disease 19 infection |
DW-2008 alone |
|
|
Dong Wha Pharmaceutical Co Ltd |
|
|
2020-06-30 |
|
|
Phase 2 Clinical |
Planned |
0 |
|
|
|
2020-05-08 |
| LDCTiP: LDCT in COVID-19 Pneumonia: a Prospective Moscow Study |
Coronavirus disease 19 infection, Viral pneumonia |
Low-dose Chest CT alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Federal State Institution "Medical Radiological Research Center" |
|
Russian Federation |
2020-05-31 |
2020-07-31 |
2020-1, LDCTiP, NCT04379531 |
Phase Not Applicable |
Not yet recruiting |
1 |
2 Months |
230 |
Anton Vladzymyrskyy, Ivan Blokhin, Valeria Chernina, Victor Gombolevskiy, PhD |
2020-05-08 |
| VOC-COVID: Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalized Patients for an Infection by SARS-CoV-2 (COVID-19) |
Coronavirus disease 19 infection, Respiratory disease |
electronic nose alone, volatile organic compounds analysis alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hopital Foch |
|
France |
2020-04-14 |
2020-11-16 |
2020-0060, NCT04379154, VOC-COVID |
Phase Not Applicable |
Recruiting |
1 |
7 Months |
60 |
Elisabeth Hulier-Ammar, Hélène Salvator |
2020-05-08 |
| A randomized clinical trial for the efficacy and safety of aliskiren and nifedipine in novel coronavirus pneumonia (COVID-19) patients with hypertension |
Coronavirus disease 19 infection, Hypertension, Viral pneumonia |
aliskiren alone, nifedipine alone, standard care alone |
Calcium channel inhibitor L-type, Renin inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
West China Hospital |
|
China |
2020-03-01 |
2020-12-31 |
ChiCTR2000032314 |
Phase 0 Clinical |
Recruiting |
5 |
10 Months |
242 |
Fengming Luo, Min Zhu |
2020-05-08 |
| Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients |
Coronavirus disease 19 infection, Lung disease, Respiratory distress syndrome, Viral pneumonia |
transcutaneous auricular vagus nerve stimulation alone, transcutaneous auricular vagus nerve stimulator (Nemechek Technologies) alone |
|
Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Nemechek Technologies |
|
|
2020-07-31 |
2021-01-31 |
NCM-001, NCT04379037 |
Phase Not Applicable |
Not yet recruiting |
0 |
6 Months |
50 |
Jean R Nemechek, JD, Patrick M Nemechek, D.O. |
2020-05-08 |
| Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic |
Coronavirus disease 19 infection |
Enriched Survey Feedback alone, Peer Resilience Champion alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Mount Sinai Hospital |
Canadian Institutes of Health Research |
Canada |
2020-06-30 |
2022-02-28 |
20-0084-E, NCT04373382 |
Phase Not Applicable |
Not yet recruiting |
1 |
20 Months |
1000 |
Robert G Maunder |
2020-05-08 |
| Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations |
Coronavirus disease 19 infection |
drug therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Tabula Rasa HealthCare Inc |
Cambia Health Solutions Inc |
US |
2020-05-05 |
2021-04-30 |
COVID19-TRHC-2020-002, NCT04378881 |
Phase Not Applicable |
Not yet recruiting |
0 |
11 Months |
100 |
Pamela Dow, MS, Veronique Michaud, Veronique Michaud, PhD |
2020-05-08 |
| UC-COVID: Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19 |
Coronavirus disease 19 infection |
Brief educational video alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of California Los Angeles |
|
US |
2020-05-31 |
2020-12-31 |
NCT04373135, UC-COVID, UCLA-20-000683 |
Phase Not Applicable |
Not yet recruiting |
0 |
7 Months |
1000 |
Lauren E Wisk, PhD, Russell G Buhr, MD, PhD |
2020-05-08 |
| Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 |
Coronavirus disease 19 infection, Dyspnea |
Standard of care alone, hydrogen + oxygen alone, hydrogen oxygen generator (AMS-H-03, Shanghai Asclepius Meditec Co., Ltd., China) alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Guangzhou Institute Of Respiratory Disease |
|
China |
2020-01-21 |
2020-03-23 |
JT202005LZ, NCT04378712 |
Phase 2 Clinical |
Completed |
2 |
2 Months |
90 |
Wei-jie Guan, PhD |
2020-05-08 |
| Platelet Count, Platelet, Mean Platelet Volume and Platelet Distribution Width in COVID-19 |
Coronavirus disease 19 infection |
|
|
|
Konya Training And Research Hospital |
|
|
2020-05-04 |
2020-05-13 |
COVID-19, NCT04378829 |
Phase Not Applicable |
Not yet recruiting |
0 |
|
40 |
Yasin TİRE |
2020-05-08 |
| Nudges to Limit COVID-19 |
Coronavirus disease 19 infection |
Behavioral Nudges (BN) alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Medical College of Wisconsin |
|
US |
2020-05-11 |
2020-10-10 |
NCT04379375 |
Phase Not Applicable |
Not yet recruiting |
0 |
5 Months |
300 |
Nicholas D Young, PhD |
2020-05-08 |
| Innovative Tool to Limit Spread of SARS-CoV-2 in Residential Aged Care Facilities |
Coronavirus disease 19 infection |
Gamification function alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Queensland |
|
|
2020-05-06 |
2020-06-04 |
CARE COLLECTIVE STUDY, NCT04377165 |
Phase Not Applicable |
Not yet recruiting |
0 |
|
9000 |
Anna Donaldson, Caitlin Falconer, David L Paterson, PhD |
2020-05-08 |
| BCG Vaccination for Healthcare Workers in COVID-19 Pandemic |
Coronavirus disease 19 infection |
BCG vaccine Danish strain 1331 (Statens Serum Institute) alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Applied Sciences Inc |
|
South Africa |
2020-05-04 |
2021-04-28 |
NCT04379336, TASK-008 BCG-CORONA |
Phase 3 Clinical |
Recruiting |
1 |
11 Months |
500 |
Caryn M Upton, MBChB, Caryn Upton, MD, Christelle Van Niekerk |
2020-05-08 |
| FRESH: Fluid Response Evaluation in Sepsis Hypotension and Shock study |
Coronavirus disease 19 infection, Hypotension, Septic shock |
Baxter’s Starling Fluid Management Monitoring System alone, Passive Leg Raises alone, vasopressor therapy alone |
|
|
Baxter International Inc |
|
UK, US |
|
|
FRESH |
Phase Not Applicable |
Status not specified |
1 |
|
|
Ivor Douglas |
2020-05-08 |
| A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19 |
Coronavirus disease 19 infection |
hydroxychloroquine alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Memorial Sloan-Kettering Cancer Center |
|
US |
2020-05-05 |
2021-05-31 |
20-187, NCT04379492 |
Phase 2 Clinical |
Recruiting |
0 |
12 Months |
120 |
Genovefa Papanicolaou, MD, Susan Seo, MD |
2020-05-08 |
| High dose intravenous vitamin C might be used as an important rescue therapy for aggravation of severe and critical novel coronavirus pneumonia (COVID-19) patients |
Coronavirus disease 19 infection, Viral pneumonia |
vitamin C alone |
|
|
Rui Jin Hospital |
Science and Technology Commission of Shanghai Municipality |
China |
2020-02-05 |
2020-04-30 |
ChiCTR2000032716 |
Phase Not Applicable |
No longer recruiting |
1 |
2 Months |
12 |
Bing Zhao, Enqiang Mao |
2020-05-08 |
| Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Texas System |
|
US |
2020-04-10 |
2021-07-30 |
2020-004-0019, NCT04378595 |
Phase Not Applicable |
Recruiting |
0 |
15 Months |
1000 |
Ana Avalos, MD, Keli Hawthorne, Keli Hawthorne, MS, Megan Gray, MD, Steve Abrams, MD, Steven Abrams |
2020-05-08 |
| Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia |
Coronavirus disease 19 infection, Respiratory disorder, Viral pneumonia |
blood sample and data record alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Universitaire de Reims |
|
France |
2020-05-15 |
2021-10-15 |
NCT04376840, PO20066 |
Phase Not Applicable |
Not yet recruiting |
1 |
17 Months |
240 |
Jeanne-Marie PEROTIN-COLLARD |
2020-05-08 |
| COM-COVID: Assessment of the Psycho-social Impact of COVID-19 Outbreak |
Coronavirus disease 19 infection |
COM-COVID anonimous survey alone |
|
Healthy volunteers accepted, Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Fundació Institut Germans Trias i Pujol |
Anaxomics Biotech, Fundació Lluita contra la SIDA |
Spain |
2020-03-31 |
2020-12-31 |
COM-COVID, COM-COVID, NCT04378452 |
Phase Not Applicable |
Recruiting |
3 |
9 Months |
65000 |
Carol Armengol, PhD, Cris Vilaplana, MD, PhD, José A Muñoz-Moreno, PhD, Judith Farrés, PhD, Lilibeth Arias, PhD, Maria Rosa Sarrias, PhD, Pau Benito, Pere-Joan Cardona, MD, PhD |
2020-05-08 |
| A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19) |
Coronavirus disease 19 infection |
standard-of-care antiviral therapy alone, vidofludimus alone, Variable regimens including chloroquine , hydroxychloroquine , vidofludimus |
Dihydroorotate dehydrogenase inhibitor, IL-17 antagonist |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Immunic AG, Immunic Inc |
FGK Clinical Research GmbH |
US, Europe |
2020-05-31 |
2020-10-31 |
NCT04379271, P2-IMU-838-COV |
Phase 2/Phase 3 Clinical |
Not yet recruiting |
0 |
5 Months |
600 |
Andreas Muehler, Dr., Neera Ahuja, Prof. |
2020-05-08 |
| EpiCoV-Brazil: Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU |
Coronavirus disease 19 infection |
|
|
Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo |
|
Brazil |
2020-05-10 |
2020-12-31 |
31382620.0.0000.0068, EpiCoV-Brazil, NCT04378582 |
Phase Not Applicable |
Not yet recruiting |
1 |
7 Months |
300 |
Juliana C Ferreira, MD |
2020-05-08 |
| GEROCOVIDobs: Geriatric Population COVID-19 Observational Study |
Coronavirus disease 19 infection |
|
|
Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universita Campus Bio MediCo Di Roma |
BLUECOMPANION FRANCE, Italian Society of Gerontology and Geriatrics |
Italy |
2020-04-25 |
2020-11-30 |
GC01-OBS, GEROCOVIDobs, NCT04379440 |
Phase Not Applicable |
Recruiting |
7 |
7 Months |
1500 |
Raffaele Antonelli Incalzi, M.D., Susanna Del Signore, M.D. |
2020-05-08 |
| COVIDHIVPrEP: COVID-19 Infection in Patients Infected With HIV and/or on PrEP |
Coronavirus disease 19 infection, HIV infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hospices Civils De Lyon |
|
France |
2020-04-30 |
2020-05-04 |
COVIDHIVPrEP, CRC_GHN_2020_002, NCT04379245 |
Phase Not Applicable |
Completed |
1 |
|
4200 |
|
2020-05-08 |
| CLUSCO: Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19 |
Coronavirus disease 19 infection, Respiratory failure |
cardiopulmonary ultrasound alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Pennsylvania |
|
US |
2020-04-23 |
2020-12-31 |
843008, CLUSCO, NCT04379544 |
Phase Not Applicable |
No longer recruiting |
0 |
8 Months |
105 |
Felipe Teran, MD |
2020-05-08 |
| Effects of tests for covid-19 on the preservation of the healthcare workforce during pandemic in Brazil |
Coronavirus disease 19 infection |
RT-PCR testing alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
University Hospital of Brasilia |
|
Brazil |
2020-04-30 |
|
3,959,938, 30540720.2.0000.0008, RBR-6w5tbk, U1111-1251-0177 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
250 |
Cleandro Pires de Albuquerque |
2020-05-08 |
| A phase II, randomized, open-label clinical study to assess safety and efficacy of masitinib in combination with isoquercetin in the treatment of hospitalized patients with moderate and severe COVID-19 |
Coronavirus disease 19 infection |
isoquercetin plus masitinib |
CSF-1 antagonist, FGF3 receptor antagonist, Fyn tyrosine kinase inhibitor, Kit tyrosine kinase inhibitor, Lyn tyrosine kinase inhibitor, PDGF receptor antagonist, Protein tyrosine kinase inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
AB Science SA |
|
France |
2020-05-06 |
|
AB20001 |
Phase 2 Clinical |
Recruiting |
1 |
|
200 |
|
2020-05-08 |
| A study to assess the efficacy of a imiquimod cream with hydroxychloroquine for primary and secondary prophylaxis of subjects with COVID19 infection |
Coronavirus disease 19 infection |
hydroxychloroquine plus imiquimod |
TLR-7 agonist |
|
University of Texas System |
|
|
|
|
|
Phase Not Applicable |
Planned |
0 |
|
|
|
2020-05-08 |
| Clinical trial on the efficacy of tocilizumab in modifying the inflammatory parameters of patients with COVID-19 |
Coronavirus disease 19 infection, Viral pneumonia |
tocilizumab (intravenous), Roche/Chugai alone |
IL-6 receptor antagonist, IL-6 receptor modulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal |
|
Spain |
2020-05-04 |
|
2020-002032-69, COVITOZ-01 |
Phase 2 Clinical |
Recruiting |
1 |
|
78 |
Departamento de Ensayos Clínicos |
2020-05-07 |
| ANA-COVID-GEAS: Clinical Trial of the Use of Anakinra (Anti-IL-1) in Cytokine Storm Syndrome (CSS) Secondary to COVID-19 |
Coronavirus disease 19 infection, Systemic inflammatory response syndrome, Viral pneumonia |
anakinra alone, standard treatment alone |
Type I IL-1 receptor antagonist |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Fundación Pública Miguel Servet |
Instituto de Salud Carlos III |
Spain |
2020-04-28 |
|
2020-001825-29, ANA-COVID-GEAS, ANA-COVID-GEAS |
Phase 2/Phase 3 Clinical |
Recruiting |
1 |
|
180 |
RUTH GARCIA |
2020-05-07 |
| A study to assess the effect of Ternatin-4 in patients with Covid-19 |
Coronavirus disease 19 infection |
Ternatin-4 alone |
|
|
University of California San Francisco |
|
|
|
|
|
Phase Not Applicable |
Planned |
0 |
|
|
|
2020-05-07 |
| SoDi: Neuroendocrine mechanisms, Social isolation and psychobiological stress during the COVID-19 pandemic |
Acute stress disorder, Coronavirus disease 19 infection, Social phobia |
psychotherapeutical counselling alone, smartphone application alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital Heidelberg |
|
Germany |
2020-04-03 |
|
DRKS00021671, S-214/2020, SoDi |
Phase Not Applicable |
Recruiting |
1 |
|
200 |
Ekaterina Schneider, Monika Eckstein |
2020-05-08 |
| A study to assess the effect of zotatifin in patients with Covid-19 |
Coronavirus disease 19 infection |
zotatifin alone |
Eukaryotic initiation factor 4A-I inhibitor |
|
University of California San Francisco |
|
|
|
|
|
Phase Not Applicable |
Planned |
0 |
|
|
|
2020-05-07 |
| COVID-19 DETOUR: Detection of a delayed Treatment of urgent ophthalmologic Treatment during the SARS-CoV-2 pandemic (COVID-19) |
Coronavirus disease 19 infection, Ocular disease |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universitatsklinikum Schleswig-Holstein Campus Kiel |
Klinik für Augenheilkunde, Germany |
Germany |
2020-05-08 |
|
20-477, COVID-19 DETOUR, DRKS00021630 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
30 |
Christoph Ehlken |
2020-05-07 |
| Control of inflammatory parameters with fish oil in parenteral nutrition |
Coronavirus disease 19 infection, Respiratory tract infection |
Variable regimens including ClinOleic , Nutriflex Lipid special , Olimel N9 , Omegaflex special , Omegaven , Smofkabiven , Smoflipid |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hospital Vall D'Hebron |
|
Spain |
2020-04-26 |
|
01-2020, 2020-000705-86 |
Phase 4 Clinical |
Recruiting |
1 |
|
117 |
DAVID BERLANA, David Berlana |
2020-05-07 |
| EMBELLIE: Barrier Measures to Limit COVID-19 Nosocomial Transmission: a Cross-sectional Evaluation |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital, Montpellier |
|
France |
2020-04-01 |
2020-12-30 |
EMBELLIE, NCT04376944, RECHMPL20_0261 |
Phase Not Applicable |
Recruiting |
1 |
8 Months |
300 |
Alain MAKINSON, MCU-PH, Marie Bistoquet, MB, Marie Bistoquet, MD |
2020-05-08 |
| CORTIVID: Early Treatment Of Pneumonia COVID-19 With Glucocorticoids: Randomized, Controlled Clinical Trial |
Coronavirus disease 19 infection, Viral pneumonia |
methylprednisolone alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Fundación Pública Miguel Servet |
Centro De Investigación Biomédica En Red De Enfermedades Neurodegenerativas |
Spain |
2020-04-30 |
|
2020-001827-15, CORTIVID, CORTIVID |
Phase 3 Clinical |
Recruiting |
1 |
|
72 |
CLINICAL TRIAL UNIT |
2020-05-07 |
| Heparin-SARS-CoV2: Impact of the use of low molecular weight heparins (LMWH), at prophylactic versus intermediate doses, on SARS-CoV2 infection (COVID-19) |
Coronavirus disease 19 infection |
enoxaparin sodium alone |
Low molecular weight heparin |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Fundacion Neumosur |
|
Spain |
2020-05-04 |
|
2020-001891-14, Heparin-SARS-CoV2, Heparin-SARS-CoV2 |
Phase 2 Clinical |
Recruiting |
1 |
|
140 |
Alejandro |
2020-05-08 |
| MindCOVID: Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic |
Anxiety disorder, Coronavirus disease 19 infection, Depression |
|
|
Healthy volunteers accepted, Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Zelazna Medical Centre, LLC |
American University of Beirut Medical Center, Central Clinical Hospital of the Internal Affairs and Administration Ministry, Chang Gung University, Charite University, Charles University, Chinese University of Hong Kong, Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal “iMaterna”, Hopital Necker Enfants Malades, Karolinska Institutet, Medical Center of Postgraduate Education, Meir Medical Center, Nicolaus Copernicus University, Polish Academy of Sciences, Pomeranian Medical University, Royal Prince Alfred Hospital, Taiji Clinic, Universita degli Studi di Brescia, University of Medicine, Tirana, University of Tromso, Wayne State University |
Albania, Germany, Italy, US, Israel, France, Norway, Czech Republic, Taiwan, Poland, Hong Kong, Spain, Lebanon, Sweden, Australia |
2020-05-01 |
2020-10-31 |
MATERNAL AXIETY AND COVID-19, MindCOVID, NCT04377412 |
Phase Not Applicable |
Recruiting |
16 |
6 Months |
8500 |
Anna Kajdy, Anna Kajdy, MD, PhD, Artur Pokropek, PhD, Professor, Barbara Baranowska, PhD, RM, Dariusz Borowski, MD, PhD, Dorota Sys, PhD, Equal Chen, Ewa Andersson, RNM, PhD, Federico Prefumo, MD, PhD, Ganesh Acharya, MD, PhD, FRCOG, Professor, Ganesh Archaya, MD, PhD, Professor, Gihad Chalouhi, MD, PhD, Heidi Tiller, MD, PhD, Jade Harris, MD, Jan Modzelewski, MD, Jon Hayett, Professor, Jon Hyett, Karine Stiberg Birkelund, Ksenia Olisova, MD, MPH, Laurent J Salomon, MD, PhD, Laurent J Salomon, MD, PhD, Professor, Liona C Poon, MBBS, MRCOG, Professor, Maria del Mar Gil Mira, MD, PhD, Maya Ben-Zion, MD, Michał Rabijewski, MD, PhD, Professor, Orion Gliozheni, MD, Pavel Calda, MD, MSc, Professor, Roksana Lewandowska, MD, Sebastian Kwiatkowski, MD, PhD, Simone Schwank, PhD M.S. M.A. Msc. Clinical Ps, Solrun Rasmussen, Sonia Hassan, MD, Stefan Verlohren, MD, Professor, Stepan Feduniw, MD, Steven Shaw, Tal Biron-Shental, MD, Tung-Yao Chang, MD, M Med Sci, Urszula Ajdacka, MD, pavel Calda, MD, MSc. |
2020-05-07 |
| Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19 |
Coronavirus disease 19 infection, Inflammatory disease |
tocilizumab alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hospital Sao Domingos |
|
Brazil |
2020-05-31 |
2020-11-30 |
COVID-19 HSD, NCT04377503 |
Phase 2 Clinical |
Not yet recruiting |
1 |
6 Months |
40 |
HUGO C LIMA, MD, JOSE A AZEVEDO, MD, PhD, PEDRO B FROTA, MD |
2020-05-07 |
| Use of the Nasal Cannula During COVID-19 |
Coronavirus disease 19 infection |
low flow nasal cannula alone |
|
Healthy volunteers accepted |
Asociación de Anestesia Analgesia y Reanimación de Buenos Aires (AAARBA) |
|
Argentina |
2020-04-30 |
2020-09-30 |
NASAL CANNULAS FLOW RATE, NCT04376580 |
Phase Not Applicable |
Recruiting |
1 |
5 Months |
100 |
Carolina Frederico |
2020-05-08 |
| Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety |
Acute stress disorder, Coronavirus disease 19 infection, Depression, Generalized anxiety disorder |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Oslo |
Modum Bad, Oslo and Akershus University College of Applied Sciences |
Norway |
2020-03-31 |
2020-04-07 |
NCT04377074, REK125510(3) |
Phase Not Applicable |
Completed |
1 |
|
2880 |
Asle Hoffart, PhD, Miriam Sinkerud Johnson, PhD, Nora Paulsen Skjerdingstad, Omid Ebrahimi, Sverre Urnes Johnson, PhD |
2020-05-07 |
| Fluoxetine to Reduce Intubation and Death After COVID19 Infection |
Coronavirus disease 19 infection |
fluoxetine hydrochloride alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
The University of Toledo Health Science Campus |
|
US |
2020-05-01 |
2021-10-20 |
FRIDA COVID19, NCT04377308 |
Phase 4 Clinical |
Recruiting |
0 |
17 Months |
2000 |
Cheryl McCullumsmith, MD PhD, Cheryl Mccullumsmith |
2020-05-08 |
| FORECAST: Finding Out if COVID-19 Infection Can be predicted by Changes in Smell and/or Taste |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University College London |
|
UK |
2020-04-23 |
2020-12-23 |
132311, 20/HRA/1879, FORECAST, NCT04377815 |
Phase Not Applicable |
Recruiting |
2 |
8 Months |
500 |
Alisia Carnemolla, PhD, Rachel L Batterham, PhD |
2020-05-07 |
| The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation |
Coronavirus disease 19 infection, Hypoxia, Lung inflammation, Respiratory failure, Viral pneumonia |
tocilizumab (intravenous), Roche/Chugai alone |
IL-6 receptor antagonist, IL-6 receptor modulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hadassah Medical Organization |
Sheba Medical Center, Wolfson Medical Center |
Israel |
2020-04-08 |
2021-05-08 |
0224-20-HMO-CTIL, NCT04377750 |
Phase 4 Clinical |
Recruiting |
4 |
13 Months |
500 |
Eithan Galun, Prof., Galia Rahav, Prof., Juli Benbenisty, MPH, Reuven Pizov, Prof., Shlomo Maayan, PROF, Yasmin Meir, Dr. |
2020-05-08 |
| COVID-Milit: A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers |
Coronavirus disease 19 infection |
hydroxychloroquine plus zinc |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Hopital Militaire Principal d'instruction de Tunis |
Dacima Consulting, UR17DN02 : Autoimmune Diseases Research Unit |
Tunisia |
2020-05-04 |
2020-07-31 |
COVID-Milit, NCT04377646, TN2020-NAT-INS-38, UR17DN02-001 |
Phase 3 Clinical |
Not yet recruiting |
1 |
2 Months |
660 |
Faida Ajili, MD, Neja Stambouli, PhD, Nejla Mrabet, PhD, Nejla Stambouli, PhD |
2020-05-07 |
| OSCAR: Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease |
Coronavirus disease 19 infection, Lung disease |
otilimab alone, standard of care alone |
GM-CSF receptor modulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
GlaxoSmithKline plc |
|
|
2020-05-18 |
2020-12-20 |
214094, NCT04376684, OSCAR |
Phase 2 Clinical |
Not yet recruiting |
0 |
7 Months |
800 |
EU GSK Clinical Trials Call Center, GSK Clinical Trials, US GSK Clinical Trials Call Center |
2020-05-07 |
| Predicting the Need for Intubation in Hospitalized COVID-19 Patients |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Central Hospital, Nancy, France |
|
France |
2020-05-31 |
2020-11-30 |
2020-A01076-33, NCT04376879 |
Phase Not Applicable |
Not yet recruiting |
2 |
6 Months |
384 |
Antoine KIMMOUN, MD-PhD, Jean Damien RICARD, MD-PhD, Julie JOSSE, PhD, Patrick ROSSIGNOL, MD-PhD |
2020-05-07 |
| Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 |
Coronavirus disease 19 infection |
anti-SARS-CoV-2 human convalescent plasma alone |
|
Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs) |
Johns Hopkins University |
|
US |
2020-05-18 |
2022-05-18 |
IRB00247557, NCT04377672 |
Phase 1 Clinical |
Not yet recruiting |
0 |
24 Months |
30 |
Mary Katherine Brosnan, Oren Gordon, MD, Sanjay K Jain, MD |
2020-05-08 |
| COVID-CT: Prediction of Clinical Course in COVID-19 Patients |
Coronavirus disease 19 infection |
computed tomography alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Universitaire de Saint Etienne |
Centre National de la Recherche Scientifique (CNRS), INSERM, Institut National Des Sciences Appliquées, Universite Jean Monnet, University of Lyon |
France |
2020-03-01 |
2020-09-30 |
20CH096, COVID-CT, NCT04377685 |
Phase Not Applicable |
Recruiting |
1 |
7 Months |
800 |
Beatrice DEYGAS, Pierre CROISILLE, PhD |
2020-05-08 |
| PiCCOVID: Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19) |
Coronavirus disease 19 infection |
transpulmonary thermodilution alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital, Montpellier |
|
France |
2020-04-01 |
2020-09-30 |
NCT04376905, PiCCOVID, RECHMPL20-0193 |
Phase Not Applicable |
Recruiting |
1 |
6 Months |
30 |
Fanny Garnier, chef de clinique, Kada KLOUCHE, MD PhD |
2020-05-08 |
| RUXCOVID-DEVENT: Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation |
Coronavirus disease 19 infection, Respiratory distress syndrome |
Standard of care alone, ruxolitinib (oral, myeloproliferative disorders), Incyte/Novartis alone |
Jak1 tyrosine kinase inhibitor, Jak2 tyrosine kinase inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Incyte Corp |
|
|
2020-05-06 |
2020-07-29 |
INCB 18424-369, NCT04377620, RUXCOVID-DEVENT |
Phase 3 Clinical |
Not yet recruiting |
0 |
2 Months |
500 |
Incyte Corporation Call Center (US) |
2020-05-08 |
| Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS) |
Coronavirus disease 19 infection, Respiratory distress syndrome |
allogeneic bone marrow-derived human mesenchymal stem (stromal) cells (MSCs) alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital Tubingen |
|
Germany |
2020-05-31 |
2021-02-28 |
NCT04377334, RESCOVID |
Phase 2 Clinical |
Not yet recruiting |
1 |
9 Months |
40 |
Peter Rosenberger, MD, Peter Rosenberger, Prof., Valbona Mirakaj, Prof. |
2020-05-08 |
| CoronaWatch: Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch |
Cardiovascular disease, Coronavirus disease 19 infection, Heart arrhythmia |
Apple watch series 5 alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital Heidelberg |
Deutsche Herzstiftung eV, Freunde und Förderer der Kardiologie Heidelberg, Klaus Tschira Stiftung GmbH |
Germany |
2020-04-15 |
2020-07-31 |
CORONAWATCH, CoronaWatch, NCT04376853 |
Phase Not Applicable |
Recruiting |
1 |
3 Months |
50 |
Benjamin Meder, Prof. Dr. |
2020-05-07 |
| ECHOVID-19: The ECHOVID-19 Study |
Coronavirus disease 19 infection, Respiratory distress syndrome |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital Gentofte |
|
Denmark |
2020-03-31 |
2021-03-01 |
ECHOVID-19, H-20021500, NCT04377035 |
Phase Not Applicable |
Recruiting |
1 |
11 Months |
1000 |
Tor Biering-Sørensen, MD, PhD, MPH, Tor Biering-sørensen, MD, PhD, MPH |
2020-05-08 |
| Safe Return to Regular Clinical Operation After COVID-19 Pandemic |
Coronavirus disease 19 infection |
ARCHITECT i2000SR system alone, RealStar SARS-CoV-2 RT-PCR Kit RUO (Altona Diagnostics) alone, SARS-CoV-2 IgG assay kit (Abbott Diagnostics) alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
King Fahad Specialist Hospital Dammam |
|
Saudi Arabia |
2020-05-17 |
2020-12-30 |
KFSH-ONC-02, NCT04377802 |
Phase Not Applicable |
Not yet recruiting |
1 |
7 Months |
400 |
Fahad Ibnshamsah, MD, Hani Al Hashmi, MD, Salem Ghandourah, PhD |
2020-05-08 |
| Convalescent Plasma Collection and Treatment in Pediatrics and Adults |
Coronavirus disease 19 infection, Dyspnea |
convalescent plasma alone |
|
Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
West Virginia University |
|
US |
2020-04-16 |
2021-03-30 |
2004965705, NCT04376034 |
Phase 3 Clinical |
Recruiting |
0 |
11 Months |
240 |
Brian Peppers, DO, PhD, Lisa Giblin Sutton, PharmD |
2020-05-07 |
| Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection |
Coronavirus disease 19 infection, Respiratory failure |
tocilizumab alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Memorial Sloan-Kettering Cancer Center |
|
US |
2020-05-01 |
2021-05-01 |
20-185, NCT04377659 |
Phase 2 Clinical |
Recruiting |
0 |
12 Months |
40 |
Ann Jubowski, MD, Boglarka Gyurkocza, MD |
2020-05-07 |
| COVID: Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals |
Coronavirus disease 19 infection |
|
|
Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Clinique Universitaires Saint-Luc, Universite Catholique de Louvain |
Society for Anesthesia and Resuscitation of Belgium |
Belgium |
2020-04-06 |
2020-09-30 |
COVID, COVID-ANESTHESIO, NCT04376398 |
Phase Not Applicable |
Recruiting |
1 |
5 Months |
200 |
Mona Momeni, MD, PhD, Vincent Bonhomme, MD, PhD |
2020-05-07 |
| COVID-BCG: Randomized, controlled trial evaluating the efficacy of vaccination with Bacillus Calmette and Guerin (BCG) in the Prevention of COVID-19 via the strengthening of innate immunity in Health Care Workers |
Coronavirus disease 19 infection |
VACCIN BCG AJVaccines alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Assistance Publique Hopitaux de Paris |
French Health Ministry |
France |
2020-04-28 |
|
2020-001678-31, APHP200462, COVID-BCG |
Phase 3 Clinical |
Recruiting |
1 |
|
1120 |
Assistance Publique Hopitaux de Paris |
2020-05-08 |
| HPI-COVID-19: Host-pathogen Interactions During SARS-CoV-2 Infection |
Coronavirus disease 19 infection, Viral pneumonia |
biological sampling alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Hospices Civils De Lyon |
|
France |
2020-05-31 |
2021-06-30 |
2020-A01102-37, 69HCL20-0342, HPI-COVID-19, NCT04376476 |
Phase Not Applicable |
Not yet recruiting |
1 |
13 Months |
450 |
Florent VALOUR, PhD, Tiphanie Ginhoux |
2020-05-08 |
| COVID-19 - Quality of Life After Infection |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Chinese University of Hong Kong |
|
Hong Kong |
2020-05-05 |
2022-04-30 |
NCT04377464, NTEC-2020-0227 |
Phase Not Applicable |
Not yet recruiting |
2 |
23 Months |
200 |
Colin Graham, MD, MPH, Joseph Walline, MD |
2020-05-08 |
| SLO-COVID-19: Slovenian National COVID-19 Prevalence Study |
Coronavirus disease 19 infection |
nasopharyngeal sampling alone |
|
|
University Of Ljubljana |
|
Slovenia |
2020-04-20 |
2020-12-31 |
NCT04376996, SLO-COVID-19, ULMF2020-COVID-19 |
Phase Not Applicable |
Recruiting |
1 |
8 Months |
3000 |
Mario Poljak, MD, PhD, Polona Maver Vodicar, MD, PhD |
2020-05-08 |
| Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19 |
Coronavirus disease 19 infection, Lung disease |
antihistamine therapy alone, standard of care alone, steroid therapy alone, Variable regimens including RBC transfusion , convalescent plasma , epinephrine , low-molecular-weight heparin , methyl prednisone , methylene blue |
Adrenergic receptor agonist |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Ain Shams University |
|
Egypt |
2020-05-05 |
2020-06-01 |
FMASU P22/2020, NCT04376788 |
Phase 2 Clinical |
Not yet recruiting |
1 |
|
15 |
Essam A Hassan, MD, Mohamed M Moussa, Mohamed M Moussa, MD |
2020-05-08 |
| THROMBCOVID2: Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy |
Coronavirus disease 19 infection, Thromboembolism, Viral pneumonia |
blood sampling alone, venous ultrasound alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Universitaire D Amiens |
|
France |
2020-05-04 |
2020-11-30 |
2020-A01084-35, NCT04377490, THROMBCOVID2 |
Phase Not Applicable |
Recruiting |
1 |
6 Months |
100 |
Claire Andrejak, Pr, Julien Maizel, Pr, Michel Slama, Pr, Philippe Lanoix, Pr, Simon Soudet, MD, Valery Salle, MD, Yoann Zerbib, MD |
2020-05-08 |
| COVID-19 infections in health care workers |
Coronavirus disease 19 infection |
|
|
|
Franciscus Gasthuis & Vlietland |
|
Netherlands |
2020-05-01 |
2020-12-31 |
NL8570, R20.030 |
Phase Not Applicable |
Not yet recruiting |
1 |
8 Months |
300 |
Hans Koeleman |
2020-05-08 |
| ReCOVER: Evaluation of a remote monitoring smartphone application and care model of COVID-19 patients in the community |
Coronavirus disease 19 infection |
TCC-COVID alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Health South Eastern Sydney Local Health District, University of New South Wales |
|
Australia |
2020-04-28 |
2021-04-30 |
ACTRN12620000524998, ReCOVER |
Phase Not Applicable |
Not yet recruiting |
4 |
12 Months |
2000 |
Dr Sze-Yuan Ooi |
2020-05-08 |
| A clinical study of CardiALLO cell therapy for the treatment of COVID-19 infection related Acute Respiratory Distress Syndrome |
Coronavirus disease 19 infection, Respiratory distress syndrome |
CardiALLO cell therapy alone |
|
|
BioCardia Inc |
|
|
|
|
|
Phase Not Applicable |
Planned |
0 |
|
|
|
2020-05-08 |
| A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients |
Coronavirus disease 19 infection |
ciclesonide (metered dose inhaler), Teijin/Covis/AstraZeneca alone |
Glucocorticoid receptor agonist |
Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Covis Pharma Sarl |
|
|
2020-05-26 |
2020-12-01 |
ALV-020-001, NCT04377711 |
Phase 3 Clinical |
Not yet recruiting |
0 |
6 Months |
400 |
|
2020-05-08 |
| COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety and Behavior |
Anxiety disorder, Coronavirus disease 19 infection, Psychiatric disorder |
health messaging alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Milton S. Hershey Medical Center |
Huck Institutes of the Life Sciences, The College of Healthcare Information Management Executives (CHIME), The Department of Family and Community Medicine, Penn State College of Medicine, The Social Science Research Institute, US |
US |
2020-04-09 |
2020-05-31 |
NCT04377581, STUDY00014798 |
Phase Not Applicable |
Recruiting |
0 |
1 Month |
25000 |
Erin McGinley, Erin McGinley, MD, JD, Robert P Lennon, MD, JD, Sherry Tate |
2020-05-07 |
| NCoS: Neonatal CoVID-19 Study to evaluate the population health impacts of COVID-19 in mothers and their newborn infants cared for in tertiary and non-tertiary hospitals in Australia |
Coronavirus disease 19 infection |
|
|
Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Hunter New England Health |
Sydney Childrens Hospital |
Australia |
2020-05-01 |
2022-11-30 |
ACTRN12620000527965, NCoS, U1111-1250-9525 |
Phase Not Applicable |
Not yet recruiting |
7 |
31 Months |
1000 |
Dr Javeed Travadi |
2020-05-08 |
| PET/CT Imaging in COVID-19 Patients |
Coronavirus disease 19 infection, Lung injury |
18F-alphavbeta6-BP alone, computed tomography (CT) alone, positron emission tomography (PET) alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of California Davis |
|
US |
2020-05-31 |
2022-05-31 |
1592298, NCT04376593 |
Phase 0 Clinical |
Recruiting |
0 |
24 Months |
10 |
Julie L. Sutcliffe |
2020-05-07 |
| COVIDECOLE: Incidence of COVID-19 in School Children |
Coronavirus disease 19 infection |
RT-PCR alone |
|
Healthy volunteers accepted, Preschool Children (2-5 yrs), Children (6-12 yrs) |
Fondation Lenval |
|
France |
2020-05-15 |
2020-09-30 |
20-HPNCL-02, COVIDECOLE, NCT04377737 |
Phase Not Applicable |
Not yet recruiting |
1 |
4 Months |
914 |
Anne-Laure HERISSE, Antoine TRAN, Antoine TRAN, MD, Diane DEMONCHY, Hervé HAAS, Hervé HAAS, MD, Lisa GIOVANNINI-CHAMI, Sarah MARCHAL |
2020-05-08 |
| CoV-ETH: Spread And Course Of COVID-19 Infections |
Coronavirus disease 19 infection |
serological testing alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
ETH Zurich |
|
Switzerland |
2020-04-27 |
2021-06-30 |
20-05, CoV-ETH, NCT04377724 |
Phase Not Applicable |
Recruiting |
1 |
14 Months |
3000 |
Christoph Kolling, MD, Goldhahn Jorg, Jörg Goldhahn, MD |
2020-05-08 |
| Hemoglobin Concentration on COVID-19 |
Coronavirus disease 19 infection, Viral pneumonia |
|
|
|
Nevsehir Public Hospital |
Konya Training And Research Hospital |
Turkey |
2020-05-10 |
2020-05-30 |
145/2020, NCT04377607 |
Phase Not Applicable |
Recruiting |
1 |
|
200 |
Ahmet Yasin, Mehmet Akif Yazar, Yasin Tire |
2020-05-07 |
| CONCOR-KIDS: Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children |
Coronavirus disease 19 infection |
COVID-19 convalescent plasma (C19-CP) alone, standard of care alone |
|
Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs) |
C17 Council, Hospital for Sick Children |
|
Canada |
2020-05-01 |
2022-05-01 |
1000070143, CONCOR-KIDS, NCT04377568 |
Phase 2 Clinical |
Not yet recruiting |
12 |
24 Months |
100 |
Anne Pham-Huy, Ari Joffe, Carol Portwine, Christoph Licht, Geoff Cuvelier Cuvelier, Julia Upton, Julia Upton, MD, MPH, Julie Autmizguine, Karina Top, Kathy Brodeur-Robb, Kirk Leifso, Kyla Hildebrand, Nancy Nashid, Peter Gill, MD, Rupeena Purewal, Sergio Fanella, Tammie Dewan |
2020-05-07 |
| Quality of Life and Patient-centered Outcomes After Hospitalization for COVID-19 |
Coronavirus disease 19 infection, Respiratory distress syndrome |
extracorporeal membrane oxygenation alone, high flow nasal cannula alone, mechanical ventilation alone, nasal catheter alone, noninvasive ventilation alone, oxygen alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Instituto de Educação e Pesquisa do Hospital Moinhos de Vento |
Beneficencia Portuguesa of Sao Paulo, Brazilian Clinical Research Institute, Brazilian Research In Intensive Care Network, Hospital Alemao Oswaldo Cruz, Hospital do Coracao, Sociedade Beneficente Israelita Brasileira Hospital Albert Einsten, Sociedade Beneficiente De Senhoras Hospital Sirio Libanes |
Brazil |
2020-06-15 |
2021-09-15 |
COALITION COVID-19: LONG-TERM, NCT04376658 |
Phase Not Applicable |
Not yet recruiting |
1 |
15 Months |
1000 |
Maicon Falavigna, MD, Regis G Rosa, MD |
2020-05-08 |
| Neuro-Covid: COVID-19 Prevalence and Cognitive Deficits in Neurological Patients |
Cognitive disorder, Coronavirus disease 19 infection, Epilepsy, Neurological disease, Seizure disorder, Stroke |
COVID-19 PCR swab test alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Aarhus University Hospital |
|
Denmark |
2020-05-07 |
2022-06-30 |
NCT04377425, NEURO-COVID-19, Neuro-Covid |
Phase Not Applicable |
Not yet recruiting |
4 |
25 Months |
100 |
Boris Modrau, Boris Modrau, MD, Grethe Andersen, MD, Grethe Andersen, MD, DMSc, Lene Rosendahl, MD, Morten Stilund, MD, PhD, Rolf Blauenfeldt, MD |
2020-05-07 |
| Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients |
Coronavirus disease 19 infection, Kidney transplantation, Pancreas transplantation, Transplantation |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
IRCCS San Raffaele |
|
Italy |
2020-05-04 |
2020-05-18 |
COVID-19 MITRA, NCT04377776 |
Phase Not Applicable |
Recruiting |
1 |
|
700 |
Antonio Secchi, Federica Pazzi, Paola Maffi, Rossana Caldara |
2020-05-07 |
| Effect of Quercetin on Prophylaxis and Treatment of COVID-19 |
Coronavirus disease 19 infection |
Quercetin alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Istanbul Bakirkoy Maternity and Children Diseases Hospital |
|
Turkey |
2020-03-20 |
2020-08-31 |
KSSEAH--0058, NCT04377789 |
Phase Not Applicable |
Recruiting |
2 |
5 Months |
50 |
Hasan Onal, Professor, Seda Y Semerci |
2020-05-08 |
| SEROCOV: Development and Evaluation of Serological Assays for COVID-19 |
Coronavirus disease 19 infection |
serological assay alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Assistance Publique Hopitaux de Paris |
|
France |
2020-05-31 |
2020-10-31 |
20MWI-SEROCOV, NCT04377763, SEROCOV |
Phase Not Applicable |
Not yet recruiting |
1 |
5 Months |
500 |
Marie-Anne RAMEIX-WELTI, MD, PhD |
2020-05-07 |
| COLOR-19: COVID-19 Pneumonitis Low Dose Lung Radiotherapy |
Coronavirus disease 19 infection, Viral pneumonia |
Single fraction whole lung radiotherapy (0.7 Gy) alone |
|
Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia |
|
Italy |
2020-05-10 |
2022-07-23 |
COLOR-19, NCT04377477, NP 4097 |
Phase Not Applicable |
Recruiting |
1 |
26 Months |
30 |
Davide Tomasini, MD, Stefano M Magrini, Prof |
2020-05-07 |
| COWAIT: Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation |
Coronavirus disease 19 infection, Heart transplantation, Kidney transplantation, Liver transplantation, Lung transplantation, Pancreas transplantation |
patient-completed survey alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital, Bordeaux |
Societe Francophone de Transplantation |
France |
2020-05-15 |
2020-12-15 |
CHUBX 2020/19, COWAIT, NCT04376775 |
Phase Not Applicable |
Not yet recruiting |
1 |
7 Months |
2000 |
Lionel COUZI, Pr |
2020-05-07 |
| A clinical study of JS-016 in treatment of patients with COVID-19 |
Coronavirus disease 19 infection |
JS-016 alone |
COVID19 Spike glycoprotein inhibitor |
|
Eli Lilly & Co, Shanghai Junshi Biosciences Co Ltd |
|
US |
2020-12-31 |
|
|
Phase Not Applicable |
Planned |
0 |
|
|
|
2020-05-08 |
| Surgical Telemedicine in the COVID-19 Pandemic Era |
Coronavirus disease 19 infection |
telemedicine program alone |
|
Healthy volunteers accepted, Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs) |
University of Colorado, Denver, US |
|
US |
2020-06-01 |
2020-12-31 |
20-1177, NCT04376710 |
Phase Not Applicable |
Not yet recruiting |
0 |
7 Months |
100 |
|
2020-05-07 |
| A study to evaluate REGN-COV2 for the prevention and treatment of SARS-CoV-2 |
Coronavirus disease 19 infection |
REGN-COV2 alone |
|
|
Regeneron Pharmaceuticals Inc |
|
|
2020-06-30 |
|
|
Phase Not Applicable |
Planned |
0 |
|
|
|
2020-05-07 |
| Correlation Between Oxidative Stress Status and COVID-19 Severity |
Coronavirus disease 19 infection, Hypoxia |
ELISA alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Shaheed Beheshti Medical University |
|
Iran |
2020-04-20 |
2020-07-01 |
NCT04375137, SBMU.12543 |
Phase Not Applicable |
Recruiting |
1 |
2 Months |
90 |
Dalili, Nooshin Dalili, Nooshin Dalili, Dr, nooshin dalili |
2020-05-08 |
| TRIIM-X: Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial |
Aging, Cancer, Cardiovascular disease, Coronavirus disease 19 infection, Dementia, Diabetes mellitus, Infectious disease, Influenza virus infection |
Variable regimens including DHEA , metformin hydrochloride , somatropin |
AMP activated protein kinase stimulator |
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Intervene Immune Inc |
|
US |
2020-10-31 |
2022-10-31 |
NCT04375657, TRIIM-X, TRIIM-X |
Phase 2 Clinical |
Recruiting |
0 |
24 Months |
85 |
Gregory M Fahy, PhD, Robert Brooke |
2020-05-08 |
| Community Pharmacists Behavior During Covid-19 |
Coronavirus disease 19 infection |
face to face interview alone, semi-structured telephone interview alone |
|
|
Damanhour University |
|
Egypt |
2020-05-02 |
2021-04-30 |
NCT04374513, PHARMACISTS AND COVID-19 |
Phase Not Applicable |
Recruiting |
2 |
11 Months |
50 |
Amira Kassem, PhD, Amira Kassem, phD, Asser Ghoneim, phD, Noha El Bassiouny, PhD |
2020-05-07 |
| The effect of addition of selenium to treatment regimen of hospitalized patients with corona on the outcome of disease compared with control group |
Coronavirus disease 19 infection |
antibiotic therapy alone, antiretroviral therapy alone, selenium alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Sabzevar University of Medical Sciences |
|
Iran |
2020-05-20 |
|
IR.MEDSAB.REC.1399.017, IRCT20160706028815N5 |
Phase 2 Clinical |
Not yet recruiting |
1 |
|
40 |
Afsaneh Kaffash, Fereshteh Ghorat |
2020-05-07 |
| I-SPY COVID: A clinical trial to rapidly identify therapies to treat acute respiratory distress syndrome (ARDS) in critically ill COVID-19 patients |
Coronavirus disease 19 infection, Respiratory distress syndrome |
standard-of-care alone |
|
|
QuantumLeap Healthcare, University of California San Francisco |
|
US |
|
|
I-SPY COVID |
Phase Not Applicable |
Status not specified |
0 |
|
|
Laura Esserman |
2020-05-07 |
| Less Frequency Hemodialysis and COVID-19 |
Coronavirus disease 19 infection, Kidney dialysis |
less-frequency hemodialysis alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Dialisis Madariaga |
|
Argentina |
2020-03-20 |
2021-03-31 |
CORONAVIRUS, NCT04374058 |
Phase Not Applicable |
No longer recruiting |
1 |
12 Months |
50 |
Esteban L Siga, MD |
2020-05-07 |
| A first in human clinical trial of DPX-COVID-19 for the potential prevention of COVID-19 |
Coronavirus disease 19 infection |
DPX-COVID-19 alone |
|
|
McGill University Health Center |
Fonds de solidarité FTQ |
|
2020-07-31 |
|
|
Phase Not Applicable |
Planned |
0 |
|
|
|
2020-05-06 |
| Early Short Course Corticosteroids in COVID-19 |
Coronavirus disease 19 infection, Viral pneumonia |
antibiotic therapy alone, antiviral therapy alone, high-flow nasal cannula therapy alone, mechanical ventilation therapy alone, renal-replacement therapy alone, standard care alone, supportive care alone, Variable regimens including hydroxychloroquine , lopinavir , methylprednisolone , remdesivir , ritonavir |
Coronavirus non structural protein 8 modulator, RNA polymerase modulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Henry Ford Health System |
|
US |
2020-03-12 |
2020-04-30 |
HFH IRB # 13739, NCT04374071 |
Phase Not Applicable |
Completed |
0 |
1 Month |
250 |
Dr. Mayur S. Ramesh |
2020-05-08 |
| Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak |
Anxiety disorder, Coronavirus disease 19 infection, Depression, Injury, Post traumatic stress disorder |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Oslo |
Modum Bad |
Norway |
2020-03-31 |
2020-04-07 |
NCT04374097, REK125510(2) |
Phase Not Applicable |
Completed |
1 |
|
1778 |
Asle Hoffart, PhD, Omid Ebrahimi, Sverre Urnes Johnson, PhD |
2020-05-07 |
| PROVID: PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study) |
Coronavirus disease 19 infection |
Prone positioning alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Assistance Publique Hopitaux de Paris |
|
France |
2020-04-30 |
2020-07-31 |
APHP200504, NCT04366856, PROVID |
Phase Not Applicable |
Not yet recruiting |
1 |
3 Months |
500 |
Anatole HARROIS, Anatole HARROIS, MD, Anatole HARROIS, MD, PhD |
2020-05-07 |
| Clinical trial of anti-SARS-CoV-2 antibodies (COVID-19), Formycon for the treatment of Covid-19 |
Coronavirus disease 19 infection |
anti-SARS-CoV-2 antibodies (COVID-19), Formycon alone |
|
|
Formycon AG |
|
|
2021-09-30 |
|
|
Phase Not Applicable |
Planned |
0 |
|
|
|
2020-05-08 |
| Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection |
Anxiety disorder, Coronavirus disease 19 infection, Depression, Dyspnea, Fatigue, Myalgia |
Pulmonary Rehabilitation alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Istanbul Bilgi University |
|
Turkey |
2020-03-11 |
2020-04-26 |
NCT04365738, PR COVID-19 |
Phase Not Applicable |
Completed |
1 |
1 Month |
270 |
Tomri̇s Duymaz |
2020-05-07 |
| Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2 (Bacterial ACE2) |
Coronavirus disease 19 infection, Lung injury |
recombinant bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) alone, standard of care alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Kafrelsheikh University |
|
Egypt |
2020-08-31 |
2020-10-31 |
NCT04375046, PROPOSED BY MAHMOUD KAZAZZAZ |
Phase 1 Clinical |
Not yet recruiting |
1 |
2 Months |
24 |
M.Sc. Mahmoud Elkazzaz, M.Sc.Biochemistry, M.Sc.Mahmoud Elkazzaz, M.Sc.Biochemistry, Mahmoud Ramadan mohamed Elkazzaz |
2020-05-07 |
| An expanded access for compassionate use program to assess stem cells in the treatment of patients with COVID-19 infection |
Coronavirus disease 19 infection |
stem cells alone |
|
|
GIOSTAR |
|
US |
|
|
|
Phase Not Applicable |
Not yet recruiting |
0 |
|
|
Dr. Prabhat Soni |
2020-05-06 |
| Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment |
Cardiac arrest, Coronavirus disease 19 infection |
Vie Scope laryngoscopy alone, endotracheal intubation alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Lazarski University |
Medical University of Bialystok, Poznan University of Medical Sciences, Wroclaw Medical University |
Poland |
2020-03-20 |
2020-05-20 |
INT_EMS_PPE_1, NCT04365608 |
Phase Not Applicable |
Recruiting |
2 |
2 Months |
90 |
Lukasz Szarpak, PhD, Marek Dabrowski, PhD |
2020-05-06 |
| MYOCOVID: Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID-19) Cases |
Coronavirus disease 19 infection, Myocarditis |
CT scan alone, bacteriological test alone, immunological test alone, myocardial MRI alone, myocardial biopsy alone, parasitic tests alone, polymerase chain reaction alone, routine care alone, transthoracic echocardiography alone, viral test alone |
|
|
Centre Hospitalier Universitaire de Toulouse |
|
France |
2020-04-15 |
2021-10-15 |
MYOCOVID, NCT04375748, RC31/20/0139 |
Phase Not Applicable |
Recruiting |
1 |
18 Months |
400 |
Audrey TOMASIK, Clément Delmas |
2020-05-06 |
| RECOVER: Trial to Promote Recovery From COVID-19 With Ivermectin or Endocrine Therapy |
Coronavirus disease 19 infection |
bicalutamide alone, standard of care alone |
Androgen receptor antagonist |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Sidney Kimmel Comprehensive Cancer Center |
|
US |
2020-06-30 |
2021-06-30 |
COV2003, IRB00249425, NCT04374279, RECOVER |
Phase 2 Clinical |
Not yet recruiting |
0 |
12 Months |
60 |
Aliya Lalji, MD, Catherine H Marshall, MD/MPH, Jeffrey Rothstein, MD/PhD, Lindsey Hayes, MD/PhD, Samuel Denmeade, MD, Shawn Kwatra, MD, Vasan Yegnasubramanian, MD/PhD |
2020-05-06 |
| Early warning model and new biomarker of severe novel coronavirus pneumonia (COVID-19) |
Coronavirus disease 19 infection, Viral pneumonia |
|
|
|
Anhui Provincial Hospital |
|
China |
2020-01-10 |
2020-05-30 |
ChiCTR2000032460 |
Phase 0 Clinical |
No longer recruiting |
1 |
4 Months |
350 |
Meiqiao Chen, Wenting Li |
2020-05-08 |
| COVID19-FOIE National Observatory |
Brain disease, Coronavirus disease 19 infection, Diabetes mellitus, Hepatitis B virus infection, Hepatitis C virus infection, Hepatocellular carcinoma, Hypertension, Liver cirrhosis, Liver disease, Metabolic syndrome X, Obesity, Renal disease |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Assistance Publique Hopitaux de Paris |
Association Française pour l’Etude du Foie (AFEF), Societe Nationale Francaise de Gastroenterologie |
France |
2020-05-05 |
2020-12-31 |
IRB00006477, NCT04375670 |
Phase Not Applicable |
Not yet recruiting |
1 |
7 Months |
1000 |
Nathalie Ganne-Carrié, MD-PhD |
2020-05-08 |
| Evaluation effect of indomethacin for Covid19 infection |
Coronavirus disease 19 infection, Viral pneumonia |
indomethacin (Aria Pharmaceutical Company) alone, usual treatment alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Isfahan University of medical Sciences |
|
Iran |
2020-05-08 |
|
IR.MUI.MED.REC.1399.045, IRCT20200427047215N1 |
Phase 2/Phase 3 Clinical |
Not yet recruiting |
1 |
|
60 |
Ali Darakhshandeh |
2020-05-08 |
| Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic |
Acute stress disorder, Anxiety disorder, Coronavirus disease 19 infection, Sleep disorder |
Calm Meditation App alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Arizona |
|
US |
2020-05-01 |
2020-10-01 |
NCT04374786, TO BE DETERMINED |
Phase Not Applicable |
Not yet recruiting |
0 |
5 Months |
328 |
Kelley Saunders, Kelley T Saunders, MD, Mike Foley, MD, Rachael Smith, DO |
2020-05-07 |
| COR-CARDIO: Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19 |
Cardiovascular disease, Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Instytut Kardiologii Im Prymasa Tysiaclecia |
|
Poland |
2020-05-05 |
2021-08-24 |
1860/2020, COR-CARDIO, NCT04374110 |
Phase Not Applicable |
Recruiting |
2 |
15 Months |
1000 |
Alekander Prejbisz, Aleksander Prejbisz, MD, PhD, Andrzej Januszewicz, MD, PhD, Piotr Dobrowolski, Piotr Dobrowolski, MD, PhD, Rafal Dabrowski, MD, PhD, Tomasz Hryniewiecki, MD, PhD |
2020-05-07 |
| Treatment of Angiotensin Peptide (1-7) for COVID-19 |
Coronavirus disease 19 infection |
angiotensin peptide (1-7) derived plasma alone, routine treatment alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Istanbul Bakirkoy Maternity and Children Diseases Hospital |
|
Turkey |
2020-04-25 |
2020-09-30 |
KSSEAH--0059, NCT04375124 |
Phase 2 Clinical |
Not yet recruiting |
1 |
5 Months |
20 |
Hasan Onal, Seda Y Semerci |
2020-05-07 |
| Investigating the efficacy of high dose of glucocorticoid in patients with moderate to severe pneumonia related to COVID-19 |
Coronavirus disease 19 infection, Viral pneumonia |
national guideline based routine treatment alone, methylprednisolone plus prednisolone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Bagheiat-allah University of Medical Sciences |
|
Iran |
2020-04-20 |
|
IR.BMSU.REC.1399.099, IRCT20080901001165N52 |
Phase 3 Clinical |
Recruiting |
1 |
|
50 |
Ahmad Zarei, Behzad Einollahi, Gholamhosein Alishiri, Parisa Kianpour, Yunes Panahi |
2020-05-08 |
| Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS |
Coronavirus disease 19 infection |
Therapeutic Plasma Exchange alone, ruxolitinib alone |
|
Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Prisma Health-Upstate |
|
US |
2020-04-30 |
2021-04-30 |
NCT04374149, PHU COVID-19-001 |
Phase 2 Clinical |
Not yet recruiting |
0 |
12 Months |
20 |
Jan Kueber, RN, Julie Martin, DNP, W. Larry Gluck, MD |
2020-05-08 |
| Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19) |
Coronavirus disease 19 infection, Dysomia, Viral respiratory tract infection |
Nasal irrigation alone, NeilMed Sinus Rinse alone, NeilMed Sinus Rinse bottle alone, Olfactory retraining alone, budesonide plus budesonide (inhaled formulations), AstraZeneca |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Lawson Health Research Institute |
|
Canada |
2020-06-30 |
2021-12-31 |
ANOSMIA_COVID 19, NCT04374474 |
Phase 4 Clinical |
Not yet recruiting |
2 |
18 Months |
75 |
Brian Rotenberg, MD, Janet Knechtel, Khrystyna Ioanidi, MD, Leigh J Sowerby, Leigh J Sowerby, MD, Leigh Sowerby, MD, FRCSC, Sherry Paiva |
2020-05-07 |
| COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit |
Coronavirus disease 19 infection |
endoscopic examination alone, nucleic acid PCR testing alone, serological screening alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
INSTITUTO ECUATORIANO DE ENFERMEDADES DIGESTIVAS GASTROCLINICA S.A |
|
Ecuador |
2020-04-20 |
2020-06-01 |
IECED-04-15-COVID, NCT04374123 |
Phase Not Applicable |
Recruiting |
1 |
1 Month |
80 |
Carlos A Robles-Medranda, MD, Roberto A Oleas, MD |
2020-05-07 |
| HEROS: COVID-19: Human Epidemiology and Response to SARS-CoV-2 |
Asthma, Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs) |
National Institute of Allergy and Infectious Diseases |
Rho Inc |
US |
2020-05-01 |
2020-12-31 |
DAIT-COVID-19-001, HEROS, NCT04375761 |
Phase Not Applicable |
Recruiting |
0 |
8 Months |
8000 |
Alexandra Connolly, Amanda Cyrus, Andrew Liu, MD, Asel Baatyrbek, Christine C. Johnson, PhD, Christine M. Seroogy, MD, Daniel J. Jackson, MD, Dolores Santoyo, Edward Zoratti, MD, Elizabeth Tesson, George T. O'Connor, MD, MS, Gurjit K. Khurana Hershey, MD, PhD, Jen Smith, Kyle Koshalek, Kyra Jones, Leonard B. Bacharier, MD, Nicole Gonzalez, Pamela Groh, Pascuala Pinedo-Estrada, Rebecca Gruchalla, MD, Sherae Hereford, Stephen Teach, MD, Tiffany Ogundipe, Tina V. Hartert, MD, MPH, Zachary Flege |
2020-05-07 |
| COLVID-19: Colchicine in COVID-19: a Pilot Study |
Coronavirus disease 19 infection, Viral pneumonia |
colchicine alone, current care alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universita Degli Studi Di Perugia |
|
Italy |
2020-04-18 |
2020-10-31 |
2020-001475-33, COLVID-19, NCT04375202 |
Phase 2 Clinical |
Recruiting |
2 |
6 Months |
308 |
Carlo Scirè, Claudia Diana, Prof Roberto Gerli |
2020-05-07 |
| Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection |
Coronavirus disease 19 infection, Viral pneumonia |
metenkefalin acetate + tridecactide acetate (injectable, multiple sclerosis), Farmacija alone, standard of care treatment alone |
ACTH receptor agonist, Adrenocorticotrophic hormone ligand, Opioid growth factor receptor agonist |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Bosnalijek Pharmaceutical & Chemical Industry Joint Stock Co |
|
Bosnia and Herzegovina |
2020-05-01 |
2020-10-31 |
EN-COVCS-01, NCT04374032 |
Phase 2/Phase 3 Clinical |
Recruiting |
1 |
6 Months |
120 |
Jasna Dzananovic, MPharm, Rusmir Baljic, doc.dr.med |
2020-05-08 |
| COVHYP: Renin-Angiotensin-Aldosterone System Inhibitors, Hypertension, and COVID-19 |
Cancer, Chill, Congestive heart failure, Coronavirus disease 19 infection, Cough, Diabetes mellitus, Dyspnea, Heart disease, Hypertension, Lung malformation, Myalgia, Viral pneumonia |
chest CT-Scan alone, chest X-ray alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Versailles University Hospital |
|
France |
2020-05-01 |
2020-07-01 |
COVHYP, NCT04374695, P20/11_COVHYP |
Phase Not Applicable |
Not yet recruiting |
1 |
2 Months |
700 |
Alisson BERTRAND, Alix PREVOT, Bernard LIVAREK, MD, Cécile LAUREANA, Floriane GILLES, MD, Guillaume ROGER, Jean-Baptiste AZOWA, Jean-François PROST, Jean-Louis GEORGES, MD, MPH, Jean-Paul BERESSI, MD, Joseph SABA, Joséphine SOLTANI, Maeva PASQUALINI, Marie DE TOURNEMIRE, Mehrsa KOUKABI FRADELIZZI, MD, Victorien MONGUILLON |
2020-05-07 |
| A Phase II, Open-Label, Randomized, Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications |
Coronavirus disease 19 infection, Respiratory distress syndrome, Sepsis |
convalescent plasma alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Max Healthcare Institute Ltd, India |
|
India |
2020-05-09 |
2021-05-09 |
CTRI/2020/04/024915, MHC-COVID-19-CP, MHC-COVID-19-CP, Version 2.0, NCT04374487 |
Phase 2 Clinical |
Not yet recruiting |
1 |
12 Months |
100 |
Deven Juneja, DNB, Rahul Naithani, MD, DM, Rajesh Saxena, Rajesh Saxena, MBA, Sandeep Budhiraja, MRCP,FACP, Sangeeta Pathak, MBBS,Diploma |
2020-05-07 |
| Stem cell therapy in COVID-19 |
Coronavirus disease 19 infection, Respiratory distress syndrome, Respiratory tract infection, Viral pneumonia |
adipose and placenta-derived mesenchymal stem cell alone, common treatment alone |
|
|
Kermanshah University of Medical Sciences |
|
Iran |
2020-05-09 |
|
IR.KUMS.REC.1399.065, IRCT20200418047121N2 |
Phase 1/Phase 2 Clinical |
Not yet recruiting |
1 |
|
6 |
Farid Najafi, Kamran Mansouri |
2020-05-07 |
| Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic |
Conjunctivitis, Coronavirus disease 19 infection, Keratoconjunctivitis, Ocular disease |
conjunctival swab sampling alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Johns Hopkins University |
|
US |
2020-05-31 |
2021-04-30 |
IRB00249598, NCT04374656 |
Phase Not Applicable |
Not yet recruiting |
0 |
11 Months |
50 |
Sezen Karakus, MD |
2020-05-08 |
| Monocytes and NK Cells Activity in Covid-19 Patients |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Università degli Studi dell'Insubria |
|
Italy |
2020-04-27 |
2020-10-31 |
67/2020, NCT04375176 |
Phase Not Applicable |
Recruiting |
1 |
6 Months |
150 |
Andrea Vigezzi, MD, Andreina Baj, MD, Angelo Genoni, Dr, Annarosaria De Vito, PhD, Caterina Franchi, MD, Daniela Dalla Gasperina, Professor, Denisa Baci, PhD, Domenico Iovino, M.D., Domenico Iovino, MD, Elisa Monti, MD, Federica Masci, MD, Francesco Acquati, Professor, Giulio Carcano, Professor, Giuseppe Ietto, M.D., Giuseppe Ietto, MD, Lorenzo Mortara, Professor, Matteo Gallazzi, PhD, Valentina Iori, MD, Walter Ageno, Professor |
2020-05-07 |
| A Study of N-acetylcysteine in Patients With COVID-19 Infection |
Coronavirus disease 19 infection |
N-acetylcysteine alone, supportive care alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Memorial Sloan-Kettering Cancer Center |
|
US |
2020-05-01 |
2021-05-31 |
20-168, NCT04374461 |
Phase 2 Clinical |
Recruiting |
0 |
13 Months |
86 |
Jedd Wolchok, MD, PhD, Santosha Vardhana, MD, PhD |
2020-05-08 |
| Inhalable Sodium Bicarbonate: a Possible Adjuvant Treatment of Patients With Novel COVID-19 |
Coronavirus disease 19 infection, Viral pneumonia |
nebulizer alone, oseltamivir plus sodium bicarbonate |
Exo-alpha sialidase inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Mansoura University |
|
Egypt |
2020-04-01 |
2020-06-01 |
NCT04374591, SODIUM BICARBONATE COVID-19 |
Phase 0 Clinical |
No longer recruiting |
1 |
2 Months |
20 |
Mohammed K Elbadrawy, PhD |
2020-05-07 |
| COVHECBEHO: COVID-19 Among Healthcare Workers in Belgian Hospitals |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Sciensano |
Instituut Voor Tropische Geneeskunde |
Belgium |
2020-04-22 |
2020-09-27 |
COVHECBEHO, NCT04373889, SCIENSANO |
Phase Not Applicable |
Recruiting |
3 |
5 Months |
800 |
Els Duysburgh, MD, MPH, PhD, Laure Mortgat, MD, MPH, Wesley Van Dessel |
2020-05-07 |
| Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19) |
Coronavirus disease 19 infection |
education sessions alone, physical exercise alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Kantonsspital Winterthur KSW |
|
Switzerland |
2020-03-15 |
2021-08-31 |
2020_00899 / COV19_2020, NCT04375709 |
Phase Not Applicable |
Recruiting |
1 |
17 Months |
60 |
Cornel Sieber, Prof. MD, David Gisi, Giuseppe Mungo, MSc, Ines Unger, MSc Cand., Karrer Urs, PD MD, Markus Hofer, MD, Martina Betschart, PhD, Natalie Ott, MSc Cand., Spencer Rezek, MSc Cand., Swantje Beyer, MD |
2020-05-06 |
| LIFESAVER: Early transfusion of Convalescent Plasma in Elderly COVID-19 Patients to Prevent Disease Progression |
Coronavirus disease 19 infection |
COVID-19 Convalescent Plasma alone, standard therapy alone |
|
Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Policlinico Universitario Agostino Gemelli |
|
Italy |
2020-05-15 |
2021-06-30 |
3205, LIFESAVER, NCT04374526 |
Phase 2/Phase 3 Clinical |
Not yet recruiting |
3 |
13 Months |
182 |
Andrea Antinori, Prof., Antonella Cingolani, Jacopo Vecchiet, Prof., Luciana Teofili, Luciana Teofili, Prof., Maurizio Sanguinetti, Raffaele Landolfi, Prof. |
2020-05-06 |
| VADER: Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE) |
Coronavirus disease 19 infection |
FFP2 alone, Face Fit test alone, Facial mask alone, PortaCount PRO+ 8038 alone, modified full-face snorkelling mask alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Clinique Universitaires Saint-Luc |
|
Belgium |
2020-05-31 |
2020-05-31 |
2020/15AVR/226, NCT04375774, VADER |
Phase Not Applicable |
Recruiting |
1 |
|
10 |
Guillaume Lemaire, MD, Marco Pettinger, MD |
2020-05-08 |
| LESSCOVID: London's Exogenous Surfactant Study for COVID19 |
Coronavirus disease 19 infection |
Bovine Lipid Extract Surfactant alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Lawson Health Research Institute |
London Health Sciences Centre Research Inc |
Canada |
2020-05-01 |
2021-07-01 |
9890, LESSCOVID, NCT04375735 |
Phase 1/Phase 2 Clinical |
Not yet recruiting |
1 |
14 Months |
20 |
Gordon Barkwell, MSc, Jim Lewis, MD, Tracey Bentall |
2020-05-07 |
| Effect of COVID-19 Pandemic on Pediatric Cancer Care |
Cancer, Coronavirus disease 19 infection |
|
|
|
south egypt cancer institute |
|
Egypt, Saudi Arabia, United Arab Emirates |
2020-05-15 |
2021-05-15 |
COVID-19 AND PEDIATRIC CANCER, NCT04374838 |
Phase Not Applicable |
Not yet recruiting |
3 |
12 Months |
20 |
Mahmoud Motaz Elzembely |
2020-05-07 |
| COVID19-HOPE: Hydroxychloroquine in Combination With Azithromycin or Sirolimus for Treating COVID-19 Patients |
Coronavirus disease 19 infection |
Variable regimens including azithromycin , hydroxychloroquine , sirolimus |
mTOR inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
King Hussein Cancer Center |
|
Jordan |
2020-05-01 |
2020-09-01 |
20 KHCC 74, COVID19-HOPE, NCT04374903 |
Phase 2 Clinical |
Not yet recruiting |
1 |
4 Months |
58 |
Abdelghani Tbakhi, PhD, Amal Al Omari, PhD, Anwar Alnassan, MD, Dalia Al Rimawi, MDS, Feras Hawari, MD, Hikmat Abdel-Razeq, MD, Iyad Ammouri, MD, Iyad Sultan, MD, Mayada Abu Shanap, MD, Mohammed Abufaraj, Prof., Nedal Al-Rawashdeh, MPH, Osama Abu Ata, MD, Rana Damsees, MPH, Rula Najjar, Pharm. D |
2020-05-06 |
| Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19 |
Coronavirus disease 19 infection, Deep vein thrombosis, Lung embolism, Viral pneumonia |
blood test alone, computed tomography angiography alone, duplex ultrasound alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hospital Vall D'Hebron |
|
Spain |
2020-04-01 |
2020-05-01 |
NCT04374617, PR(AG)213/2020 |
Phase Not Applicable |
Completed |
2 |
1 Month |
230 |
Sergi Bellmunt, MD,PhD |
2020-05-07 |
| Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With CoronaVirus Induced Disease 2019 (COVID-19) and Pulmonary Distress |
Coronavirus disease 19 infection, Respiratory failure |
ibrutinib alone, standard care alone |
Btk tyrosine kinase inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
AbbVie Inc |
Janssen Research & Development LLC |
US |
2020-05-06 |
2020-08-27 |
M20-310, NCT04375397 |
Phase 2 Clinical |
Recruiting |
0 |
3 Months |
46 |
ABBVIE CALL CENTER, AbbVie Inc. |
2020-05-08 |
| ACT: Asymptomatic COVID-19 Trial |
Coronavirus disease 19 infection |
Hydroxychloroquine sulfate alone, Hydroxychloroquine sulfate plus azithromycin |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Rutgers University |
|
US |
2020-05-05 |
2021-04-30 |
ACT, NCT04374552, PRO2020000872 |
Phase 2 Clinical |
Not yet recruiting |
0 |
11 Months |
140 |
Helaine Noveck, MPH, Jeffrey L Carson, MD |
2020-05-08 |
| Novel Agents for Treatment of High-risk COVID-19 Positive Patients |
Coronavirus disease 19 infection, Viral pneumonia |
camostat mesylate alone, hydroxychloroquine sulfate alone, Variable regimens including azithromycin , hydroxychloroquine sulfate , ivermectin |
Chloride channel modulator, Serine protease inhibitor, Trypsin inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Kentucky |
|
US |
2020-05-01 |
2021-05-31 |
MCC-20-COVID-01-PMC, NCT04374019 |
Phase 2 Clinical |
Recruiting |
0 |
13 Months |
240 |
Susanne Arnold, M.D., Susanne Arnold, MD |
2020-05-08 |
| Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia |
Coronavirus disease 19 infection, Viral pneumonia |
High-Titer Anti-SARS-CoV-2 (COVID 19) Convalescent Plasma alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Virginia |
|
US |
2020-05-05 |
2021-04-05 |
200114, NCT04374565 |
Phase 2 Clinical |
Not yet recruiting |
0 |
11 Months |
29 |
Alex Kadl, MD, Amy Mathers, MD, Archana Thakur, PhD, Chelsea Sheppard, MD, James Gorham, MD, Jeffrey M. Sturek, MD, PhD, Jeffrey Sturek, Karen Ballen, MD, Kristen M Petros De Guex, MA, Lawrence G. Lum, MD, DSc, Melinda Poulter, PhD, Patrick Jackson, MD, Qin Liu, MD, PhD, Scott Heysell, MD, Taison Bell, MD, Tania Thomas, MD, MPH, William B Harrington, MPH |
2020-05-07 |
| COVIDANS Study: Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) |
Autonomic nervous system disease, Coronavirus disease 19 infection |
ECG-Holter alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Universitaire de Saint Etienne |
|
France |
2020-04-30 |
2020-10-31 |
2020-A01082-37, 20CH095, COVIDANS Study, NCT04374045 |
Phase Not Applicable |
Recruiting |
1 |
6 Months |
25 |
Béatrice DEYGAS, CRA, David CHARIER, MD, Frédéric ROCHE, MD-PhD, Isabelle COURT-FORTUNE, MD, Jerome MOREL, MD-PhD, Serge MOLLIEX, MD-PhD |
2020-05-07 |
| SARSCoV2 (COVID-19) Convalescent Plasma (CP) Expanded Access Protocol (EAP) |
Coronavirus disease 19 infection |
betacoronavirus (SARSCoV2) convalescent plasma (CP) alone |
|
Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
AdventHealth |
|
US |
|
|
1596191, NCT04374370 |
Phase Not Applicable |
Recruiting |
0 |
|
|
Chris Ensor, PharmD, Eduardo Oliveira, MD |
2020-05-07 |
| Incidence and risk factors for acute kidney injury in COVID-19 |
Coronavirus disease 19 infection, Renal injury |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Klinikum der Albert-Ludwigs Universitaet Freiburg |
|
Germany |
2020-03-01 |
2020-04-30 |
276/20, DRKS00021658 |
Phase Not Applicable |
Completed |
1 |
2 Months |
100 |
Johanna Schneider |
2020-05-07 |
| Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection |
Coronavirus disease 19 infection, Respiratory failure |
Anti-SARS-COV-2 convalescent plasma alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Pontificia Universidad Catolica De Chile |
Arturo Lopez Perez Foundation |
Chile |
2020-05-04 |
2021-12-31 |
200415015, NCT04375098 |
Phase 2 Clinical |
Recruiting |
1 |
19 Months |
30 |
Maria Elvira Balcells, MD |
2020-05-07 |
| A trial to evaluate TerraCoV2 for the treatment and prevention of Coronavirus disease 19 infection |
Coronavirus disease 19 infection |
TerraCoV2 vaccine (COVID-19), Noachis Terra alone |
COVID19 Spike glycoprotein modulator |
|
Oragenics Inc |
Noachis Terra Inc |
|
|
|
|
Phase Not Applicable |
Planned |
0 |
|
|
|
2020-05-07 |
| CovOM: Investigating the microorganisms found in the mouths of SARS-Cov-2 positive patients |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Ferrara |
|
Italy |
2020-04-09 |
2020-10-01 |
COVOM, CovOM, ISRCTN87832712 |
Phase Not Applicable |
Not yet recruiting |
3 |
5 Months |
20 |
Prof Caselli |
2020-05-07 |
| Homoeopathy as adjuvant in management of coronavirus infection |
Coronavirus disease 19 infection |
homoeopathic medicines alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Bajaj Auto Ltd |
|
India |
2020-05-08 |
|
CTRI/2020/04/024925 |
Phase 2 Clinical |
Not yet recruiting |
1 |
|
100 |
Dr Abhay S Talwalkar, Dr Anil Khurana, Dr Ayushi Shrikhande, Dr Govindarajan Sankaran |
2020-05-07 |
| COVID Immunity: The COVID Immunity Study |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Translational Genomics Research Institute |
|
US |
|
|
COVID Immunity |
Phase Not Applicable |
Planned |
0 |
|
|
Dr. John Zaia |
2020-05-08 |
| A medical records based retrospective study: leukopenia is more common in asymptomatic patients less than 18 years old with novel coronavirus pneumonia (COVID-19) in convalescence |
Coronavirus disease 19 infection |
|
|
Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs) |
Guizhou Provincial Staff Hospital, The Science and Technology Department of Guizhou Province |
|
China |
2020-04-01 |
|
ChiCTR2000032458 |
Phase Not Applicable |
No longer recruiting |
1 |
|
25 |
Wei Zhang |
2020-05-07 |
| A Clinical Trial to Ascertain the Effect of Homoeopathic Medicines in Prevention of Outbreak of Symptoms in Asymptomatic Coronavirus and Suspected Coronavirus Patients |
Coronavirus disease 19 infection |
homoeopathic medicine alone |
|
Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Naiminath Homoeopathic Medical College, Hospital and Research Centre |
|
India |
2020-05-10 |
|
C-2020/05, CTRI/2020/04/024926 |
Phase 3 Clinical |
Not yet recruiting |
1 |
|
100 |
Dr Ritu Gupta |
2020-05-07 |
| Diagnostic value of chest CT in outpatient for novel coronavirus pneumonia (COVID-19) compared to RT-PCR |
Coronavirus disease 19 infection, Viral pneumonia |
RT-PCR alone, chest-CT alone |
|
|
The Fifth People's Hospital of Ganzhou |
|
China |
2020-01-01 |
2020-02-29 |
ChiCTR2000032574 |
Phase Not Applicable |
No longer recruiting |
1 |
2 Months |
248 |
Zhang Weiwei |
2020-05-07 |
| A randomized, double-blind, controlled trial for Bu-Fei-Huo-Xue Capsule in the treatment of novel coronavirus pneumonia (COVID-19) convalescence patient with ''Fei-Pi-Qi-Xu zhen'' |
Coronavirus disease 19 infection, Viral pneumonia |
Bufei Huoxue Capsule alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
State Key Laboratory Of Respiratory Diseases, The Fifth Affiliated Hospital of Guangzhou Medical University |
|
China |
2020-05-02 |
2021-05-01 |
ChiCTR2000032573 |
Phase 0 Clinical |
Not yet recruiting |
5 |
12 Months |
120 |
Jian Wang, Nanshan Zhong |
2020-05-07 |
| Placental Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection: A Phase I/II Clinical Trial |
Coronavirus disease 19 infection, Respiratory distress syndrome, Viral pneumonia |
placental mesenchymal stem cell therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
National Institute for Medical Research Developement, Oghaf Organization and charity, Opal Parsian Company |
|
Iran |
2020-03-20 |
|
IR.TUMS.VCR.REC.1399.009, IRCT20200413047063N1 |
Phase 1/Phase 2 Clinical |
Recruiting |
2 |
|
20 |
Masoud Soleimani, Mohamad Azimi, Mohammad Alian Nejad, Mohammad Mokhber, Mohammad Reza Hashemian, Mohammad Vasei, Reza Malekzadeh, Sayed Mahdi Khamooshi |
2020-05-07 |
| Ozone Autohemotherapy in COVID-19 |
Coronavirus disease 19 infection |
conventional therapy alone, major autohemotherapy alone, ozone alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Tabriz University of Medical Sciences |
|
Iran |
2020-04-25 |
|
IR.TBZMED.REC.1399.022, IRCT20190618043923N4 |
Phase 2/Phase 3 Clinical |
Recruiting |
1 |
|
20 |
Dawood Aghamohammadi, Mohammad Samiei |
2020-05-07 |
| PIONEER: A Randomized, Controlled Trial of Early Intervention in COVID-19: Favipiravir Versus Hydroxycholorquine and Azithromycin and Zinc versus Standard Care |
Coronavirus disease 19 infection, Influenza virus infection |
favipiravir alone, standard clinical care alone, Variable regimens including Plaquenil , azithromycin , zinc sulfate |
RNA polymerase inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Chelsea & Westminster NHS Trust |
FUJIFILM Toyama Chemical Co Ltd, Imperial College London, Neat Id Foundation, Universitaire Ziekenhuizen Leuven |
UK |
2020-05-01 |
2021-03-31 |
2020-001449-38, CW002, NCT04373733, PIONEER |
Phase 3 Clinical |
Not yet recruiting |
2 |
11 Months |
450 |
Bobby Mann, Pallav Shah, Research Delivery Operations Manager |
2020-05-07 |
| A Clinical Trial to study the effectiveness of Homoeopathy as an additional mode of treatment in combating Corona Virus infection |
Coronavirus disease 19 infection |
Homoeopathy (Arsenic Album, Bryonia Alba, Gelsemium, Antimonium Tartaricum, Crotalus Horridus) alone |
|
Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Central Council for Research in Homeopathy, Naiminath Homoeopathic Medical College, Hospital and Research Centre |
|
India |
2020-05-05 |
|
C-2020/01, CTRI/2020/04/024905 |
Phase 3 Clinical |
Not yet recruiting |
1 |
|
100 |
Dr Shaurabh Kumar |
2020-05-07 |
| PROTEGO: Prospective, Observational, Cohort Trial Evaluating Correlation of Clinical Findings, Symptoms And Disease Development Of German In- Or Outpatients Infected With SARS-CoV-2 - A CHIR-Net Student-Initiated German Medical Audit trial COVID-19 study (CHIR-Net SIGMA study group) |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital Heidelberg |
|
Germany |
2020-05-07 |
|
DRKS00021226, PROTEGO, S-215/2020, U1111-1250-1571 |
Phase Not Applicable |
Not yet recruiting |
2 |
|
500 |
André Mihaljevic |
2020-05-07 |
| The effect of Intravenous immunoglobulin on COVID-19 infection |
Coronavirus disease 19 infection |
Intratect alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Gonabad University of Medical Sciences |
|
Iran |
2020-03-10 |
|
IR.GMU.REC.1399.009, IRCT20200418047116N1 |
Phase 2 Clinical |
Recruiting |
1 |
|
20 |
Dr. Shahla Khosravan, Najme Davoodian, Negar Shafaei Bajestani |
2020-05-06 |
| ATTACC: Antithrombotic Therapy to Ameliorate Complications of COVID-19 |
Coronavirus disease 19 infection |
dalteparin sodium alone, enoxaparin sodium alone, tinzaparin sodium alone, unfractionated heparin alone |
Antithrombin III, Factor IIa antagonist, Factor Xa antagonist, Low molecular weight heparin |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Manitoba |
Hamilton Health Sciences Corp, Hopital Montfort, The University Health Network |
Canada |
2020-05-31 |
2021-01-31 |
ATTACC, ATTACC, NCT04372589, OZM-113 |
Phase 2 Clinical |
Not yet recruiting |
4 |
8 Months |
3000 |
Jean-Philippe Galanaud, MD, Marc Carrier, MD, Patrick Lawler, MD, Peter Gross, MD, Ryan Zarychanski, MD |
2020-05-06 |
| C-reactive Protein Levels Among Individuals With COVID-19 |
Coronavirus disease 19 infection |
C-reactive protein test alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Frederiksberg University Hospital |
|
Denmark |
2020-05-04 |
2020-11-30 |
APPI2-CV-2020-02, NCT04373798 |
Phase Not Applicable |
Not yet recruiting |
1 |
6 Months |
3000 |
Henning Bliddal, DMSc |
2020-05-06 |
| An international, investigator-initiated clinical trial to evaluate the efficacy of Lambda in the treatment of patients with COVID-19 infection |
Coronavirus disease 19 infection |
peginterferon lambda-1a, Eiger BioPharmaceuticals alone |
Interferon receptor modulator, Interleukin-29 ligand |
|
University of Toronto |
Eiger BioPharmaceuticals Inc |
Canada |
2020-04-30 |
|
|
Phase Not Applicable |
Recruiting |
1 |
|
|
|
2020-05-05 |
| An international, investigator-initiated clinical trial to evaluate the efficacy of Lambda in the treatment of patients with COVID-19 infection |
Coronavirus disease 19 infection |
peginterferon lambda-1a, Eiger BioPharmaceuticals alone |
Interferon receptor modulator, Interleukin-29 ligand |
|
Mount Sinai Hospital |
Eiger BioPharmaceuticals Inc |
US |
2020-04-30 |
|
|
Phase Not Applicable |
Recruiting |
0 |
|
|
|
2020-05-05 |
| COVID-APE: Incidence of Acute Pulmonary Embolism in COVID-19 Patients on CT Angiography and Relationship to D-dimer Levels |
Coronavirus disease 19 infection, Lung embolism |
chest CT angiography alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hopitaux Universitaires de Strasbourg |
|
France |
2020-03-03 |
2020-05-01 |
7840, COVID-APE, NCT04373486 |
Phase Not Applicable |
Recruiting |
1 |
1 Month |
160 |
Aissam LABANI, MD, Catherine ROY, MD, Coralie PAUZET, MD, Françis SCHNEIDER, MD, PhD, François SEVERAC, MD, Ian LEONARD-LORANT, MD, Julie HELMS, MD, PhD, Mickaël OHANA, MD, PhD, Olivier COLLANGE, MD, PhD, Pascal BILBAULT, MD, PhD, Pierre LEYENDECKER, MD, Saïd CHAYER, PhD, HDR, Sébastien MOLIERE, MD, Xavier DELABRANCHE, MD, PhD |
2020-05-06 |
| An international, investigator-initiated clinical trial to evaluate the efficacy of Lambda in the treatment of patients with COVID-19 infection |
Coronavirus disease 19 infection |
peginterferon lambda-1a, Eiger BioPharmaceuticals alone |
Interferon receptor modulator, Interleukin-29 ligand |
|
Soroka University Medical Center |
Eiger BioPharmaceuticals Inc |
Israel |
2020-04-30 |
|
|
Phase Not Applicable |
Recruiting |
1 |
|
|
|
2020-05-05 |
| COVID-SHIELD: COVID-19 prophylaxis with hydroxychloroquine in Front-line Health and Allied-Health Care Workers |
Coronavirus disease 19 infection |
hdroxychloroquine alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Walter and Eliza Hall Institute of Medical Research |
Australian Government |
Australia |
2020-04-28 |
|
ACTRN12620000501943p, COVID-SHIELD, U1111-1250-4307 |
Phase 2/Phase 3 Clinical |
Not yet recruiting |
15 |
|
2250 |
Arunee Wilson, Ms Liz Williams, Prof Marc Pellegrini |
2020-05-06 |
| VM Spacer plus MDI use in Outpatient ED - COVID-19 Pandemic |
Coronavirus disease 19 infection, Respiratory disorder |
Venturi Mask alone |
|
|
Hospital Kuala Lumpur |
|
Malaysia |
2020-05-01 |
2021-04-30 |
54673, NMRR-20-840-54673 |
Phase Not Applicable |
Not yet recruiting |
1 |
12 Months |
103 |
Dr. Jacelyn Ong Jia Whey, KOH HOCK PENG |
2020-05-06 |
| Health Outcome Rheum Pt on SoC Dur Covid-19 |
Coronavirus disease 19 infection |
standard of care alone |
|
|
Selayang Hospital |
|
Malaysia |
2020-05-04 |
2020-05-28 |
54731, NMRR-20-839-54731 |
Phase Not Applicable |
Status not specified |
1 |
|
|
Dr Lim Shiau Li |
2020-05-05 |
| Survey of WHOQoL-Bref Scores Among Persons with Chronic Illness and Public During COVID-19 Pandemic in Malaysia |
Coronavirus disease 19 infection |
|
|
|
HOSPITAL TENGKU AMPUAN RAHIMAH KLANG |
|
Malaysia |
2020-04-29 |
2020-12-31 |
54818, NMRR-20-838-54818 |
Phase Not Applicable |
Not yet recruiting |
1 |
8 Months |
|
Dr. Jacelyn Ong Jia Whey, Dr. Muralitharan Perumal |
2020-05-05 |
| McMonty: A reusable personalised ventilation hood: a phase I safety study of a new device (McMonty) in patients with suspected or confirmed COVID-19 |
Coronavirus disease 19 infection |
McMonty hood device alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Western Health |
Sunshine Hospital, University of Melbourne |
Australia |
2020-05-01 |
|
ACTRN12620000500954p, McMonty, U1111-1250-6657 |
Phase 1 Clinical |
Not yet recruiting |
2 |
|
20 |
Dr Forbes McGain |
2020-05-06 |
| A study to assess the effectiveness of Ayurvedic formulation in addition to standard of care in COVID-19 positive patients in a tertiary hospital |
Coronavirus disease 19 infection |
Tinospora cordifolia stem kashaya alone, standard of care alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Medanta The Medicity, Ministry of Ayush |
Central Council for Research in Ayurvedic Sciences, Council of Scientific and Industrial Research (India) |
India |
2020-04-28 |
|
CTRI/2020/04/024882 |
Phase 3 Clinical |
Not yet recruiting |
1 |
|
60 |
DrSushila Kataria, Mr.Kuldeep K Chauhan |
2020-05-06 |
| The CERA Study: The COVID-19 Emergency Response Assessment Study: a survey of the psychological health of frontline doctors in the UK and Ireland during the coronavirus pandemic |
Coronavirus disease 19 infection |
|
|
|
North Bristol NHS Trust |
Royal College of Emergency Medicine |
UK, Ireland |
2020-03-12 |
2020-10-01 |
ISRCTN10666798, The CERA Study, V5.0, IRAS 281944 |
Phase Not Applicable |
Recruiting |
2 |
6 Months |
7000 |
Dr Tom Roberts |
2020-05-06 |
| Treatment of COVID19 : A randomized controlled trial |
Coronavirus disease 19 infection, Viral pneumonia |
hydroxychloroquine alone, azithromycin plus hydroxychloroquine |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Ministry of Defence |
|
India |
2020-05-11 |
|
CTRI/2020/04/024904 |
Phase 3 Clinical |
Not yet recruiting |
6 |
|
300 |
AirCmde V K Sashindran, Ajay Kumar, Col Anurag Khera, Col Sanjeevan Sharma, Dheeraj Kumar, Kuldeep Ashta, Rajneesh Thakur, Snehangsh Dash |
2020-05-07 |
| HelloBetter Corona: Naturalistic evaluation of an Internet-based psychological training program for mental strain associated with the coronavirus / COVID-19 pandemic |
Coronavirus disease 19 infection, Psychiatric disorder |
HelloBetter Corona online training alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Friedrich-Alexander-Universitaet Erlangen-Nuernberg |
|
Germany |
2020-05-06 |
|
172_20 B, DRKS00021588, HelloBetter Corona |
Phase Not Applicable |
Not yet recruiting |
1 |
|
1000 |
Mathias Harrer |
2020-05-05 |
| SROCL: Stroke Rehabilitation Outcome During COVID-19 Lockdown |
Coronavirus disease 19 infection, Hemorrhagic stroke, Ischemic stroke |
physical activity engagement alone, rehabilitation therapy alone, upper limb usage alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Zurich |
|
Switzerland |
2020-04-16 |
2021-04-30 |
BASEC-NR. 2020-00761, NCT04373109, SROCL |
Phase Not Applicable |
Recruiting |
1 |
12 Months |
70 |
Andreas R Luft, Prof, Janne M Veerbeek, PhD, Jeremia Held, Jeremia PO Held, PhD |
2020-05-07 |
| Characteristics of seriously ill COVID-19 patients admitted to a tertiary care center |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
All India Institute of Medical Sciences |
|
India |
2020-05-08 |
|
CTRI/2020/04/024914 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
60 |
Dr Sulagna Bhattacharjee |
2020-05-05 |
| Impact of Quarantine on Quality of Life Among Persons Screened for COVID-19 in Malaysia |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
HOSPITAL TENGKU AMPUAN RAHIMAH KLANG |
|
Malaysia |
2020-04-30 |
2020-07-29 |
54817, NMRR-20-837-54817 |
Phase Not Applicable |
Not yet recruiting |
1 |
3 Months |
|
Dr Yap Soong Yiing, Dr. Muralitharan Perumal |
2020-05-05 |
| Clinical research on safety and efficacy of ZingiVir-H as an add on therapy in COVID-19 patients |
Coronavirus disease 19 infection |
ZingiVir-H alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Pankajakasthuri Ayurveda Medical College and Post Graduate Center |
|
India |
2020-04-29 |
|
CTRI/2020/04/024883 |
Phase 4 Clinical |
Recruiting |
1 |
|
112 |
Dr Shan Sasidharan, DrJHareendran Nair |
2020-05-05 |
| PRIEST: Evaluation of COVID-19 assessment in emergency departments and ambulance services |
Coronavirus disease 19 infection, Respiratory tract infection |
Emergency triage alone |
|
|
Sheffield Teaching Hospitals NHS Foundation Trust |
NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC) |
UK |
2012-10-01 |
2020-07-31 |
CPMS 12725, IRAS 101138, ISRCTN28342533, PRIEST |
Phase Not Applicable |
Recruiting |
64 |
94 Months |
|
Prof Goodacre |
2020-05-05 |
| Clinical and immunological predictors of SARS-CoV-2 infection and COVID-19 diseases in patients with renal diseases and healthy persons |
Coronavirus disease 19 infection, Renal disease |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Nierenzentrum Heidelberg |
Nierenzentrum e.V. |
Germany |
2020-04-06 |
|
DRKS00021297, S-224/2020 |
Phase Not Applicable |
Recruiting |
1 |
|
100 |
Claudia Sommerer |
2020-05-05 |
| Antiviral Therapy and Baricitinib for the Treatment of Patients With Moderate or Severe COVID-19 |
Coronavirus disease 19 infection, Viral pneumonia |
Variable regimens including baricitinib , hydroxychloroquine , lopinavir + ritonavir , remdesivir |
Coronavirus non structural protein 8 modulator, HIV protease inhibitor, Jak1 tyrosine kinase inhibitor, Jak2 tyrosine kinase inhibitor, RNA polymerase modulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Southern California |
National Cancer Institute |
US |
2020-04-24 |
2022-04-24 |
0S-20-3, NCI-2020-02685, NCT04373044, P30CA014089 |
Phase 2 Clinical |
Not yet recruiting |
0 |
24 Months |
59 |
Heinz-Josef Lenz, MD, Tali Homsey, BA |
2020-05-07 |
| The Prophylactic Effect Of Hydroxychloroquine On Novel Corona Virus |
Coronavirus disease 19 infection |
hydroxychloroquine, Tehran Darou, Iran alone, routine care alone |
|
|
Arak University of Medical Sciences and Health Services |
|
Iran |
2020-04-13 |
|
IR.ARAKMU.REC.1398.345, IRCT20151222025660N2 |
Phase 3 Clinical |
Recruiting |
2 |
|
140 |
Dr Alirza Kamali, Dr. Ramin Parvizrad, Dr.Ramin Parvizrad |
2020-05-06 |
| Survive and Thrive: exploring the wellbeing of doctors in a post-COVID-19 era |
Anxiety disorder, Coronavirus disease 19 infection, Depression |
|
|
|
University Of Southampton |
Health Education England |
UK |
2020-01-21 |
2021-12-31 |
55747, ISRCTN20867558 |
Phase Not Applicable |
Recruiting |
1 |
23 Months |
350 |
Dr Simons |
2020-05-06 |
| Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients |
Coronavirus disease 19 infection, Viral pneumonia |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Semmelweis University |
|
Hungary |
2020-04-16 |
2020-08-31 |
57/2020., NCT04372576 |
Phase Not Applicable |
Recruiting |
1 |
4 Months |
30 |
Bence Mogyoródi, MD, Zsolt Iványi |
2020-05-06 |
| PredictCovidT: Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients |
Coronavirus disease 19 infection |
blood sample alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Universitaire De Nice |
|
France |
2020-04-22 |
2020-10-22 |
20-PP-09, NCT04369456, PredictCovidT |
Phase Not Applicable |
Recruiting |
7 |
6 Months |
115 |
Alexandre HERTIG, Antoine SICARD, Barbara SEITZ-POLSKI, Christophe MARIAT, Dany ANGLICHEAU, Elisa DEMONCHY, Jean DELLAMONICA, Moglie Le Quintrec, Olivier THAUNAT, Renaud SNANOUDJ, Valerie MOAL, alexandre HERTIG, christophe MARIAT, cynthia CAILLON, sophie Caillard Ohlmann, valerie MOAL |
2020-05-06 |
| INVICTUS: Weaning From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic Ultrasound |
Coronavirus disease 19 infection, Respiratory distress syndrome |
combined thoracic ultrasound-based mechanical ventilation weaning alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Universitaire de Toulouse |
|
France |
2020-04-22 |
2020-09-22 |
2020-A00916-33, INVICTUS, NCT04372680, RC31/20/0138 |
Phase Not Applicable |
Recruiting |
2 |
5 Months |
200 |
AUDREY BELLOC, Beatrice RIU-POULENC, PH, Béatrice RIU-POULENC, NADERA AINAOUI, PHD, Paul BOURZEIX, Philippe VIGNON, PU PH, Stein SILVA, PU PH |
2020-05-06 |
| Efficacy of solnatide to treat pulmonary permeability oedema in SARS-Cov-2 positive patients with moderate-to-severe ARDS |
Coronavirus disease 19 infection, Pulmonary edema, Respiratory distress syndrome |
solnatide (liquid aerosol inhalation, pulmonary edema), Apeptico/ Mediolanum alone |
Sodium channel stimulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Medical University of Vienna |
Apeptico Forschung und Entwicklung GmbH |
Austria |
2020-04-11 |
|
2020-001244-26, COV-2-SOLNATIDE-20 |
Phase 2 Clinical |
Recruiting |
1 |
|
40 |
Markus Zeitlinger |
2020-05-07 |
| Effect of Atorvastatin in Treatment of COVID-19 Infection |
Coronavirus disease 19 infection |
atorvastatin alone, standard treatment alone |
HMG CoA reductase inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Islamic Azad University |
|
Iran |
2020-04-13 |
|
IR.IAU.PS.REC.1399.002, IRCT20200413047062N1 |
Phase 3 Clinical |
Recruiting |
1 |
|
76 |
Farshad Hashemian, Hamidreza Moezi, Keyhan Mohammadi, Maysa Ghayyem |
2020-05-06 |
| Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19 |
Coronavirus disease 19 infection, Viral pneumonia |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Stanford University |
National Institute of Allergy and Infectious Diseases |
US |
2020-04-08 |
2022-04-30 |
2U19AI057229, IRB-55689, NCT04373148 |
Phase Not Applicable |
Recruiting |
0 |
24 Months |
1000 |
Hena Din, Kari Nadeau, MD, PhD |
2020-05-06 |
| Analysis of clinical features of novel coronavirus pneumonia (COVID-19): a medical records based study |
Coronavirus disease 19 infection, Viral pneumonia |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Xiangya Hospital Of Central South University |
|
China |
2020-03-23 |
2021-03-23 |
ChiCTR2000032476 |
Phase Not Applicable |
Recruiting |
1 |
12 Months |
500 |
Pinhua Pan |
2020-05-06 |
| A medical records based retrospective study for effect of applying individualized Chinese herbal medicine in treatment of patients with novel coronavirus pneumonia (COVID-19) |
Coronavirus disease 19 infection, Viral pneumonia |
Chinese herbal medicine alone |
|
|
The Affiliated Hospital of Chengdu University of Traditional Chinese Medicine |
Science & Technology Department of Sichuan Province |
China |
2020-05-06 |
2020-07-31 |
ChiCTR2000032461, ChiMCTR2000003266 |
Phase Not Applicable |
Not yet recruiting |
3 |
2 Months |
500 |
Chunguang Xie, Huizhen Chen |
2020-05-06 |
| Assessment of effect of levamisole on pneumonia caused by COVID-19 |
Coronavirus disease 19 infection, Viral pneumonia |
levamisole alone, symptomatic therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Shiraz University of Medical Sciences |
|
Iran |
2020-05-04 |
|
IR.SUMS.REC.1399.178, IRCT20131215015805N2 |
Phase 4 Clinical |
Recruiting |
1 |
|
50 |
Dr Mohsen Moghaddami, Dr Payam Peymani, Dr mohsen moghadami, Kamran Bagheri Lankarani |
2020-05-06 |
| MeHeS-STAFF |
Coronavirus disease 19 infection |
|
|
|
Hospital Tunku Azizah |
|
Malaysia |
2020-05-01 |
2020-10-31 |
54721, NMRR-20-852-54721 |
Phase Not Applicable |
Not yet recruiting |
1 |
6 Months |
|
Dr LUI SZE CHIANG |
2020-05-06 |
| SOAP: School opening in Norway during the COVID-19 pandemic |
Coronavirus disease 19 infection |
school opening program alone |
|
|
Norwegian Institute of Public Health |
|
Norway |
2020-03-18 |
2020-09-30 |
ISRCTN44152751, SOAP |
Phase Not Applicable |
Not yet recruiting |
1 |
6 Months |
125 |
Prof Atle Fretheim |
2020-05-06 |
| ACICOVID: Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs |
Cardiac arrest, Coronavirus disease 19 infection, Viral pneumonia |
cardiopulmonary resuscitation alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer |
|
France |
2020-05-31 |
2020-12-31 |
2020-CHITS-004, ACICOVID, NCT04373759 |
Phase Not Applicable |
Not yet recruiting |
35 |
7 Months |
100 |
Alain Gaffinel, Arnaud Galbois, Arnaud Galbois, MD, Asmaa JOBIC, Benjamin Sztrymf, Benjamin Sztrymf, MD, Camille Foucault, Camille Foucault, MD, Cedric Bruel, Cedric Bruel, MD, Cedric Daubin, Cedric Daubin, MD, Charles Damoisel, MD, Christophe Vinsonneau, Christophe Vinsonneau, MD, Clement Suply, Coralie Gernez, Damien Roux, MD, Damien Vimpere, David Schnell, David Schnell, MD, Didier Thevenin, Didier Thevenin, MD, Dorothee Carpentier, Dorothee Carpentier, MD, Elena Skripkina, Elena Skripkina, MD, Gaetan Plantefeve, Gaetan Plantefeve, MD, Guillaume Geri, Guillaume Geri, MD, Jean-Philippe Suppini, Jean-Pierre Quenot, Jean-Pierre Quenot, MD, Jennifer Brunet, Jobic Asmaa, Jonathan Chelly, Jonathan Chelly, MD, Julie Noublanche, Julien Fournier, Karim Chaoui, MD, Laurent Guérin, Lionel Lamhaut, Ly Van Vong, Ly Van Vong, MD, Marie-Anne Mélone, MD, Marine Paul, Marine Paul, MD, Marjorie Fleury, Maxime Leloup, Maxime Leloup, MD, Michel Kaidomar, Natacha Kapandji, Natacha Kapandji, MD, Nicolas Deye, Nicolas Deye, MD, Nicolas Pichon, Nicolas Pichon, MD, Nicolas Terzi, Nicolas Terzi, MD, Riad Chelha, MD, Richard Descamps, MD, Romain Persichini, Romain Persichini, MD, Saad Nseir, Saad Nseir, MD, Sandie Mazerand, Santiago Freita Ramos, Santiago Freita Ramos, MD, Santiago Picos, Sebastien Ehrminger, MD, Sebastien Jochmans, Sebastien Jochmans, MD, Tai Pham, Thomas Hullin, Thomas Hullin, MD, Toufik Kamel, Toufik Kamel, MD, Vivien Hong Tuan Ha, Vivien Hong Tuan Ha, MD |
2020-05-07 |
| Screening of Cancer Patients to Assess Impact of COVID-19 |
Coronavirus disease 19 infection |
nasopharyngeal (NP) swab alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
The University Health Network |
|
Canada |
2020-05-04 |
2020-12-04 |
CAPCR 20-5337, NCT04373005, U-DEPLOY: RESPONSE |
Phase Not Applicable |
Not yet recruiting |
1 |
7 Months |
1000 |
Stephanie Lheureux, M.D. |
2020-05-06 |
| HARMONICOV: Human Ab Response and immunomonitoring of COVID-19 Patients |
Coronavirus disease 19 infection, Respiratory distress syndrome |
blood sampling alone, immunomonitoring alone, saliva collection alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Rennes University Hospital |
|
France |
2020-05-15 |
2020-11-15 |
2020-A01100-39, 35RC20_9795_HARMONICOV, HARMONICOV, NCT04373200 |
Phase Not Applicable |
Not yet recruiting |
1 |
6 Months |
75 |
Alexandre MANSOUR, MD, Florian REIZINE, MD, Isabelle GOUIN, MD, Jean-Marc TADIE, MD, PhD, Karin TARTE, MD, PhD, Mathieu LESOUHAITIER, MD, Michel COGNE, MD, PhD, Mikaël ROUSSEL, MD |
2020-05-07 |
| COVENTRY: One-Year Quality of Life and Functional Prognosis of COVID-19 Patients in Post-ICU Setting |
Coronavirus disease 19 infection |
lung ultrasound alone, muscle ultrasound alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Groupe Hospitalier Paris Saint-Joseph |
Hôpital Forcilles |
France |
2020-04-16 |
2021-09-16 |
COVENTRY, COVENTRY, NCT04373811 |
Phase Not Applicable |
Recruiting |
1 |
17 Months |
50 |
Andreia LOPES, PT, Aymeric LE NEINDRE, PT, PhD, Carlos DIAZ, PT, MSc, Gérald CHOUKROUN, MD, Hélène BEAUSSIER, PharmD, PhD, Joséphine COTTIAS, PT, Nesrine BEN NASR, PharmD, PhD, Pascal MEYER, MD |
2020-05-06 |
| BRACE-CORONA: Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19 |
Coronavirus disease 19 infection |
Suspension of Angiotensin Receptor Blockers and Angiotensin-converting Enzymes alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Instituto D'Or de Pesquisa |
Brazilian Clinical Research Institute |
Brazil |
2020-04-06 |
2020-12-01 |
BRACE-CORONA, NCT04364893, PRJ_2003 |
Phase Not Applicable |
Recruiting |
1 |
7 Months |
500 |
Renato D. Lopes, MD, PhD |
2020-05-08 |
| Study for using sulfate in the prevention and control of novel coronavirus pneumonia (COVID-19) in high and low prevalence communities |
Coronavirus disease 19 infection, Viral pneumonia |
hydroxychloroquine sulfate alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Shanghai Public Health Clinical Center |
|
China |
2020-03-01 |
2020-09-30 |
ChiCTR2000032487 |
Phase 4 Clinical |
Not yet recruiting |
1 |
7 Months |
2000 |
Lu Xia, Shuihua Lu |
2020-05-06 |
| CRC-COVID: COVID-19 Infection: Exploration of Respiratory Control Center Abnormalities |
Coronavirus disease 19 infection |
14.3 and 12.7% FIO2, hypercapnia 7% CO2, inspiratory mechanical constraint alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Assistance Publique Hopitaux de Paris |
|
|
2020-04-27 |
2021-11-27 |
APHP200476, CRC-COVID, NCT04363749 |
Phase Not Applicable |
Not yet recruiting |
0 |
19 Months |
30 |
Thomas Similowski, MD, PhD |
2020-05-08 |
| Comparison of three methods of treatment in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with and without coronavirus positive test (COVID-19) |
Coronavirus disease 19 infection, Vitamin C deficiency, Vitamin D deficiency |
routine treatment alone, vitamin C supplement alone, vitamin D supplement alone |
|
Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Sabzevar University of Medical Sciences |
|
Iran |
2020-04-20 |
|
IR.MEDSAB.REC.1399.015, IRCT20140305016852N4 |
Phase 2/Phase 3 Clinical |
Recruiting |
1 |
|
30 |
Ebrahim Shirzade, Fereshteh Ghorat, Somayyeh Nayyeri |
2020-05-06 |
| COVIDOP-DVT: Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU |
Coronavirus disease 19 infection, Deep vein thrombosis, Viral pneumonia |
Doppler Echo alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Versailles University Hospital |
|
France |
2020-04-27 |
2020-10-30 |
COVIDOP-DVT, NCT04363528, P20/08 |
Phase Not Applicable |
Not yet recruiting |
1 |
6 Months |
50 |
Aurelien Maurizot |
2020-05-07 |
| KAPFM |
Coronavirus disease 19 infection |
respiratory protective device alone |
|
|
HOSPITAL SERI MANJUNG |
|
Malaysia |
2020-05-04 |
2020-12-01 |
54775, NMRR-20-850-54775 |
Phase Not Applicable |
Status not specified |
1 |
6 Months |
|
Gobi Hariyanayagam a/l Gunasekaran |
2020-05-06 |
| Clinical study on Dabur Chyawanprash as a preventive remedy in pandemic of Covid-19 |
Coronavirus disease 19 infection |
Chyawanprash alone |
|
Healthy volunteers accepted, Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Dabur India Ltd |
|
India |
2020-05-15 |
|
CTRI/2020/05/024981, DCP-CVD-19/2020/01 |
Phase Not Applicable |
Not yet recruiting |
5 |
|
600 |
Dr Arun Gupta, Dr Pawankumar Godatwar, Dr Pranita Deshmukh, Dr Raman Ghungralekar, Dr Sanjay Tamoli, Dr Shailesh Deshpande, Dr Vaishali Deshpande |
2020-05-07 |
| COVI-DOSE: Weight-Adjusted versus Fixed Low-Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 |
Coronavirus disease 19 infection, Thromboembolism, Viral pneumonia |
Variable regimens including dalteparin sodium , enoxaparin sodium , nadroparin calcium , tinzaparin sodium |
Antithrombin III, Factor IIa antagonist, Factor Xa antagonist, Low molecular weight heparin |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Central Hospital, Nancy, France |
Ministry of Health, France |
France |
2020-05-31 |
2020-10-31 |
2020-001709-21, COVI-DOSE, NCT04373707 |
Phase 4 Clinical |
Not yet recruiting |
14 |
5 Months |
602 |
Alessandra Bura-Rivière, Amer Hamadé, Béatrice Terriat, Dominique Stephan, El Mehdi Siaghy, Francis Couturaud, Gabrielle Sarlon-Bartoli, Isabelle Quéré, Julien Bertrand, Nicolas Meneveau, Olivier Sanchez, Patricia Costa, Patrick Mismetti, Saïda Khaled-Jousselin, Res Proj Man, Simon Soudet, Stéphane Zuily, Stéphane Zuily, MD, PhD, Wael Younès, Yohann Bernard, Res Proj Man |
2020-05-06 |
| Homoeopathy as adjuvant in management of Covid-19 infection |
Coronavirus disease 19 infection, Viral pneumonia |
Homoeopathic medicines alone, standard treatment alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Naiminath Homoeopathic Medical College, Hospital and Research Centre |
|
India |
2020-05-10 |
|
CTRI/2020/05/024969 |
Phase 2/Phase 3 Clinical |
Not yet recruiting |
1 |
|
100 |
Dr Anil Khurana, Dr Debadatta Nayak, Prof Dr Pradeep Kumar Gupta |
2020-05-07 |
| PROVID-19: Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress |
Coronavirus disease 19 infection |
conventional positioning alone, prone position alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Régional d'Orléans |
|
France |
2020-05-31 |
2022-05-31 |
CHRO-2020-09, NCT04363463, PROVID-19 |
Phase Not Applicable |
Not yet recruiting |
14 |
24 Months |
400 |
Amanda LOPES, Dr, Aurélie DESPUJOLS, Aymeric SEVE, Dr, Elodie POUGOUE TOUKO, Elsa NYAMANKOLLY, Elsa NYAMANKOLLY, Dr, François MAILLOT, Pr, Jean-François GAUTIER, Pr, Laurent PLANTIER, Pr, Louis BERNARD, Pr, Léa COLOMBAIN, Dr, MARINE MORIER, Mai-Anh NAY, Dr, Marine MORIER, Dr, Nicolas BIZIEN, Dr, Pierre SELLIER, Pr, Sylvie DRUELLE, Sylvie DRUELLE, Dr, Xavier POUGET-ABADIE, Xavier POUGET-ABADIE, Dr |
2020-05-07 |
| COVID'HEMOS: Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19 |
Coronavirus disease 19 infection |
blood sampling alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hospital Boisguillaume |
|
France |
2020-04-09 |
2020-07-31 |
2020/0104/OB, COVID'HEMOS, NCT04367662 |
Phase Not Applicable |
Recruiting |
1 |
3 Months |
100 |
Francois CARON, Pr, Julien BLOT, Manuel ETIENNE, Pr, Paul BILLOIR, Pharmacist, Paul BILLOIR, pharmacist, Véronique LE CAM, MD |
2020-05-06 |
| COVID-19 social study: the effects of quarantine on mental health |
Coronavirus disease 19 infection, Psychiatric disorder |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University College London |
Nuffield Foundation |
UK |
2020-03-23 |
2020-12-31 |
12467/005, ISRCTN97041334 |
Phase Not Applicable |
Recruiting |
1 |
9 Months |
1000000 |
Ms Vas James |
2020-05-06 |
| Developing and validating of clinical prediction model for novel coronavirus pneumonia (COVID-19) patients progressing to critical type, acute respiratory distress syndrome and death: a medical records based study |
Coronavirus disease 19 infection, Viral pneumonia |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Tongji Medical College |
|
China |
2020-05-01 |
2021-04-30 |
ChiCTR2000032527 |
Phase Not Applicable |
Not yet recruiting |
1 |
12 Months |
8500 |
Shusheng Li, Yi Bian |
2020-05-06 |
| Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care Workers |
Coronavirus disease 19 infection |
modified IPAC-UHN PPE alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
The University Health Network |
|
Canada |
2020-05-07 |
2020-08-31 |
20-5448, NCT04373096 |
Phase Not Applicable |
Not yet recruiting |
1 |
3 Months |
42 |
Anahi Perlas, MD,FRCPC, Mehdi Soheili, Rongyu Jin |
2020-05-06 |
| MUM: Global Mental Health of Urban Mothers |
Anxiety disorder, Coronavirus disease 19 infection, Depression, Post traumatic stress disorder |
Web-based psychosocial peer-to-peer support alone |
|
Healthy volunteers accepted, Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Karolinska Institutet |
Swiss National Science Foundation |
Sweden, China, Hong Kong |
2020-06-30 |
2023-06-30 |
MUM, NCT04363177, P2SKP3_187728 |
Phase Not Applicable |
Not yet recruiting |
3 |
36 Months |
300 |
Ewa Andersson, PhD, Hsuan-Ying Huang, PhD, Liping Zhu, PhD |
2020-05-07 |
| A clinical study of anti-SARS-CoV-2 antibodies for the treatment of COVID-19 |
Coronavirus disease 19 infection |
anti-SARS-CoV-2 antibodies (COVID-19), AbCellera/Eli Lilly alone |
|
|
AbCellera Biologics Inc |
|
|
2020-07-31 |
|
|
Phase Not Applicable |
Planned |
0 |
|
|
|
2020-05-05 |
| Effect of curcumin-piperine supplementation on disease duration, severity and clinical signs, and inflammatory factors in patients with coronavirus (COVID-19): A randomized, double-blind, placebo-controlled clinical trial study |
Coronavirus disease 19 infection |
curcumin capsules plus piperine capsules |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Isfahan University of medical Sciences |
|
Iran |
2020-05-04 |
|
IR.MUI.MED.REC.1399.049, IRCT20121216011763N46 |
Phase Not Applicable |
Recruiting |
1 |
|
100 |
Gholamreza Askari, Shaghayegh Haghjou |
2020-05-06 |
| Application of pulmonary rehabilitation exercise in the treatment of novel coronavirus pneumonia (COVID-19) patients during convalescence period |
Coronavirus disease 19 infection, Viral pneumonia |
pulmonary rehabilitation exercise alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Huazhong University of Science and Technology |
Beijing Chao-Yang Hospital |
China |
2020-05-01 |
2020-05-31 |
ChiCTR2000032457 |
Phase Not Applicable |
Not yet recruiting |
1 |
1 Month |
60 |
Wang Feng, Zhang Jianchu |
2020-05-06 |
| PLASCOSSA: Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients |
Coronavirus disease 19 infection |
SARS-CoV-2 convalescent plasma alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Direction Centrale du Service de Sante des Armees |
University Hospital, Grenoble |
France |
2020-05-31 |
2021-05-31 |
2020-A01166-33, NCT04372979, PLASCOSSA |
Phase 3 Clinical |
Not yet recruiting |
4 |
12 Months |
80 |
Catherine VERRET, Christophe MARTINAUD, Christophe MARTINAUD, PU PH, Christophe RENARD, Cécile FICKO, Damien RICARD, Fabien DUTASTA, Hervé FOEHRENBACH, Hélène SAVINI, Jean-Luc BOSSON, Jean-Paul HYRIEN, Katia AVMART, Marc ALETTI |
2020-05-06 |
| Effects of convalescent plasma in COVID-19 |
Coronavirus disease 19 infection, Respiratory distress syndrome |
COVID-19 convalescent plasma alone, standard national guideline treatment alone |
|
|
Oroumia University of Medical Sciences |
Urmia University of Medical Sciences |
Iran |
2020-05-04 |
|
IR.UMSU.REC.1399.030, IRCT20200501047258N1 |
Phase 2/Phase 3 Clinical |
Recruiting |
1 |
|
120 |
Iraj Mohebbi, Rahim Asgari, Rahim Asghari |
2020-05-06 |
| Clinical trial on Immunity and antiviral for quarantine patients of COVID-19 |
Coronavirus disease 19 infection, Immune disorder |
MyVir alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
MiLab LifeSciences (P) Ltd |
|
India |
2020-05-11 |
|
CT/MiLab/MyVir/2020, CTRI/2020/05/024967 |
Phase 4 Clinical |
Not yet recruiting |
1 |
|
30 |
Dr CR Jayanthi, MrLAKSHMANA PERUMAL SPT |
2020-05-07 |
| A Randomized Controlled Trial for the Effects of Low-Oxygen Consumption Instruction on the Prognosis of Patients with Novel Coronavirus Pneumonia (COVID-19) |
Coronavirus disease 19 infection, Viral pneumonia |
low oxygen consumption alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Shanghai Public Health Clinical Center |
|
China |
2020-03-01 |
2020-05-01 |
ChiCTR2000032456 |
Phase Not Applicable |
Completed |
1 |
2 Months |
100 |
Shuihua Lu, Yang Yang |
2020-05-06 |
| TREAT NOW: Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19 |
Coronavirus disease 19 infection, Respiratory tract infection |
hydroxychloroquine alone, lopinavir + ritonavir alone |
HIV protease inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Vanderbilt University Medical Center, US |
AbbVie Inc |
US |
2020-05-01 |
2021-05-01 |
200827, NCT04372628, TREAT NOW |
Phase 2 Clinical |
Not yet recruiting |
0 |
12 Months |
900 |
Adit A Ginde, MD, Lani L. Finck, Margaret A. Hays, Margaret Hays, Nathan I. Shapiro, M.D., Nathan L Shapiro, MD, Sharon Hayes, RN, Todd Rice, MD, Todd W. Rice, M.D., Todd W. Rice, MD |
2020-05-06 |
| The use of topical Povidone Iodine (PVP-I) oropharyngeal and intranasal application during the current coronavirus pandemic as a potential measure to reduce viral transmission |
Coronavirus disease 19 infection |
Povidone Iodine alone, standard oral antiviral therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
WIN MEDICARE PVTLTD |
Drugs Control Administration |
India |
2020-05-05 |
|
CTRI/2020/05/024962 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
96 |
Dr Sumita Shankar |
2020-05-07 |
| COST ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients |
Coronavirus disease 19 infection |
BioMedomics COVID-19 IgM-IgG Rapid Test alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Ospedale San Paolo |
|
Italy |
2020-03-30 |
2020-09-30 |
2020/ST/057, COST ACTION, NCT04367402 |
Phase Not Applicable |
Recruiting |
1 |
6 Months |
600 |
Stefano Centanni, Full Professor |
2020-05-06 |
| Home Pulse Oximeter Use in Patients With COVID-19 |
Coronavirus disease 19 infection |
pulse oximetry alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Swedish Hospital |
|
US |
2020-03-20 |
2020-04-22 |
2020032301, NCT04373161 |
Phase Not Applicable |
Completed |
0 |
1 Month |
209 |
Kaushal Majmudar, Sonia Shah, DO |
2020-05-07 |
| MIA-COVID-19: Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients |
Coronavirus disease 19 infection |
CT-scan alone |
|
|
Jessa Hospital |
Antwerp University Hospital, Universiteit Hasselt |
Belgium |
2020-04-14 |
2020-12-31 |
JESSAH_COVID-19_MIA, MIA-COVID-19, NCT04366882 |
Phase Not Applicable |
Recruiting |
1 |
8 Months |
45 |
Jan Vanrusselt, MD, Janneke Cox, MD, PhD |
2020-05-06 |
| A study for the mental health status of novel coronavirus pneumonia (COVID-19) convalescent patients and first-line medical staff and Isolate residents and Hospital staffand the intervention strategy of psychological crisis in Ningxia |
Coronavirus disease 19 infection |
psychological crisis intervention alone |
|
Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Ningxia Medical University |
|
China |
2020-04-28 |
2021-12-31 |
ChiCTR2000032455 |
Phase 0 Clinical |
Recruiting |
1 |
20 Months |
140 |
Jiang Hong, Ma Xin-rong |
2020-05-06 |
| US3R: Health Care Use During the COVID-19 Crisis |
Coronavirus disease 19 infection |
online questionnaire alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universite Catholique de Louvain |
|
Belgium |
2020-05-01 |
2021-10-31 |
NCT04372030, US3R, US3R |
Phase Not Applicable |
Not yet recruiting |
1 |
18 Months |
10000 |
Dominique Vanpee, MD, Sandy Tubeuf, PhD |
2020-05-06 |
| RFCIM: RFCIM |
Coronavirus disease 19 infection |
|
|
|
Government of Malaysia |
|
Malaysia |
2020-05-01 |
2022-04-30 |
54832, NMRR-20-861-54832, RFCIM |
Phase Not Applicable |
Status not specified |
1 |
24 Months |
|
Associate Prof Dr Awang bulgiba awang mahmud, Devi Peramalah |
2020-05-08 |
| Economic burden of COVID-19 in Malaysia |
Coronavirus disease 19 infection |
|
|
|
Government of Malaysia |
|
Malaysia |
2020-05-04 |
2022-12-19 |
54823, NMRR-20-865-54823 |
Phase Not Applicable |
Not yet recruiting |
1 |
31 Months |
|
Dr Amirah binti Azzeri, Dr Maznah Dahlui |
2020-05-07 |
| Clinical characteristics of renal patients with COVID-19 infection |
Coronavirus disease 19 infection, Renal failure |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Nierenzentrum Heidelberg |
|
Germany |
2020-04-06 |
|
DRKS00021295, S-223/202 |
Phase Not Applicable |
Recruiting |
1 |
|
100 |
Claudia Sommerer |
2020-05-07 |
| A multicenter, randomized, open comparative clinical trial of the drug Favipiravir in patients hospitalized with COVID-19 |
Coronavirus disease 19 infection |
favipiravir alone |
RNA polymerase inhibitor |
|
ChemRar High Tech Center, Russian Direct Investment Fund |
|
Russian Federation |
2020-04-28 |
|
|
Phase 2 Clinical |
Recruiting |
3 |
|
330 |
|
2020-05-05 |
| Convalescent Plasma for the Treatment of Patients With COVID-19 |
Coronavirus disease 19 infection, Dyspnea, Respiratory failure |
COVID-19 convalescent plasma alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Colorado, Denver, US |
|
US |
|
|
20-0990, NCT04372368 |
Phase Not Applicable |
Recruiting |
0 |
|
|
John D Beckham, MD |
2020-05-06 |
| A clinical trial of XRx-101 for prevention of acute kidney injury due to coronavirus/COVID-19 infection |
Coronavirus disease 19 infection, Renal injury |
oxypurinol (acute kidney injury/lung injury/COVID-19), XORTX Therapeutics alone |
Xanthine oxidase inhibitor |
|
XORTX Therapeutics Inc |
|
|
|
|
|
Phase Not Applicable |
Planned |
0 |
|
|
|
2020-05-05 |
| A clinical trial of Wyss-designed swabs for COVID-19 |
Coronavirus disease 19 infection |
Wyss-designed swabs alone |
|
|
Wyss Institute for Biologically Inspired Engineering |
|
US |
|
|
|
Phase Not Applicable |
Planned |
0 |
|
|
|
2020-05-08 |
| Convalescent Plasma to Limit SARS-CoV-2 Associated Complications |
Coronavirus disease 19 infection |
SARS-CoV-2 convalescent plasma (HCIP) alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Johns Hopkins University |
Bloomberg Philanthropies, University of Maryland |
US |
2020-05-11 |
2023-01-31 |
CSSC-004, IRB00247590, NCT04373460 |
Phase 2 Clinical |
Not yet recruiting |
0 |
32 Months |
1344 |
David J Sullivan, MD, David Sullivan, MD |
2020-05-06 |
| SQuISH-COVID: SQuISH-COVID: A Pilot Study |
Coronavirus disease 19 infection, Sepsis |
SeptiScan System alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Cytovale Inc |
Biomedical Advanced Research and Development Authority (BARDA) |
US |
2020-04-07 |
2020-05-29 |
CV-CLN-003, NCT04372472, SQuISH-COVID |
Phase Not Applicable |
No longer recruiting |
0 |
1 Month |
300 |
Hollis R O'Neal, Jr., MD, MSc |
2020-05-06 |
| COVID Liver |
Coronavirus disease 19 infection, Liver disease |
|
|
|
Selayang Hospital |
|
Malaysia |
2020-05-20 |
2020-06-30 |
54896, NMRR-20-856-54896 |
Phase Not Applicable |
Status not specified |
1 |
1 Month |
|
Dr Tan Soek Siam |
2020-05-07 |
| CoNFINE: Limitations of social life in the context of the COVID-19 pandemic - Effects on physical performance and health-related quality of life of older people |
Coronavirus disease 19 infection |
Milon-circuit training alone |
|
Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Carl Von Ossietzky Universität Oldenburg |
|
Germany |
2020-04-20 |
|
2020-061, CoNFINE, DRKS00021432 |
Phase Not Applicable |
Recruiting |
1 |
|
100 |
Jessica Koschate, Tania Zieschang |
2020-05-06 |
| Evaluation of the Fluid Response of SARS-CoV-2 (COVID-19) Patients in Intensive Care; Pleth Variability Index |
Coronavirus disease 19 infection |
fluid management alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Erzincan University |
|
Turkey |
2020-05-05 |
2020-06-15 |
EBYU COVİD PVI, NCT04373213 |
Phase Not Applicable |
Not yet recruiting |
1 |
1 Month |
30 |
ILKE KUPELI |
2020-05-07 |
| Max Ivermectin - COVID-19 Study Versus Standard of Care Treatment for COVID-19 Cases. A Pilot Study |
Coronavirus disease 19 infection |
ivermectin alone, standard treatment alone |
Chloride channel modulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Max Healthcare Institute Ltd, India |
|
India |
2020-04-25 |
2020-07-25 |
MHC-COVID-19- INV- ACT-BHR, NCT04373824 |
Phase 2 Clinical |
Recruiting |
1 |
3 Months |
50 |
Rajesh Saxena, MBA, Ram Shankar Mishra, DNB, FRCP, Sandeep Budhiraja, MRCP, FACP |
2020-05-07 |
| Duvelisib to Combat COVID-19 |
Coronavirus disease 19 infection, Respiratory failure |
duvelisib alone |
Phosphoinositide-3 kinase delta inhibitor, Phosphoinositide-3 kinase gamma inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Washington University School of Medicine, US |
Verastem Oncology |
US |
2020-06-30 |
2021-12-31 |
04-28-20-DIPERSIO, NCT04372602 |
Phase 2 Clinical |
Not yet recruiting |
0 |
18 Months |
25 |
Erik Dubberke, M.D., MSPH, John DiPersio, M.D., Ph.D., Mark Fiala, MSW |
2020-05-07 |
| CHIC: Covid High-intensity Immunosuppression in Cytokine release syndrome |
Coronavirus disease 19 infection, Viral pneumonia |
methylprednisolone plus tocilizumab |
|
|
Zuyderland Medical Center, Heerlen |
|
Netherlands |
2020-04-23 |
2020-07-31 |
CHIC, NL8551 |
Phase Not Applicable |
Recruiting |
1 |
3 Months |
160 |
Sofia Ramiro |
2020-05-07 |
| BREATH: Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness |
Anxiety disorder, Coronavirus disease 19 infection, Depression, Insomnia |
Health Enhancement Program alone, Sudarshan Kriya Yoga (SKY) alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Lawson Health Research Institute |
Art Of Living foundation |
Canada |
2020-05-10 |
2021-06-30 |
115855, BREATH, NCT04368676 |
Phase 0 Clinical |
Not yet recruiting |
1 |
13 Months |
60 |
Akshya Vasudev, MBBS, MD, Akshya Vasudev, MD, Emily Ionson, Hr.BSC |
2020-05-06 |
| CoVUm: Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial |
Coronavirus disease 19 infection |
blood sampling alone, urine and feces sampling alone |
|
Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Umea University |
Västerbotten County Council, Sweden |
Sweden |
2020-04-28 |
2026-04-14 |
COVUM, CoVUm, NCT04368013 |
Phase Not Applicable |
Not yet recruiting |
1 |
71 Months |
400 |
Alicia Edin, M.D., Clas Ahlm, Professor, Johan Normark, Docent |
2020-05-06 |
| Hydroxychloroquine for Post-Exposure Prophylaxis of COVID-19 among naval personnel: a placebo-controlled, randomized, clinical trial |
Coronavirus disease 19 infection |
hydroxychloroquine alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
University of Kelaniya |
Sri Lanka Navy, Ministry of Defense, State Pharmaceuticals Manufacturing Corporation of Sri Lanka |
Sri Lanka |
2020-05-04 |
2020-05-31 |
P/22/04/2020, SLCTR/2020/011, U1111-1251-3613 |
Phase 4 Clinical |
Not yet recruiting |
1 |
|
400 |
Niriella MA |
2020-05-06 |
| COVUSt: COVID19 ultrasound triage |
Coronavirus disease 19 infection |
Point-of-Care Ultrasound alone |
|
Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Isala |
|
Netherlands |
2020-04-14 |
2020-06-01 |
COVUSt, NL8543 |
Phase Not Applicable |
Recruiting |
1 |
1 Month |
50 |
Svenja Haak |
2020-05-06 |
| PAPR: Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization |
Coronavirus disease 19 infection |
Prone Positioning alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Utah |
|
US |
2020-04-30 |
2021-01-31 |
IRB_00132123, NCT04368000, PAPR |
Phase Not Applicable |
Not yet recruiting |
0 |
9 Months |
60 |
Stacy A Johnson, MD |
2020-05-07 |
| ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Columbia University |
|
US |
2020-04-18 |
2021-10-31 |
AAAS9998, NCT04367857 |
Phase Not Applicable |
Recruiting |
0 |
18 Months |
1000 |
Brett Gray, Magdalena Sobieszczyk, MD, MPH |
2020-05-06 |
| The PRONE study: Sleep position related to hospital length of stay in admitted COVID-19 patients |
Coronavirus disease 19 infection |
Sleep Position Trainer alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Franciscus Gasthuis & Vlietland |
|
|
2020-04-17 |
2021-04-17 |
NL8538, The PRONE study |
Phase Not Applicable |
Planned |
0 |
12 Months |
342 |
Vivan Baggen |
2020-05-06 |
| A randomized, double-blind, placebo-controlled trial of intravenous plasma-purified alpha-1 antitrypsin for severe COVID-19 illness |
Coronavirus disease 19 infection |
plasma-purified alpha-1 antitrypsin alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Royal College of Surgeons in Ireland |
Health Research Board Clinical Research Coordination Ireland |
Ireland |
2020-04-24 |
|
2020-001391-15, V1Mar2020 |
Phase 2 Clinical |
Recruiting |
1 |
|
|
Mandy Jackson |
2020-05-07 |
| NEUMONIA: Neurological Manifestations of COVID-19 and Indications of an Association with Respiratory Failure |
Coronavirus disease 19 infection, Respiratory failure |
neurological examination alone |
|
|
Zuyderland Medical Center, Heerlen |
|
Netherlands |
2020-04-28 |
2020-07-31 |
METCZ20200077, NEUMONIA, NL8536 |
Phase Not Applicable |
Recruiting |
1 |
3 Months |
285 |
M. Beckers |
2020-05-06 |
| Functional status and health status in COVID-19 patients pre and post rehabilitation |
Coronavirus disease 19 infection |
rehabilitation alone |
|
|
CIRO TRADE PRIVATE LIMITED |
|
Netherlands |
2020-03-30 |
2020-11-30 |
METC 2020-1340, NL8535 |
Phase Not Applicable |
Recruiting |
1 |
8 Months |
30 |
Anouk Vaes |
2020-05-06 |
| PredictCovid-D: Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Hemodialysis Patients |
Coronavirus disease 19 infection, Renal disease |
blood sampling alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Universitaire De Nice |
|
France |
2020-04-22 |
2021-02-22 |
20-PP-08, NCT04371510, PredictCovid-D |
Phase Not Applicable |
Recruiting |
1 |
10 Months |
115 |
SICARD Antoine, SICARD Antoine, Ph, sicard antoine, ph |
2020-05-06 |
| COVID-19 Health Messaging to Underserved Communities |
Coronavirus disease 19 infection |
Messaging alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over), African Ancestry, European Ancestry |
National Bureau of Economic Research Inc |
Harvard University, Massachusetts General Hospital, Massachusetts Institute of Technology, Stanford University, Yale University |
|
2020-05-08 |
2021-06-30 |
2003000118, NCT04371419 |
Phase Not Applicable |
Not yet recruiting |
0 |
13 Months |
20000 |
|
2020-05-06 |
| Evaluation of the therapeutic effect of a combination drug including apocynin, niacin, and tannin on COVID-19 |
Cardiovascular disease, Coronavirus disease 19 infection, Respiratory disease, Viral pneumonia |
current standard treatment alone, Variable regimens including apocynin , niacin , tannin |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Isfahan University of medical Sciences |
|
Iran |
2020-04-25 |
|
IR.MUI.MED.REC.1399.050, IRCT20200418047122N1 |
Phase 2/Phase 3 Clinical |
Recruiting |
1 |
|
80 |
Dr Hossein Khanahmad, Dr Mehrdad Zeinalian, Dr Pourajam, Dr Shirani |
2020-05-06 |
| Usage of topical lignocaine to decrease the gag reflex while sampling for Covid-19: Does it affect the yield of specimen? |
Coronavirus disease 19 infection |
qualitative reverse transcription real-time Polymerase Chain Reaction test alone, lidocaine plus lignocaine |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
All India Institute of Medical Sciences |
|
India |
2020-05-05 |
|
CTRI/2020/05/024983 |
Phase 2 Clinical |
Not yet recruiting |
1 |
|
30 |
Alok Thakar, Dr Anupam Kanodia |
2020-05-06 |
| Effects of using hydroxychloroquine and azithromycin in the treatment of confirmed COVID-19 positive patients |
Coronavirus disease 19 infection |
azithromycin plus hydroxychloroquine |
|
Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
All India Institute of Medical Sciences, Raipur |
|
India |
2020-05-15 |
|
CTRI/2020/05/024982 |
Phase 2 Clinical |
Not yet recruiting |
1 |
|
50 |
Dr PUGAZHENTHAN T |
2020-05-06 |
| Evaluation of the Sleep Hygiene in the Lebanese Population During the COVID-19 Confinement Period |
Coronavirus disease 19 infection |
Sleep Hygiene Index questionnaire alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Saint Joseph's University |
|
Lebanon |
2020-04-30 |
2020-09-30 |
CEHDF1650, NCT04372043 |
Phase Not Applicable |
Not yet recruiting |
1 |
5 Months |
1200 |
Jad Costa, Jeanine El Helou, MD, MSc |
2020-05-07 |
| CARDICoVRISK: Predictors of Cardiovascular Risk in COVID-19 Patients During Acute Disease and at Short-Term Follow-up |
Cardiovascular disease, Coronavirus disease 19 infection, Viral pneumonia |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Istituto Auxologico Italiano |
|
Italy |
2020-04-30 |
2020-09-10 |
CARDICoVRISK, CE_2020_03_26_02, NCT04371289 |
Phase Not Applicable |
Not yet recruiting |
1 |
4 Months |
5500 |
Gianfranco Parati, MD, PhD |
2020-05-07 |
| PREVENT: Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk |
Coronavirus disease 19 infection |
hydroxychloroquine sulfate alone |
|
Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Texas Cardiac Arrhythmia Research Foundation |
|
US |
2020-06-30 |
2021-07-31 |
NCT04371926, PREVENT, TCAI_PREVENT |
Phase Not Applicable |
Not yet recruiting |
0 |
13 Months |
64 |
Andrea Natale, Andrea Natale, MD, Angel Mayedo, MD, Bryan MacDonald, MD |
2020-05-06 |
| Effect of of Inhalation of Thyme Oil in COVID-19 |
Coronavirus disease 19 infection |
Variable regimens including hydroxychloroquine , lopinavir + ritonavir , thyme |
HIV protease inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Shoushtar School of Medical Sciences |
|
Iran |
2020-05-04 |
|
IR.SHOUSHTAR.REC.1399.005, IRCT20200426047212N1 |
Phase 2/Phase 3 Clinical |
Recruiting |
1 |
|
48 |
Ali Hatami, Barat Barati, Hassan Hassanzadeh Namin, Mohammad Nikzadian |
2020-05-06 |
| MG-COVID: Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients |
Coronavirus disease 19 infection |
standard of care alone, Plaquenil plus azithromycin |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Assistance Publique Hopitaux de Paris |
|
France |
2020-05-02 |
2020-09-02 |
2020-001702-35, APHP200447, MG-COVID, NCT04371406 |
Phase 3 Clinical |
Not yet recruiting |
1 |
4 Months |
2770 |
Alix PENEL, Julie CHASTANG, Dr, Sarra POCHON |
2020-05-07 |
| Study the effectiveness of concomitant use of vitamin C, metformin, azithromycin and doxycycline on improving patients with COVID-19 |
Coronavirus disease 19 infection |
Variable regimens including azithromycin , doxycycline hyclate , metformin hydrochloride , vitamin C |
AMP activated protein kinase stimulator |
|
Kermanshah University of Medical Sciences |
|
Iran |
2020-05-09 |
|
IRCT20200418047121N1, ir.kums.rec.1399.079 |
Phase 3 Clinical |
Not yet recruiting |
1 |
|
40 |
Dr. Faizullah Mansouri, Dr. Farid Najafi, Dr. Kamran Mansouri |
2020-05-06 |
| Trifluoperazine Effectiveness in Treatment of Coronavirus |
Coronavirus disease 19 infection |
standard care alone, trifluoperazine alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Rasht University of Medical Sciences |
|
Iran |
2020-05-04 |
2020-05-27 |
IR.GUMS.REC.1399.021, IRCT20200329046892N1 |
Phase 2/Phase 3 Clinical |
Recruiting |
1 |
|
70 |
Nematollah Ahangar, Seyed Ali Alavi |
2020-05-08 |
| Genetics of COVID-19 Susceptibility and Manifestations |
Coronavirus disease 19 infection |
SNP chip assay alone, genome sequencing alone |
|
Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
National Human Genome Research Institute |
National Institutes of Health Clinical Center |
US |
2020-05-12 |
2025-06-01 |
20-HG-0090, 200090, NCT04371432 |
Phase Not Applicable |
Recruiting |
0 |
60 Months |
2500 |
Julie Sapp, Leslie G Biesecker, M.D. |
2020-05-08 |
| CATCH COVID-19: Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection |
Coronavirus disease 19 infection |
Serology test alone, Viral RNA test alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Texas Cardiac Arrhythmia |
|
US |
2020-05-31 |
2021-06-30 |
CATCH COVID-19, NCT04372004, TCAI_CATCH COVID-19 |
Phase Not Applicable |
Not yet recruiting |
0 |
13 Months |
100 |
Andrea Natale, Executive Medical Director, Deb Cardinal, RN MBA, MITRA Mohanty, MD |
2020-05-05 |
| Direct evidence of rectal cancer patient infected with novel coronavirus pneumonia (COVID-19) |
Coronavirus disease 19 infection, Viral pneumonia |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Zhangnan Hospital |
|
China |
2020-05-06 |
2020-05-16 |
ChiCTR2000032514 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
13 |
Jiang Congqing |
2020-05-05 |
| COVISLEEP: Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID-19 ARDS |
Coronavirus disease 19 infection, Respiratory distress syndrome |
neck inspiratory muscle (NIM) activation alone, polysomnography (PSG) alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital, Bordeaux |
|
France |
2020-04-30 |
2020-09-30 |
CHUBX 2020/14, COVISLEEP, NCT04371029 |
Phase Not Applicable |
Not yet recruiting |
1 |
5 Months |
25 |
Léo GRASSION, Dr, Renaud PREVEL, Dr |
2020-05-06 |
| Provider Burnout During COVID-19 |
Acute stress disorder, Coronavirus disease 19 infection |
coping strategies video alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Pittsburgh |
|
US |
2020-04-29 |
2020-10-29 |
NCT04370938, STUDY20040051 |
Phase Not Applicable |
Recruiting |
0 |
6 Months |
250 |
Sara Myers, MD, Sara P Myers, MD, PhD |
2020-05-06 |
| Recruit Blood Donors Via SMS During Epidemic of COVID-19 |
Coronavirus disease 19 infection |
blood donation SMS alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Guangzhou Blood Center |
|
China |
2020-04-30 |
2020-05-10 |
NCT04370886, RECRUIT BLOOD DONORS VIA SMS |
Phase Not Applicable |
Recruiting |
1 |
|
394578 |
|
2020-05-05 |
| Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity: a NutriQuebec Sub-study |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universite Laval |
|
Canada |
2020-04-16 |
2020-05-07 |
2018-042PHASE IIA6/09-04-2020, NCT04371848 |
Phase Not Applicable |
No longer recruiting |
1 |
|
2465 |
Benoît Lamarche |
2020-05-04 |
| A randomized, double-blind, placebo-controlled, Phase II/III trial to determine the safety and efficacy of DSTAT in COVID-19 patients with acute lung injury (ALI) |
Acute lung injury, Coronavirus disease 19 infection |
dociparstat (iv, AML/acute lung injury/COVID-19), Chimerix alone |
CXCR4 chemokine modulator, Cathepsin G inhibitor, Complement cascade inhibitor, Elastase inhibitor, Heparin agonist, High mobility group protein B1 inhibitor, L selectin antagonist, P selectin antagonist, Platelet factor 4 ligand inhibitor, Stromal cell-derived factor 1 ligand modulator |
|
Chimerix Inc |
|
|
2020-04-29 |
|
|
Phase 2/Phase 3 Clinical |
Recruiting |
0 |
|
524 |
|
2020-05-05 |
| Effect of Formoterol in treatment of covid19 |
Coronavirus disease 19 infection |
formoterol(Medochemie Company) alone, standard treatment alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
National Research Institute of Tuberculosis and Lung Diseases |
|
Iran |
2020-04-18 |
|
IR.SBMU.NRITLD.REC.1398.003, IRCT20170210032478N3 |
Phase 3 Clinical |
Recruiting |
1 |
|
50 |
Dr. Parisa Farnia, Fariba Ghorbani, Giti Pourdoulat, Guitti Pourdowlat |
2020-05-05 |
| Study on data management and diagnosis-treatment mode of TCM intervention for novel coronavirus pneumonia (COVID-19) convalescence |
Coronavirus disease 19 infection, Viral pneumonia |
TCM intervention alone |
|
|
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, National Science and Technology Support Plan of the People's Republic of China |
|
China |
2020-04-29 |
2021-04-22 |
2020YFC0845000, ChiCTR2000032480, ChiMCTR2000003257 |
Phase Not Applicable |
Not yet recruiting |
5 |
11 Months |
1000 |
Liu Baoyan, Liu Jia |
2020-05-05 |
| Effect of interactive psycho-educational interventions on patients infected with COVID-19 |
Coronavirus disease 19 infection |
psycho-educational interventions alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Shiraz University of Medical Sciences |
|
Iran |
2020-05-14 |
|
IR.SUMS.REC.1399.012, IRCT20130616013690N7 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
50 |
Maryam Shaygan, Younes Ghasemi |
2020-05-05 |
| Evaluation of the efficacy of melatonin tablets as auxiliary medication in accelerating the improvement of the COVID-19 symptoms and clinical findings |
Coronavirus disease 19 infection |
hydroxychloroquine plus melatonin |
|
|
Gonabad University of Medical Sciences |
|
Iran |
2020-04-14 |
|
IR.GMU.REC.1399.016, IRCT20200408046988N1 |
Phase 2/Phase 3 Clinical |
Recruiting |
1 |
|
60 |
Najmeh Davoodian, Najmeh Davoudian, Shayla khosravan |
2020-05-05 |
| FORCE: Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia |
Coronavirus disease 19 infection, Hypoxia, Respiratory distress syndrome, Viral pneumonia |
avdoralimab (IPH5401) alone |
CXCR1 chemokine antagonist, Complement C5a receptor antagonist, IL-8 receptor antagonist, Monocyte chemotactic protein 1 ligand inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Assistance Publique Hopitaux De Marseille |
Innate Pharma SA |
France |
2020-04-27 |
2020-10-27 |
2020-001686-36, 2020-21, FORCE, NCT04371367 |
Phase 2 Clinical |
Recruiting |
1 |
6 Months |
108 |
Direction de la Recherche Santé, Emilie Garrido-Pradalie, Julien CARVELLI, Julien CARVELLI, MD, Nicolas, SCHLEINITZ, MD |
2020-05-07 |
| Clinical trial study on the therapeutic effect of Tenofovir besides Kaletra and Chloroquinein in patients with Coronavirus disease 2019 (COVID-19) |
Coronavirus disease 19 infection |
Variable regimens including alfamed tenofovir , chloroquine , lopinavir + ritonavir |
HIV protease inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Ahvaz University of Medical Sciences |
|
Iran |
2020-04-18 |
|
IR.AJUMS.REC.1399.082, IRCT20200422047168N1 |
Phase 2/Phase 3 Clinical |
Recruiting |
1 |
|
60 |
Ali Akbar Shayesteh, Ali akbar Shayesteh, Zahra Shokati |
2020-05-06 |
| KILLER: Povidone-iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19 |
Coronavirus disease 19 infection |
povidone-iodine alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Universitaire De Poitiers Etablissement D’Hospitalisation |
|
France |
2020-05-01 |
2020-08-01 |
KILLER, KILLER, NCT04371965 |
Phase 2 Clinical |
Not yet recruiting |
1 |
3 Months |
24 |
Olivier MIMOZ, Professor, Sabrina SEGUIN, CRA |
2020-05-05 |
| Evaluation of the effect of Iranian medicine product, Algro, on patients with Coronavirus 19 |
Coronavirus disease 19 infection |
Algro alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Bagheiat-allah University of Medical Sciences |
|
Iran |
2020-05-04 |
2020-05-19 |
IR.BMSU.REC.1399.038, IRCT20160131026298N3 |
Phase 2/Phase 3 Clinical |
Recruiting |
1 |
|
80 |
Ahmad Reza Sharifi Olounabadi, REZAMOHTASHAMI, AHMAD REZA SHARIFI OLOUNABADI, Reza Mohtashami |
2020-05-05 |
| SirCO-1: Sirolimus in COVID-19 Phase I |
Coronavirus disease 19 infection |
Standard medical care alone, sirolimus alone |
mTOR inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Thomas Jefferson University |
|
US |
2020-05-31 |
2020-08-31 |
15680, NCT04371640, SirCO-1 |
Phase 1 Clinical |
Recruiting |
0 |
3 Months |
40 |
Angela C Pallotto, RN, BSN, Edwin Lam, PharmD, Walter K Kraft, MD |
2020-05-08 |
| Outcomes of Covid Protective Measures in Endoscopy |
Coronavirus disease 19 infection |
Covid PCR tests alone, endoscopy alone, protective protocol implementation alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Fundación Pública Miguel Servet |
|
Spain |
2020-04-27 |
2020-07-27 |
2020-COCHE, NCT04371354 |
Phase Not Applicable |
Not yet recruiting |
2 |
3 Months |
100 |
Juan J Vila, PhD, Ruth Garcia |
2020-05-06 |
| Evaluation effect of treatment with im (intramuscular) D3 on clinical, paraclinical symptoms and signs and inhospital outcome at patient admitted with COVID-19 |
Coronavirus disease 19 infection |
vitamin D alone |
|
|
Shahrood University of Medical Sciences |
|
Iran |
2020-05-21 |
|
IR.SHMU.REC.1399.013, IRCT20200411047024N1 |
Phase 1/Phase 2 Clinical |
Not yet recruiting |
1 |
|
100 |
Erfan Kazemi, Mohammad Hassan Emamian, hossien sheybani |
2020-05-05 |
| Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019 |
Coronavirus disease 19 infection, Viral pneumonia |
hormones therapy alone, mechanical ventilation alone, oxygen therapy alone, supportive therapy alone, oseltamivir plus umbilical cord mesenchymal stem cells |
Exo-alpha sialidase inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Fuzhou general hospital |
|
China |
2020-03-01 |
2022-12-31 |
MSC-COVID-2020, NCT04371601 |
Phase 0 Clinical |
No longer recruiting |
1 |
34 Months |
60 |
Jianming Tan Tan, M.D and Ph.D |
2020-05-05 |
| A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia |
Coronavirus disease 19 infection, Viral pneumonia |
standard of care alone, tocilizumab (intravenous), Roche/Chugai alone |
IL-6 receptor antagonist, IL-6 receptor modulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Genentech Inc |
|
|
2020-05-08 |
2020-10-05 |
ML42528, NCT04372186 |
Phase 3 Clinical |
Not yet recruiting |
0 |
4 Months |
379 |
Clinical Trials |
2020-05-07 |
| The COVID-ICU Healthcare Professional Study |
Coronavirus disease 19 infection |
electronic questionnaire on views and experiences alone |
|
Healthy volunteers accepted |
Oslo University Hospital |
|
Norway |
2020-04-30 |
2021-04-30 |
136144, NCT04372056 |
Phase Not Applicable |
Not yet recruiting |
1 |
12 Months |
2200 |
Irene LIe, Irene Lie, Siv Stafseth |
2020-05-07 |
| Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting |
Coronavirus disease 19 infection |
Variable regimens including azithromycin , doxycycline , hydroxychloroquine , zinc sulfate |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
St. Francis Hospital, New York |
|
US |
2020-04-28 |
2020-12-31 |
20-21, NCT04370782 |
Phase 4 Clinical |
Not yet recruiting |
0 |
8 Months |
750 |
Avni Thakore MD, Avni Thakore, MD, Elizabeth Haag, RN, Elizabeth S Haag, RN |
2020-05-05 |
| Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children |
Coronavirus disease 19 infection |
|
|
Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs) |
St Jude Children's Research Hospital |
|
US |
2020-04-27 |
2022-06-30 |
COVID-19, NCT04371315 |
Phase Not Applicable |
Recruiting |
0 |
26 Months |
400 |
Diego Hijano, MD |
2020-05-05 |
| Tocilizumab for Patients With Cancer and COVID-19 Disease |
Coronavirus disease 19 infection, Viral pneumonia |
tocilizumab (intravenous), Roche/Chugai alone |
IL-6 receptor antagonist, IL-6 receptor modulator |
Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
National Cancer Institute |
|
US |
2020-05-01 |
2022-01-01 |
NCI-2020-02987, NCT04370834, TRC-10446 |
Phase 2 Clinical |
Not yet recruiting |
0 |
20 Months |
200 |
Richard F Little |
2020-05-06 |
| Study of Resilience and Loneliness in Youth (18 to 25 Years Old) During the SARS-CoV2 Pandemic Lock-down Measures |
Coronavirus disease 19 infection, Psychiatric disorder |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs) |
Erasme Hospital |
King Baudouin Foundation, Universite Libre de Bruxelles |
Belgium |
2020-04-20 |
2020-12-30 |
NCT04371250, SRB2020_158 |
Phase Not Applicable |
Not yet recruiting |
1 |
8 Months |
600 |
Simone Marchini, MD |
2020-05-05 |
| COVID-HO: Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients |
Coronavirus disease 19 infection |
endotracheal intubation and ventilation alone, non-invasive ventilation alone |
|
|
Universiteit Hasselt |
|
Belgium |
2020-04-01 |
2020-12-01 |
COVID-HO, COVID-HO, NCT04371679 |
Phase Not Applicable |
Recruiting |
1 |
8 Months |
40 |
Lieven Herbots, Lieven Herbots, MD, PhD |
2020-05-05 |
| STC-19: Covid-19 Pandemic Triage Score |
Coronavirus disease 19 infection |
STC-19 score test alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier de La Rochelle |
Numa Health International |
France |
2020-03-01 |
2020-04-30 |
2020/P04/288, NCT04371471, STC-19 |
Phase Not Applicable |
No longer recruiting |
1 |
2 Months |
50 |
David Chalvet, MD, Jean-Claude Lapraz, MD, Kamyar M. Hedayat, MD, Serge Bénéteaud, MD |
2020-05-06 |
| EXPOCOVIA: Prevalence of COVID-19 Infection Among HCW in a French University Hospital |
Coronavirus disease 19 infection |
reverse transcription polymerase chain reaction (RT-PCR) alone, serological testing alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Regional Universitaire de Lille |
Fondation Santé Roquette |
France |
2020-04-30 |
2020-09-30 |
2020-A00951-38, 2020_35, EXPOCOVIA, NCT04371692 |
Phase Not Applicable |
Not yet recruiting |
1 |
5 Months |
100 |
Annie SOBASZEK, MD, Annie SOBASZEK, MD,PhD |
2020-05-05 |
| MSCs in COVID-19 ARDS |
Coronavirus disease 19 infection, Respiratory distress syndrome, Respiratory failure |
Standard of care alone, remestemcel-L alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Mount Sinai Medical Center |
Mesoblast Ltd |
US |
2020-04-30 |
2022-04-30 |
GCO 08-1078-0014, NCT04371393 |
Phase 3 Clinical |
Recruiting |
0 |
24 Months |
300 |
Abhijit Duggal, Alex Iribarne, MD, Alexis Mark, Annetine C Gelijns, PhD, Bradley Leshnower, MD, Chari Ponder, China Green, Christina Riggsbee, Denise Kosty-Sweeney, Edward Jauch, MD, Edward Lozano, Eustace Fernandes, MD, Guruprasad Jambaulikar, Hank Stokes, Hunter McDaniel, Jeffrey Sturek, MD, Jonathan Golob, MD, Kathleen Lane, Keren Osman, MD, Lydia McGowan, Manal Al-Suqi, Mary Beth Marks, Mary Lou Mayer, Michael Bowdish, MD, Michael Mack, MD, Mission Hospital, Nimesh Desai, MD, P. Eugene Parrino, MD, Peter Hou, MD, Peter Smith, MD, Rehma Shabbir, Robert Gottliebb, MD, Sharon Eichman, Sunjay Kaushal, MD |
2020-05-08 |
| Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Region Zealand |
|
Denmark |
2020-04-17 |
2020-04-24 |
ARTHROCANCELLATIONSUH2020, NCT04370678 |
Phase Not Applicable |
Completed |
1 |
|
79 |
Jesper S Nielsen, MD |
2020-05-08 |
| A trial to evaluate the effect of plasma therapy for the prevention and treatment of coronavirus infection |
Coronavirus disease 19 infection |
plasma therapy alone |
|
|
Columbia University |
Amazon.com Inc |
|
|
|
|
Phase 3 Clinical |
Status not specified |
0 |
|
450 |
|
2020-05-04 |
| COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings |
Coronavirus disease 19 infection, HIV infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
National Centre in HIV Epidemiology and Clinical Research |
The University of Liverpool, UNITAID, University of Montpellier, University of Witwatersrand |
South Africa, Australia, UK, Switzerland, France |
2020-05-15 |
2021-12-31 |
2020-04-COHIVE, COHIVE, NCT04371835 |
Phase Not Applicable |
Not yet recruiting |
5 |
19 Months |
1500 |
Alexandra Calmy, MD, PhD, Emmanuelle Papot, MD, Eric Delaporte, MD, PhD, Francois WD Venter, MD, Joana Woods, MD, Maria E Arriaga, PhD, Mark Polizzotto, MD, PhD, Saye Khoo, MD, PhD |
2020-05-05 |
| ACCORD 2: A Phase II Study for the Treatment of COVID 19 in Hospitalized Patients |
Coronavirus disease 19 infection |
Variable regimens including MEDI-3506 , acalabrutinib , bemcentinib , zilucoplan |
Axl tyrosine kinase receptor inhibitor, Btk tyrosine kinase inhibitor, Complement C5 factor inhibitor, Interleukin 33 ligand inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital Southampton NHS Foundation Trust |
|
UK |
2020-04-28 |
|
2020-001736-95, ACCORD 2, MasterACCORD-2-001subACCORD-2-002 |
Phase 2 Clinical |
Recruiting |
1 |
|
825 |
Emma Perry |
2020-05-06 |
| London Ambulance Service Experience of COVID-19 |
Coronavirus disease 19 infection |
|
|
|
London Ambulance Service NHS Trust |
London School of Hygiene and Tropical Medicine |
UK |
2020-04-09 |
2021-04-08 |
LAS-INT-2020-01, NCT04372069 |
Phase Not Applicable |
No longer recruiting |
1 |
12 Months |
40 |
Rachael Fothergill, PhD |
2020-05-05 |
| QT-Logs: Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19 |
Coronavirus disease 19 infection |
artificial intelligence QT measurement alone, smartwatch ECG collection alone, azithromycin plus hydroxychloroquine |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Assistance Publique Hopitaux De Marseille |
|
France |
2020-04-17 |
2020-05-11 |
CIL 2020-52, NCT04371744, QT-Logs |
Phase Not Applicable |
Recruiting |
1 |
|
100 |
Jean Claude Deharo, MD |
2020-05-06 |
| HYdILIC: Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19 |
Coronavirus disease 19 infection |
antibiotic therapy alone, oxygen therapy alone, standard of care alone, steroid therapy alone, Variable regimens including diltiazem , hydroxychloroquine , niclosamide , paracetamol |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Regional Universitaire de Lille |
University of Lille Nord de France |
France |
2020-05-31 |
2023-05-31 |
2020-002188-72, 2020_40, HYdILIC, NCT04372082 |
Phase 3 Clinical |
Not yet recruiting |
1 |
36 Months |
480 |
Karine Faure, MD,PhD |
2020-05-05 |
| AMBU-COVID: Proactive Care of Ambulatory COVID-19 Patients |
Coronavirus disease 19 infection |
azithromycin alone, teleconsultation alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Universitaire D Amiens |
|
France |
2020-04-29 |
2020-07-31 |
AMBU-COVID, NCT04371107, PI2020_843_0039 |
Phase 3 Clinical |
Not yet recruiting |
1 |
3 Months |
64 |
Jean-Philippe Lanoix, Jean-Philippe Lanoix, Pr |
2020-05-07 |
| Severity Score For COVID-19 Pneumonia |
Coronavirus disease 19 infection, Viral pneumonia |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Policlinico Universitario Agostino Gemelli |
|
Italy |
2020-04-29 |
2020-05-27 |
3112, NCT04372199 |
Phase Not Applicable |
Recruiting |
1 |
|
248 |
Massimo Montalto, Massimo Montalto, Professor |
2020-05-05 |
| Investigating the efficacy and safety of Hydroxychloroquine nasal spray in controlling the symptoms of patients with COVID-19 |
Coronavirus disease 19 infection |
Hydroxychloroquine nasal spray alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Baqiyatallah University of Medical Sciences |
|
Iran |
2020-05-01 |
|
IR.BMSU.REC.1399.091, IRCT20080901001165N51 |
Phase 3 Clinical |
Recruiting |
1 |
|
80 |
Nematollah Jonaidi, Parisa Kianpour, Yunes Panahi |
2020-05-05 |
| Effect of Deferiprone on the improvement of symptoms of Coronavirus 2019 (COVID-19) |
Coronavirus disease 19 infection |
deferiprone alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Sanandaj University of Medical Sciences |
|
Iran |
2020-05-04 |
|
IR.MUK.REC.1399.012, IRCT20180114038350N3 |
Phase 3 Clinical |
Recruiting |
1 |
|
80 |
Karim Naseri, Khaled Rahmani |
2020-05-05 |
| CO VOR IT: COVID-19: aaddition of azithromycin to chloroquine treatment |
Coronavirus disease 19 infection |
azithromycin alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Erasmus University Medical Center Rotterdam |
|
Netherlands |
2020-04-21 |
|
2020-001527-14, CO VOR IT |
Phase 4 Clinical |
Recruiting |
1 |
|
60 |
J.G.J.V. Aerts |
2020-05-07 |
| CHAMPS: COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Villanova University |
|
US |
2020-04-27 |
2040-04-27 |
CHAMPS, IRB FY2020-215, NCT04370821 |
Phase Not Applicable |
Recruiting |
0 |
240 Months |
20000 |
Donna Havens, PhD,RN,FAAN, Janell Mensinger, PhD,FAED, Peter G. Kaufmann, PhD, Sandra Schultz |
2020-05-08 |
| DYNAMIC: Doxycycline Ambulatoire COVID-19 |
Coronavirus disease 19 infection |
GRANUDOXY alone |
|
Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
CHU De Nantes |
|
France |
2020-05-01 |
2020-12-01 |
DYNAMIC, NCT04371952, RC20_0191 |
Phase 3 Clinical |
Not yet recruiting |
6 |
7 Months |
330 |
Amir KHAMMARI, Amir Khammari, Anne DOMPMARTIN-BLANCHERE, Brigitte DRENO, Brigitte DRENO, PUPH, Eve MAUBEC, Fabrice BONNET, Lionel PIROTH, Marie-Thérèse Leccia |
2020-05-08 |
| TCM Intervention study for novel coronavirus pneumonia (COVID-19) patient during home/designate-unit isolation based on community prevention and control |
Coronavirus disease 19 infection, Viral pneumonia |
TCM Intervention alone |
|
|
Guang'Anmen Hospital China Academy of Chinese Medical Sciences, TCM China Academy of Traditional Chinese Medicine Institute of Medicine |
|
China |
2020-02-03 |
2020-05-01 |
ChiCTR2000032478, ChiMCTR2000003256 |
Phase Not Applicable |
Recruiting |
5 |
2 Months |
3000 |
Liu Jia |
2020-05-07 |
| BCG-DENMARK-COVID: Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic |
Coronavirus disease 19 infection |
BCG vaccine alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Bandim Health Project |
AJ Vaccines A/S, University of Southern Denmark |
Denmark |
2020-05-31 |
2021-01-31 |
2020-001888-90, 20201504, BCG-DENMARK-COVID, BCG-DENMARK-COVID, NCT04373291 |
Phase 3 Clinical |
Not yet recruiting |
1 |
8 Months |
1500 |
Anne Marie Rosendahl Madsen, MD, Christine Stabell Benn, Professor, Clinical Institute, OPEN, Frederik Schaltz-Buchholzer, MD |
2020-05-06 |
| Experimental use of tocilizumab in COVID-19 related pneumonia |
Coronavirus disease 19 infection, Viral pneumonia |
standard of care alone, tocilizumab (intravenous), Roche/Chugai alone |
IL-6 receptor antagonist, IL-6 receptor modulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Clinique Inter-universitaire Ambroise Paré |
F Hoffmann-La Roche AG |
Belgium |
2020-04-21 |
|
2020-001770-30, 2020COVID-19TCZ |
Phase 2 Clinical |
Recruiting |
1 |
|
60 |
dr Camelia Rossi |
2020-05-07 |
| RECOP: Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID Infection (Unit 'COVID Possible') |
Coronavirus disease 19 infection, Dyspnea |
|
|
Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Universitaire de Toulouse |
|
France |
2020-03-13 |
2021-03-31 |
NCT04371328, RC31/20/0094, RECOP |
Phase Not Applicable |
Recruiting |
1 |
12 Months |
2000 |
Frédéric Balen, MD, Paul-Henri Auboiroux, MD |
2020-05-04 |
| Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19 |
Coronavirus disease 19 infection, Non-insulin dependent diabetes |
insulin plus linagliptin |
Dipeptidyl peptidase IV inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Rabin Medical Center |
|
Israel |
2020-05-15 |
2021-09-30 |
0303-20-RMC, NCT04371978 |
Phase 3 Clinical |
Not yet recruiting |
2 |
16 Months |
100 |
Alon Grossman, MD, Ran Abuhasira, Ran Abuhasira, MD |
2020-05-06 |
| Efficacy of Sn-protoporphyrin IX (SnPPIX) and Sulfonatoporphyrin(TPPS) Against Covid-19 |
Coronavirus disease 19 infection, Viral pneumonia |
Sn-protoporphyrin IX alone, sulfonated tetra-anthracenyl porphyrin alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Kafrelsheikh University |
|
Egypt |
2020-05-31 |
2020-08-31 |
NCT04371822, PROPOSED BY MAHMOUD ELKAZZ |
Phase 1 Clinical |
Not yet recruiting |
1 |
3 Months |
56 |
M.Sc. Mahmoud Elkazzaz, M.Sc.Biochemistry, M.Sc.Mahmoud Elkazzaz, M.Sc.Biochemistry, Mahmoud ELkazzaz |
2020-05-06 |
| Randomized, Double-Blind, Controlled Trial of Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection |
Coronavirus disease 19 infection |
hydroxychloroquine alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Sanford Health |
|
|
2020-04-30 |
2023-04-20 |
NCT04372017, SH HCQ |
Phase 3 Clinical |
Not yet recruiting |
0 |
35 Months |
1739 |
Christie Ellison, BSN, Susan Hoover, MD |
2020-05-04 |
| BREATH: Vitamin D Polymorphisms and Severity of COVID-19 Infection |
Coronavirus disease 19 infection, Vitamin D deficiency |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universidade de Lisboa |
Cardiovascular Centre of Universidade de Lisboa (CCUL), Cardiovascular Centre of Universidade de Lisboa (CCUL), Center for Health Technology and Services Research, Centro Hospitalar Sao Joao, HeartGenetics, Genetics & Biotechnology, S.A., Hospital de Santa Maria, Instituto Gulbenkian de Ciencia (IGC), Nova Medical School |
Portugal |
2020-06-30 |
2021-03-31 |
BREATH, COVID19-BREATH, NCT04370808 |
Phase Not Applicable |
Not yet recruiting |
2 |
9 Months |
500 |
Ana Freitas, PhD, Ana Miranda, MD, Conceição Calhau, PhD, Fausto J Pinto, PhD, Fausto Pinto, PhD, Fátima Casaca, BSc, Helena Proença, MD, Melo Cristino, PhD, Tiago Guimarães, PhD |
2020-05-08 |
| Investigating the efficacy and safety of Azithromycin inhaled spray in controlling the symptoms of patients with COVID-19 |
Coronavirus disease 19 infection |
Azithromycin inhaled spray alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Baqiyatallah University of Medical Sciences |
|
Iran |
2020-05-01 |
|
IR.BMSU.REC.1399.092, IRCT20080901001165N50 |
Phase 3 Clinical |
Recruiting |
1 |
|
80 |
Morteza Izadi, Parisa Kianpour, Yunes Panahi |
2020-05-08 |
| A real-time, smartphone-based data collection study in order to uncover scientifically significant trends about the current coronavirus pandemic |
Coronavirus disease 19 infection |
smartphone-based data collection alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
American Lung Association, Northwestern University, University of California San Francisco |
|
|
|
|
|
Phase Not Applicable |
Recruiting |
0 |
|
|
|
2020-05-04 |
| PROVIDE: Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers |
Coronavirus disease 19 infection |
hydroxychloroquine sulfate alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
St Josephs Healthcare Hamilton |
|
Canada |
2020-05-01 |
2020-08-30 |
3190, NCT04371523, PROVIDE |
Phase 3 Clinical |
Not yet recruiting |
1 |
3 Months |
1100 |
Kimberley Lewis, Waleed Al-Hazzani, Waleed Alhazzani |
2020-05-05 |
| Study for the water extract of soybean in the treatment of patients with novel coronavirus pneumonia (COVID-19) |
Coronavirus disease 19 infection, Viral pneumonia |
soybean extract alone |
|
|
Wuhan University |
|
China |
2020-03-01 |
|
ChiCTR2000030162 |
Phase 0 Clinical |
Terminated |
1 |
|
|
|
2020-05-05 |
| A phase I/IIa clinical study to assess cVLP vaccine in the treatment of patietns with COVID-19 infection |
Coronavirus disease 19 infection |
cVLP vaccine (COVID19 infection), AdaptVac alone |
|
|
AdaptVac |
EU Horizon 2020, ExpreS2ion Biotechnologies, Koebenhavns Universitet, Leiden University Medical Center, University Hospital Tubingen, Wageningen University and Research |
|
|
|
|
Phase 1/Phase 2 Clinical |
Planned |
0 |
|
|
|
2020-05-04 |
| Predicting Death and ICU Admission in COVID-19 Patients in ED |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Policlinico Universitario Agostino Gemelli |
|
Italy |
2020-03-01 |
2020-04-15 |
0017055/20, NCT04371562 |
Phase Not Applicable |
Completed |
1 |
1 Month |
300 |
Francesco Franceschi, MD PhD |
2020-05-06 |
| J-COVID: Prospective, observational study on diagnosis and treatment of COVID-19 |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Japanese Red Cross Medical Center |
|
Japan |
2020-02-01 |
|
J-COVID, UMIN000040295 |
Phase Not Applicable |
Recruiting |
1 |
|
100 |
Takehiro Izumo |
2020-05-06 |
| A clinical study of hydroxychloroquine versus the standard of care for the treatment in patients hospitalized with COVID-19 infection |
Coronavirus disease 19 infection |
hydroxychloroquine alone |
|
Male |
Food and Drug Administration |
|
US |
|
|
|
Phase Not Applicable |
Status not specified |
0 |
|
368 |
|
2020-05-04 |
| A pilot study to assess the clinical activity, safety and tolerability of Selective Cytopheretic Device (SCD) among patients who have ARDS prior to CRRT and/or AKI with CRRT |
Adult respiratory distress syndrome, Coronavirus disease 19 infection |
Selective Cytopheretic Device (SCD) alone |
|
|
Seastar Medical Inc |
Empiristat Inc. |
US |
2020-04-28 |
|
SCD-005 |
Phase Not Applicable |
Recruiting |
0 |
|
35 |
|
2020-05-05 |
| Pharmacodynamics of the Nasalferon in healthy volunteers |
Coronavirus disease 19 infection |
recombinant interferon alfa 2b (Nasalferon) alone |
|
Healthy volunteers accepted, Male, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Center for Genetic Engineering and Biotechnology |
Ministerio de Salud Publica |
Cuba |
2020-05-04 |
2020-06-09 |
IG / IAGN / VS / 2001, RPCEC00000308 |
Phase 1 Clinical |
Not yet recruiting |
1 |
1 Month |
30 |
Carlos Alberto GonzAlez Delgado, Hugo Nodarse Cuni |
2020-05-05 |
| Study for construction and assessment of early warning score of the clinical risk of novel coronavirus (COVID-19) infected patients |
Coronavirus disease 19 infection |
|
|
|
West China Hospital |
Science & Technology Department of Sichuan Province |
China |
2020-01-01 |
2020-12-31 |
2020YFS0009, ChiCTR2000029907 |
Phase 0 Clinical |
Not yet recruiting |
1 |
12 Months |
1000 |
Yao, Rong |
2020-05-05 |
| Construction and Analysis of Prognostic Predictive Model of Novel Coronavirus Pneumonia (COVID-19) |
Coronavirus disease 19 infection, Viral pneumonia |
|
|
|
Zhangnan Hospital |
Hubei Clinical Research Center |
China |
2020-02-01 |
2021-05-01 |
ChiCTR2000029953 |
Phase Not Applicable |
Not yet recruiting |
1 |
15 Months |
400 |
Xianlong Zhou, Yan Zhao |
2020-05-05 |
| HOPE study: Evaluation of the effect and safety of HeberFERON versus Heberon alfa in patients infected with the SARS-CoV-2 coronavirus (COVID-19) |
Coronavirus disease 19 infection |
HeberFERON alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Center for Genetic Engineering and Biotechnology |
Ministerio de Salud Publica |
Cuba |
2020-04-10 |
2020-07-30 |
HOPE study, IG / IAG / CV / 2001, RPCEC00000307 |
Phase 2 Clinical |
Recruiting |
1 |
3 Months |
120 |
Idelsis Esquivel Moynelo, Irraldo Bello Rivero |
2020-05-05 |
| Triple combination therapy in patients infected with COVID-19 |
Coronavirus disease 19 infection, Viral pneumonia |
Variable regimens including hydroxychloroquine sulfate , lopinavir + ritonavir , oseltamivir |
Exo-alpha sialidase inhibitor, HIV protease inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Gunma University Hospital |
|
Japan |
2020-04-01 |
|
jRCTs031190227 |
Phase 2 Clinical |
Recruiting |
1 |
|
50 |
Nakamura Tetsuya, Tokue Yutaka |
2020-05-05 |
| Favipiravir in patients infected with COVID-19 |
Coronavirus disease 19 infection, Viral pneumonia |
favipiravir alone |
RNA polymerase inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Gunma University Hospital |
|
Japan |
2020-03-14 |
|
jRCTs031190226 |
Phase 2 Clinical |
Recruiting |
1 |
|
50 |
Nakamura Tetsuya, Tokue Yutaka |
2020-05-05 |
| RACCO: A multicenter, open-label, randomized, controlled trial to evaluate the efficacy and safety of inhaled ciclesonide for asymptomatic and mild patients with COVID-19 |
Coronavirus disease 19 infection, Viral pneumonia |
ciclesonide alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Japanese Ministry of Health, Labor and Welfare |
|
Japan |
2020-04-03 |
|
RACCO, jRCTs031190269 |
Phase 2 Clinical |
Recruiting |
1 |
|
90 |
Junko Terada, Sugiyama Haruhito |
2020-05-05 |
| Favipiravir for SARS-CoV-infected patients |
Coronavirus disease 19 infection |
favipiravir alone |
RNA polymerase inhibitor |
Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Japan Agency for Medical Research and Development |
|
Japan |
2020-03-02 |
|
jRCTs041190120 |
Phase 2 Clinical |
Recruiting |
1 |
|
86 |
Doi Yohei, Kondo Masashi |
2020-05-05 |
| CHARTER: COVID-19: can nebulized heparin reduce time to extubation in SARS-CoV-2 patients requiring mechanical ventilation |
Coronavirus disease 19 infection |
heparin alone, invasive mechanical ventilation alone, standard care alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
St Vincents Hospital (Melbourne) Ltd |
Victorian State Government |
Australia |
2020-05-21 |
2021-07-25 |
ACTRN12620000517976p, CHARTER |
Phase 3 Clinical |
Not yet recruiting |
3 |
14 Months |
172 |
Dr Barry Dixon |
2020-05-05 |
| SARS-CoV2 in children presenting to hospital: a repeating point prevalence study during the COVID-19 pandemic in South East Queensland |
Coronavirus disease 19 infection |
PCR alone |
|
Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs) |
Gold Coast Hospital |
Griffith University |
Australia |
2020-04-29 |
2020-09-18 |
ACTRN12620000512921, HREC/2020/QGC/63198 |
Phase Not Applicable |
Not yet recruiting |
1 |
4 Months |
400 |
A/Prof Shane George |
2020-05-05 |
| ARDS Caused by COVID-19 |
Coronavirus disease 19 infection, Respiratory distress syndrome, Respiratory failure |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hospital Clinic of Barcelona |
Ubikare company |
Spain |
2020-03-12 |
2020-12-31 |
COVID-19 ARDS, NCT04368975 |
Phase Not Applicable |
Recruiting |
1 |
9 Months |
500 |
Carlos Ferrando, Carlos Ferrando, PhD, Sara Darriba, PhD |
2020-05-05 |
| Clinical Application of Methylene Blue for Treatment of Covid-19 Patients |
Coronavirus disease 19 infection |
MCN (methylene blue, vitamin C, N-acetyl cysteine) alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Mashhad University of Medical Sciences |
|
Iran |
2020-04-19 |
2020-09-21 |
IR.MUMS.REC.1399.122, NCT04370288 |
Phase 1 Clinical |
Recruiting |
1 |
5 Months |
20 |
Ahmad Bagheri Moghaddam, M.D, Amir Yarahmadi, Ph.D, Daryoush Hamidi Alamdari, Ph.D |
2020-05-05 |
| Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia |
Acute lung injury, Coronavirus disease 19 infection, Respiratory distress syndrome, Viral pneumonia |
Best Supportive Care alone, ravulizumab alone |
Complement C5 factor inhibitor, IgG receptor FcRn large subunit p51 modulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Alexion Pharmaceuticals Inc |
|
|
2020-05-06 |
2021-02-28 |
ALXN1210-COV-305, NCT04369469 |
Phase 3 Clinical |
Recruiting |
0 |
9 Months |
270 |
Alexion Pharmaceuticals, Inc. |
2020-05-08 |
| Repeated Measures Trial of Temporary Automated Manual Ventilation Versus Noninvasive Oxygenation or Conventional Vent |
Coronavirus disease 19 infection, Lung infection, Respiratory failure |
Mechanical ventilation alone, automated BVM compressor device, Spiro LLC/10x beta alone, rocuronium alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Massachusetts General Hospital |
|
|
2020-05-31 |
2020-11-30 |
2020P001051, NCT04369274 |
Phase 2 Clinical |
Not yet recruiting |
0 |
6 Months |
30 |
Blair Parry, CCRC, Keith A Marill, MD |
2020-05-05 |
| BATTLE: COVID-19: BCG as Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement |
Coronavirus disease 19 infection |
BCG vaccine alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universidade Estadual de Campina |
Botucatu Medical School, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Faculdade de Medicina de Ribeirão Preto, Federal University of Sao Paulo, Instituto de Infectologia Emílio Ribas, Paulinia Municipal Hospital, Pontificia Universidade Catolica de Campinas, State Hospital Dr. Leandro Franceschini |
Brazil |
2020-06-30 |
2022-05-31 |
BATTLE, COVID-19 BATTLE TRIAL, NCT04369794 |
Phase 4 Clinical |
Not yet recruiting |
1 |
23 Months |
1000 |
Bethania F Nascimento, BSN, Leonardo O Reis, MD, PhD |
2020-05-04 |
| Anxiety And Depression During COVID-19 In India |
Anxiety disorder, Coronavirus disease 19 infection, Depression |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Max Healthcare Institute Ltd, India |
|
India |
2020-04-24 |
2021-02-24 |
COVID-19/MHC/PSYCH/20-10, NCT04369300 |
Phase Not Applicable |
Not yet recruiting |
1 |
10 Months |
1000 |
|
2020-05-04 |
| MATCH: Multi-site Adaptive Trials Using Hydroxycholoroquine for COVID-19 |
Coronavirus disease 19 infection |
famotidine plus hydroxychloroquine |
Histamine H2 receptor antagonist |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Northwell Health Inc |
|
US |
2020-04-07 |
2021-04-07 |
20-0268, MATCH, NCT04370262 |
Phase 3 Clinical |
Recruiting |
0 |
12 Months |
1170 |
Amanda Tice, RN, Asha Mellor, CCRC, Christina Brennan, MD, John Boockvar, MD, Joseph Conigliaro, MD, Julie DiGregorio, CCRP, Negin Hajizadeh, MD, Neubert Philippe, MD, Patricia Nadraus, RN, Richard Dima, MD, Tamika Wong, MPH |
2020-05-06 |
| Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q Vest |
Coronavirus disease 19 infection, Hypoxia, Respiratory distress syndrome, Respiratory failure |
V/Q Vest alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Emory University |
Georgia Institute for Clinical Research, Georgia Institute of Technology |
US |
2020-05-31 |
2021-03-31 |
NCT04369599, STUDY00000402 |
Phase Not Applicable |
Not yet recruiting |
0 |
10 Months |
24 |
Maxwell Weinmann, MD |
2020-05-04 |
| Curie-O-SA: COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Institut Curie |
|
France |
2020-04-28 |
2021-01-28 |
Curie-O-SA, IC 2020-07, NCT04369066 |
Phase Not Applicable |
Recruiting |
1 |
9 Months |
2500 |
Isabelle Turbiez, Olivier Lantz, MD, Pierre Fumoleau, PhD |
2020-05-04 |
| XPro-1595 for the Treatment of Pulmonary Complications From COVID-19 |
Coronavirus disease 19 infection, Lung disease |
INB-03 alone, standard of care alone |
TNF alpha ligand inhibitor |
Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
INmune Bio Inc |
|
|
2020-06-30 |
2021-01-31 |
NCT04370236, XPRO1595-COVID-19 |
Phase 2 Clinical |
Not yet recruiting |
0 |
7 Months |
150 |
Christopher Barnum, PhD |
2020-05-05 |
| COVID-19.KDIR.01: Long-term Analysis and Evaluation of morphologic and clinical Parameters in COVID-19 Patients: prospective development of a practical risk score |
Coronavirus disease 19 infection, Viral pneumonia |
CT scan alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Stuttgart Cancer Center |
|
Germany |
2020-04-17 |
|
COVID-19.KDIR.01, DRKS00021537, F-2020-047, U1111-1251-0942 |
Phase Not Applicable |
Recruiting |
1 |
|
150 |
Götz Martin Richter |
2020-05-04 |
| SARS-CoV-2 in tears in patients with COVID-19 |
Coronavirus disease 19 infection, Ocular disease |
RT-PCR assay alone, funduscopy alone, slit-lamp examination alone |
|
|
Universitatsklinikum Schleswig-Holstein Campus Kiel |
|
Germany |
2020-04-29 |
|
D 469/20, DRKS00021416 |
Phase Not Applicable |
Recruiting |
1 |
|
30 |
Mr. Prof. Dr. med. Johann Baptist Roider, Ms. Dr. med. Kristin Hosel |
2020-05-04 |
| ATHLOS: Telerehabilitation in Patients With COVID-19 After Hospitalization |
Coronavirus disease 19 infection |
aerobic exercise alone, breathing exercise alone, resistive training exercise alone, telerehabilitation alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory |
University of Athens, University of Ioannina, University of Thessaly |
Greece |
2020-04-30 |
2021-03-31 |
1, ATHLOS, NCT04368845 |
Phase Not Applicable |
Not yet recruiting |
1 |
11 Months |
100 |
ELENI KAPRELI, PhD, PT, ELENI KORTIANOU, PhD, PT, Eleni Kortianou |
2020-05-04 |
| Management of Covid-19 Patients During Home Isolation |
Coronavirus disease 19 infection |
oxygen alone, physical therapy alone |
|
Young Adults (18-44 yrs) |
Cairo University |
|
Egypt |
2020-03-15 |
2020-05-20 |
2318087, NCT04368923 |
Phase 2 Clinical |
No longer recruiting |
1 |
2 Months |
60 |
Mahmoud Sedky |
2020-05-04 |
| COVID-OZO: Ozone Auto-hemotherapy for COVID-19 Pneumonia |
Coronavirus disease 19 infection, Viral pneumonia |
ozone auto-hemotherapy alone, standard treatment alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
L'Institut d Investigacio Biomedica de Girona |
Hospital Nuestra Señora del Rosario, Sociedad Española de Ozonoterapia |
Spain |
2020-05-04 |
2020-12-25 |
COVID-19 NETWORKING GROUP, COVID-OZO, NCT04370223 |
Phase 3 Clinical |
Not yet recruiting |
9 |
7 Months |
208 |
Alberto Hernández, MD, PhD, Antònia Flor, MD, Eduardo Tamayo, MD, PhD, Isabel Guitart, MD, Javier Ripolles, MD, PhD, Marc Vives, MD, Marc Vives, MD, PhD, Miguel Angel Garcia, MD, Noelia Zurera Plaza, MD |
2020-05-06 |
| JoCORE: Acute Cardiovascular Events Triggered by COVID-19-Related Stress |
Acute stress disorder, Cardiovascular disease, Coronavirus disease 19 infection, Myocardial infarction, Shock, Sudden cardiac death, Ventricular tachycardia |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Jordan Collaborating Cardiology Group |
|
Jordan |
2020-05-03 |
2020-08-30 |
JCCG.JOCORE.4.4040, JoCORE, NCT04368637 |
Phase Not Applicable |
Recruiting |
6 |
3 Months |
50 |
Ayadeh Madanat, MD, Ayman Hammoudeh, MD, FACC, Ayman J Hammoudeh, MD, FACC, Ayman J. Hammoudeh, MD, FACC, Eyadeh Madanat, MD, Hadi Abu Hantash, MD, FACC, Hadi Abu hantash, MD, FACC, Imad Alhaddad, MD, Mahmoud Fakhri, MD, Mahmoud Izraiq Mahmoud Izraiq, MD, Walaa Abu Moghli, PharmD, Zaid Khouri, MD, Zeina Abu Orabi, MD |
2020-05-06 |
| VIRUS: Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19 |
Coronavirus disease 19 infection, Respiratory failure |
clinical-echo score prediction alone, pleuro-pulmonary ultrasound alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
CHU De Nantes |
WINFOCUS-France |
France |
2020-04-09 |
2020-06-30 |
NCT04370249, RC20_0164, VIRUS |
Phase Not Applicable |
Recruiting |
1 |
2 Months |
400 |
Philippe LE CONTE, Philippe LE CONTE, MD-PHD, Philippe PES, MD |
2020-05-04 |
| CONFIDODO: Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry |
Anxiety disorder, Coronavirus disease 19 infection, Depression, Sleep disorder |
routine psychiatric care alone |
|
Healthy volunteers accepted, Children (6-12 yrs) |
Centre Hospitalier René-Dubos |
|
France |
2020-05-31 |
2020-06-30 |
CHRD 0520, CONFIDODO, NCT04370210 |
Phase Not Applicable |
Not yet recruiting |
1 |
1 Month |
464 |
Erwan VION, Maryline Delattre, Véronique Da Costa |
2020-05-04 |
| Project D: Observational Study to Assess the Seroconversion Status of Health Care Workers and Suspected or Confirmed Cases of COVID-19 Patients |
Coronavirus disease 19 infection |
COVID-19 testing alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Max Healthcare Institute Ltd, India |
|
India |
2020-04-22 |
2020-07-30 |
COVID-19/MHC-2/2020, NCT04368884, Project D |
Phase Not Applicable |
Recruiting |
1 |
3 Months |
1000 |
Samreen Siddiqui, PhD, Sujeet Jha, MRCP (U.K), Swati Waghdhare, MD |
2020-05-04 |
| Observational Study of COVID-19 Treatment Efficacy |
Coronavirus disease 19 infection, Respiratory distress syndrome |
hydroxychloroquine alone, remdesivir alone, azithromycin plus hydroxychloroquine |
Coronavirus non structural protein 8 modulator, RNA polymerase modulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
OSF Healthcare System |
|
US |
2020-04-14 |
2021-04-14 |
1589936, NCT04369989 |
Phase Not Applicable |
Recruiting |
0 |
12 Months |
1000 |
David Hall |
2020-05-04 |
| TEACH: Treating COVID-19 With Hydroxychloroquine |
Coronavirus disease 19 infection |
hydroxychloroquine alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
NYU Langone Health |
SUNY Downstate Medical Center |
US |
2020-04-15 |
2020-06-30 |
20-00463, NCT04369742, TEACH |
Phase 2 Clinical |
Recruiting |
0 |
2 Months |
626 |
Jack A. DeHovitz, MD, MPH, MHCDS, FACP, Mark Mulligan, MD, Mark Mulligan, MD, FIDSA, Robert Ulrich, MD |
2020-05-04 |
| COVERSCAN: Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection |
Coronavirus disease 19 infection |
MRI alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Perspectum Diagnostics Ltd |
|
UK |
2020-04-21 |
2023-05-31 |
20/SC/0185, COVERSCAN, NCT04369807 |
Phase Not Applicable |
Recruiting |
2 |
37 Months |
507 |
Mary Norris Xu, BSc, RN, Rajarshi Banerjee, MSc, DPhil, Sandeep Kapur, BSc, MBBS |
2020-05-04 |
| Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant |
Coronavirus disease 19 infection |
SARS-CoV recombinant vaccine (nanoparticle), Novavax alone, Matrix M plus SARS-CoV recombinant vaccine (nanoparticle), Novavax |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Novavax Inc |
|
Australia |
2020-05-15 |
2021-07-31 |
2019NCOV-101, NCT04368988 |
Phase 1/Phase 2 Clinical |
Not yet recruiting |
2 |
14 Months |
131 |
Biljana Georgievska |
2020-05-04 |
| Stroke-Covid19: Covid-19 Epidemic on Acute Stroke Management |
Coronavirus disease 19 infection, Stroke |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hopitaux Universitaires de Strasbourg |
|
France |
2020-03-03 |
2020-04-30 |
7826, NCT04370197, Stroke-Covid19 |
Phase Not Applicable |
Recruiting |
1 |
1 Month |
300 |
Raoul POP, MD, Rémy BEAUJEUX, MD, PhD, Saïd CHAYER, PhD, HDR |
2020-05-04 |
| PROTECT: Improving prenatal care during confinement |
Coronavirus disease 19 infection, Parturition |
remote consultation alone |
|
Healthy volunteers accepted, Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Central Hospital, Nancy, France |
|
|
2020-05-01 |
2021-09-30 |
2020-A01023-36, NCT04368832, PROTECT |
Phase Not Applicable |
Not yet recruiting |
0 |
17 Months |
108 |
Gaëlle Ambroise, Nadine JUGE |
2020-05-04 |
| Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults |
Coronavirus disease 19 infection |
Variable regimens including BNT-162a1 , BNT-162b1 , BNT-162b2 , BNT-162c2 |
COVID19 Spike glycoprotein modulator |
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
BioNTech SE |
Pfizer Inc |
US |
2020-04-29 |
2023-01-27 |
C4591001, NCT04368728 |
Phase 1/Phase 2 Clinical |
Recruiting |
0 |
32 Months |
7600 |
Pfizer CT.gov Call Center |
2020-05-08 |
| Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers |
Coronavirus disease 19 infection |
hydroxychloroquine alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
SERVICES INSTITUTE OF MEDICAL SCIENCES |
|
Pakistan |
2020-05-15 |
2020-10-15 |
16082019, NCT04370015 |
Phase 2 Clinical |
Not yet recruiting |
1 |
5 Months |
374 |
Khadija I Khawaja, FCPS, Saira Burney, FRCP (Edin) |
2020-05-07 |
| CORRECT: COvid (Covid-19) Registry REChts der Isar intensive care Trial |
Adult respiratory distress syndrome, Coronavirus disease 19 infection |
extracorporeal organ support alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Technical University of Munich |
|
Germany |
2020-03-30 |
|
178/20S, CORRECT, DRKS00021612 |
Phase Not Applicable |
Recruiting |
1 |
|
500 |
Sebastian Rasch |
2020-05-04 |
| TeleCoviDiab: Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic |
Coronavirus disease 19 infection, Insulin dependent diabetes, Non-insulin dependent diabetes |
teleconsultation alone, telemedicine alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital of Strasbourg |
|
France |
2020-05-31 |
2020-12-31 |
7775, NCT04370171, TeleCoviDiab |
Phase Not Applicable |
Not yet recruiting |
1 |
7 Months |
200 |
Eric DEMONSANT |
2020-05-06 |
| SeCo: Screening for SARS-CoV-2-Infections and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers |
Coronavirus disease 19 infection |
Anti-SARS-CoV2 S protein IgG ELISA alone, SARS-CoV-2 PCR alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Medicine Greifswald |
EUROIMMUN GmbH, Friedrich Loeffler Institute |
Germany |
2020-04-27 |
2025-05-31 |
BB 068/20, NCT04370119, SeCo |
Phase Not Applicable |
Recruiting |
2 |
61 Months |
4000 |
Andreas Greinacher, Prof.Dr., Christine Rutscher, Dipl.-Med., Henry Völzke, Prof.Dr., Karsten Becker, Prof.Dr., Lena Ulm, Dr., Marek Zygmunt, Prof.Dr., Martin Beer, Prof.Dr., Martin Groschup, Prof.Dr., Matthias Nauck, Prof.Dr., Mladen V. Tzvetkov, Prof.Dr., Nicole Endlich, Prof.Dr., Nils-Olaf Hübner, Prof.Dr., Thomas C. Mettenleiter, Prof.Dr., Wolfgang Schlumberger, Dr. |
2020-05-04 |
| PAN-COVID: A global registry of women affected by COVID-19 in pregnancy and their babies, to guide treatment and prevention |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Imperial College London |
United Kingdom Research & Innovation |
Egypt, Israel, India, Mexico, Romania, US, Argentina, Canada, Greece, UK, Japan, Lebanon, Belgium, Indonesia, Germany, Russian Federation, Czech Republic, Austria, Guatemala, Tunisia, Brazil, Netherlands, South Africa, Bosnia and Herzegovina, Colombia, Nigeria, Spain, Malta, Peru, Thailand, Uganda, Latvia, United Arab Emirates, Hungary, Italy, Australia, Ireland, Qatar, Estonia, Portugal, Ecuador, Chile |
2020-01-01 |
2021-09-30 |
20QC5917, IRAS 282655, ISRCTN68026880, PAN-COVID |
Phase Not Applicable |
Recruiting |
42 |
21 Months |
1000 |
Dr Mullins |
2020-05-04 |
| POCUSars-CoV-2: Accuracy of Lung Ultrasound in the Diagnosis of COVID-19 Pneumonia |
Coronavirus disease 19 infection, Respiratory disease, Viral pneumonia |
lung ultrasound alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Latisana Hospital |
|
Italy |
2020-04-23 |
2020-05-31 |
CEUR-2020-OS-086, NCT04370275, POCUSars-CoV-2 |
Phase Not Applicable |
Recruiting |
1 |
1 Month |
235 |
Carmine C Di Gioia, MD, Daniele Orso, MD, Roberto Copetti, MD, Director |
2020-05-04 |
| In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity |
Coronavirus disease 19 infection |
|
|
Male, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Applied Biology Inc |
Hospital Universitario Ramon y Cajal |
Spain |
2020-05-01 |
2020-12-01 |
AB-IVD-COV-001, NCT04368897 |
Phase Not Applicable |
Recruiting |
1 |
7 Months |
200 |
Andy Goren, MD, Carlos Wambier, MD, Sabina Herrera, MD |
2020-05-07 |
| Hungarian CoronaVirus Disease-19 Epidemiological Research |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Semmelweis University Heart and Vascular Center |
Semmelweis University, University Of Pécs, University of Debrecen, University of Szeged |
Hungary |
2020-05-01 |
2021-08-01 |
H-UNCOVER, NCT04370067 |
Phase Not Applicable |
Not yet recruiting |
4 |
15 Months |
11200 |
Andor Sebestyén, MD,PhD, Annamaria Kosztin, MD,PhD, Béla Merkely, PhD,DSc, Csaba Lengyel, MD,PhD, Ervin László Berényi, MD,PhD |
2020-05-04 |
| Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: a Prospective Study |
Coronavirus disease 19 infection |
real time reverse transcriptase polymerase chain reaction(rRT-PCR) alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Max Healthcare Institute Ltd, India |
|
India |
2020-04-28 |
2021-05-30 |
COVID-19/RFTC/MHC/2020, NCT04368871 |
Phase Not Applicable |
Not yet recruiting |
1 |
13 Months |
200 |
Bharat Aggarwal, Rajesh Saxena |
2020-05-05 |
| GROCO: Obstetric and Perinatal Outcomes of Women With COVID-19 |
Coronavirus disease 19 infection |
|
|
Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Assistance Publique Hopitaux De Marseille |
|
France |
2020-04-23 |
2021-04-22 |
2020-18, GROCO, ID RCB, NCT04369859 |
Phase Not Applicable |
Recruiting |
1 |
12 Months |
1300 |
Florence BRETELLE, PU-PH, Jean-Olivier ARNAUD, Director |
2020-05-05 |
| C5-COV: C5a Receptor Expression - COVID-19 |
Coronavirus disease 19 infection, Respiratory distress syndrome |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Assistance Publique Hopitaux De Marseille |
Innate Pharma SA |
France |
2020-03-31 |
2020-11-30 |
2020-14, C5-COV, IDRCB, NCT04369820 |
Phase Not Applicable |
Recruiting |
1 |
8 Months |
100 |
Emilie EGP GARRIDO-PRADALIE, Julien CARVELLI, Julien JC CARVELLI, MD, Kahéna AMICHI, Kahéna KA AMICHI, Laurent PAPAZIAN, Lionel VELLY, Marc GAINNIER, Nicolas SCHLEINITZ, Pierre-Yves CORDIER |
2020-05-05 |
| C19Survey: The Psychological, Social, and Economic Impacts of COVID-19 |
Coronavirus disease 19 infection, Psychiatric disorder |
online survey alone |
|
Healthy volunteers accepted, Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Ottawa |
CHEO Research Institute, Centre for Addiction and Mental Health, Ciusss du Nord-De-L'île-De-Montréal, Hopital Du Sacre-Coeur De Montreal, Johns Hopkins University, McGill University, Ottawa Heart Institute Research Corp, Ottawa Hospital Research Institute, Southlake Regional Health Centre, Sunnybrook Health Sciences Centre, The Royal's Institute of Mental Health Research, Universite De Montreal |
Canada |
2020-04-03 |
2021-04-03 |
2131, C19Survey, NCT04369690 |
Phase Not Applicable |
Recruiting |
10 |
12 Months |
1000 |
Addo Boafo, MD, Alexander Daros, PhD, CPsych, Cynda Rushton, RN, PhD, Denis Lafortune, PhD, Edward Spilg, FRCP, MSc, Elizaveta Solomonova, PhD, Janet Jeffrey, RN, PhD, Jennifer Phillips, PhD, Jodi Edwards, PhD, Kaitlyn Lopes, Lena Quilty, PhD, CPsych, Mamta Gautam, FRCP MBA, Marie-Hélène Pennestri, PhD, Mysa Saad, MSc, Raj Bhatla, MD FRCPC, Richard H Swartz, MD, PhD, Richard Swartz, MD, PhD, Roger Godbout, PhD, Rébecca Robillard, Rébecca Robillard, PhD, Samuel Paul Louis Veissière, PhD, Tetyana Kendzerska, MD PhD, Tetyana Kendzerska, MD, PhD, Wendy Gifford, RN, PhD, Zachary Kaminsky, PhD |
2020-05-04 |
| DigitalDoc: The Digital Doc in the Emergency Department: The solution for patient care in the Covid-19 pandemic? |
Coronavirus disease 19 infection |
telemedicine alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Maxima Medical Center |
|
Netherlands |
2020-04-08 |
2020-09-01 |
DigitalDoc, NL8522 |
Phase Not Applicable |
Recruiting |
1 |
4 Months |
50 |
Bart Candel |
2020-05-04 |
| Neuroinvasion in COVID-19 |
Coronavirus disease 19 infection, Respiratory disease |
RT-PCR alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Zuyderland Medical Center, Heerlen |
|
Netherlands |
2020-04-26 |
2020-06-26 |
NL8526 |
Phase Not Applicable |
Not yet recruiting |
1 |
2 Months |
10 |
Floris Smeets |
2020-05-04 |
| Volatile Anesthetics in COVID-19 – a pilot study |
Coronavirus disease 19 infection, Respiratory distress syndrome |
isoflurane alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universitair Medisch Centrum Utrecht |
|
Netherlands |
2020-04-26 |
2020-05-31 |
NL8523 |
Phase 2 Clinical |
Not yet recruiting |
1 |
1 Month |
20 |
Jan Dieleman |
2020-05-04 |
| Duke COVID-19 Shared Data and Specimen Repository |
Coronavirus disease 19 infection |
|
|
|
Duke University |
|
US |
2020-05-05 |
2025-04-30 |
NCT04368234, PRO00105316 |
Phase Not Applicable |
Recruiting |
0 |
59 Months |
100000 |
Chris Woods, MD, Lynn Sutton |
2020-05-04 |
| COVILUS: Lung Ultrasound to Diagnose COVID-19 |
Coronavirus disease 19 infection, Respiratory failure |
lung ultrasound alone, reverse transcription polymerase chain reaction test alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Universitaire D Amiens |
|
France |
2020-04-28 |
2020-09-28 |
COVILUS, NCT04368338, PI2020_843_0030 |
Phase Not Applicable |
Recruiting |
1 |
5 Months |
100 |
Stéphane Bar, Dr, Stéphane Bar, MD |
2020-05-04 |
| SCOPe: To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Max Healthcare Institute Ltd, India, Max Super Speciality Hospital |
|
India |
2020-04-25 |
2020-07-25 |
CTRI/2020/04/024859, NCT04367064, SCOPE/MHC/COVID-19/2020, SCOPe |
Phase Not Applicable |
Recruiting |
1 |
3 Months |
1000 |
Dr Ram Shankar Mishra, Rajesh Saxena, Rajesh Saxena, MBA, Ram Shankar Mishra, DNB, FRCP, Sandeep Budhiraja, MRCP, FACP |
2020-05-04 |
| ELCOVID: Electrocardiogram Analysis in COVID-19 Patients |
Cardiovascular disease, Coronavirus disease 19 infection |
blood test alone, cardiac magnetic resonance imaging alone, radiographic examination alone, transthoracic echocardiography alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Azienda Ospedaliero-Universitaria di Ferrara |
|
Italy |
2020-04-14 |
2021-12-01 |
385/2020/OSS/AOUFE, ELCOVID, NCT04367129 |
Phase Not Applicable |
Recruiting |
1 |
19 Months |
1000 |
Matteo Bertini, MD, PhD, Michele Malagù, MD |
2020-05-06 |
| EuroECMO-COVID: European/Euro-ELSO Survey on Adult and Neonatal/Pediatric COVID-19 Patients in ECMO |
Cardiogenic shock, Coronavirus disease 19 infection, Lung disease, Septic shock |
extracorporeal membrane oxygenation alone |
|
|
Maastricht University Medical Center |
Antwerp University Hospital, Azienda Ospedaliera Citta della Salute e della Scienza di Torino, Azienda Ospedaliero-Universitaria Ospedali Riunit, Azienda Ospedaliero-Universitaria di Udine, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Cardiocentro Ticino, Centre Hospitalier Universitaire Saint Pierre, Centre Hospitalier Universitaire de Liege, Centro Hospitalar Sao Joao, Charles University, Chelyabinsk Regional Clinical Hospital, City Clinical Hospital No. 67, Moscow, Russia, City Hospital No 40, City Hospital No 41, Ekaterinburg, Department of Cardiovascular Surgery, German Heart Center Munich, Erasme Hospital, Erasmus University Medical Center Rotterdam, European chapter of the Extracorporeal Life Support Organization, G Gaslini Children's Hospital, G. Pasquinucci Heart Hospital, Massa, General University Hospital, Prague, Great Ormond Street Hospital for Children NHS Foundation Trust, Guy's & St Thomas' Hospital NHS Trust, Hannover Medical School, Heart Center Leipzig GmbH, Heim Pal Children's Hospital, Henri Mondor Hospital, Herlev Hospital Region Hovedstaden, Hopital Prive La Louviere, Hopital Universitaire de la Pitie Salpetriere, Hopitaux Universitaires De Geneve, Hospices Civils De Lyon, Hospital Miguel Servet, Hospital San Gerardo, Hospital Sant Joan de Deu, Hospital Universitario Ramon y Cajal, Hospital Vall D'Hebron, Hôpital Civil Marie Curie de Charleroi, IRCCS Policlinico San Matteo, Istituto Scientifico H San Raffaele, Karolinska University Hospital, Kemerovo Regional Clinical Cardiological Center named after academician L.S. Barbarash, Klinik Hirslanden, Klinikum Kassel GmbH, Krasnodar Regional Hospital no 1, Landesklinikum Sankt Polten, Leiden University Medical Center, Medical University of Vienna, Medical University of Warsaw, Newcastle Upon Tyne Hospitals NHS Trust, Niguarda Hospital, Novosibirsk City Hospital #2, Onze-Lieve-Vrouwziekenhuis Aalst Hospital, Ospedale Maurizio Bufalini, Ospedale Papa Giovanni XXIII, Ospedale Pediatrico Bambino Gesù (IRCCS), Ospedale S. Giovanni Bosco, Ospedale San Donato, Ospedale Umberto, Ospedale dell'Angelo, Paediatric Intensive Care Glasgow, Politecnico Di Milano, Rennes University Hospital, Rijksuniversiteit te Groningen, Royal Brompton & Harefield NHS Trust, San Bortolo Hosp, San Camillo Hospital, Rome, San Giorgio Clinic, Skåne University Hospital, St. Orsola Hospital, The Mediterranean Institute for Transplantation and Advanced Specialized Therapies, Tirol Kliniken, Universitair Medisch Centrum Utrecht, Universitair Ziekenhuis Brussel, Universitair Ziekenhuis Gent, Universitaire Ziekenhuizen Leuven, Universitat Duisburg Essen, Universitatsklinikum Essen, University General Hospital of Alexandroupolis, University Hospital Basel, University Hospital Regensburg, University Hospital Tubingen, University Hospital, Aachen, University Hospital, Bordeaux, University Hospital, Montpellier, University Hospitals of Leicester - Leicester Royal Infirmary, University of Bern, University of Erlangen-Nurnberg Medical School, University of Lausanne Hospitals, University of Zurich, Universitätklinikum Düsseldorf, Universitätsklinikum Koln, Vilnius University Hospital Santariškių Klinikos |
Netherlands, Lithuania, Greece, Poland, Denmark, Russian Federation, Portugal, Spain, Italy, Israel, France, Austria, Czech Republic, UK, Hungary, Germany, Switzerland, Sweden, Belgium |
2020-04-10 |
2021-04-30 |
EuroECMO-COVID, METC 2020-1343, NCT04366921 |
Phase Not Applicable |
Recruiting |
97 |
12 Months |
150 |
Aaron Blandino, Ortiz, Alain Combes, Prof., Alberto Weber, Prof. Dr., Alessandro Paradiso, Dr., Alexander Kersten, Dr., Alexander Skopets, Alexandr Turchaninov, Alexandra Shilova, Allesandro Circelli, Dr., Andrea Montalto, Dr., Andrea Moscatelli, Angelo Polito, Antioco Cappai, Dr., Antonella Degani, Antonio Loforte, Dr., Aron Frederik Popov, Prof., Bernard Stockman, Dr., Christian Napp, Dr., Christoph Krapf, Dr., Claire Westrope, Daniel De Backer, Dr., Daniil Shelukhin, Dario Candura, Dr., Dario Fina, Dr., David Schibilsky, Dr., Davide Ghitti, Dr., De Piero, Drs., Dimitri Vandeweghe, Dimitrios Soufleris, Dinis Reis Miranda, Dr., Diyar Saeed, Prof., Edgars Grins, Esther Dreier, Dr., Fabio Taccone, Prof., Felix Hennig, Dr., Finn Moeller Pedersen, Dr., Gabriel Saiydoun, Dr., Gerdy Debeuckelaere, Giacomo Cavallaro, Gianluca Agus, Dr., Gil Bolotin, Dr., Giovanni Chiarini, Dr., Giovenni Landoni, Grünenfelder Jürg, Prof. Dr., Halbe Maximillian, Dr., Harlinde Peperstraete, Ignazio Condello, Igor Komilov, Ivan Akufov, J.J. van der Heijden, Dr., Jacinta Maas, Dr., Jan Belohlavek, Prof., Jan Schmitto, Prof., Jenni Hansjoerg, Jolanda Consiglio, Jordi Riero del Brio, Dr., Judit Llevadias, Justyna Swol, Dr., Katherine Brown, Lars Broman, Dr., Leen Vercaemst, Dr., Lo Coco, Drs., Lorusso, Prof. Dr., Luis Filipe Pinto, Dr., Maged Makhoul, Dr., Malaika Mendoca, Mara Scandroglio, Marc Lagny, Marco Giani, Dr., Marco Moscarelli, Dr., Marco Piccichè, Marco Ranucci, Dr., Maria Elena De Piero, Dr., Mariusz Kowaleswsky, Dr., Mark Davidson, Martin Kneyber, Matteo Di Nardo, Matteo Pozzi, Dr., Matthias Thielman, Prof., Maximillian Malfertheiner, Dr., Michael Piagnerelli, Mirko Belliato, Dr., Nicholas Bartlett, Dr., Nikolaos Bonaros, Prof., Olivier Brissaud, Olivier Germay, Pablo Ruiz, Dr., Paolo Del Sarto, Paolof Meani, Dr., Patrick Biston, Dr., Peter Schellongowski, Dr., Philipp Hen, Dr., Phillipe Gaudard, Pierre Tissieres, Ralf Muellenbach, Prof, Reina Gianfranco, Dr., Robertas Samalavicius, Dr., Roberto Carozza, Roberto Rona, Dr., Romain Courcelle, Roman Komelyuk, Sandrelli Luca, Dr., Sandro Sponga, Dr., Sergei Minin, Simone Schafer, Dr., Susana Segura Matute, Sven Maier, Dr., Thierry Folliguet, Prof., Thomas Doebele, Torje Iuliu, Dr., Udo Boeken, Prof., Vaclav Vobruba, Verna Aquino, Veronika Maraczi, Vito Fanelli, Dr., Xavier Bechtold |
2020-05-04 |
| COVID-19 outbreak and solid organ transplantation (SOT): an international, web-based survey |
Coronavirus disease 19 infection, Organ transplantation |
|
|
|
Policlinico Universitario Agostino Gemelli |
|
Italy |
2020-03-24 |
2020-04-17 |
COVID-19_V1, NCT04367896 |
Phase Not Applicable |
Completed |
1 |
|
1819 |
|
2020-05-01 |
| COVID PRAYER: The COVID-19 ICU PRAYER Study |
Coronavirus disease 19 infection |
remote intercessory multi-denominational prayer alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Kansas City Heart Rhythm Institute |
|
US |
2020-05-01 |
2020-08-31 |
COVID PRAYER, COVID PRAYER STUDY, NCT04361838 |
Phase Not Applicable |
Not yet recruiting |
0 |
4 Months |
1000 |
Dhanunjaya Lakkireddy, MD, Donita Atkins, RN, BSN |
2020-05-01 |
| COVID19-CHIEF: COVID-19 Infection in Patients With Hepatocellular Carcinoma |
Coronavirus disease 19 infection, Hepatocellular carcinoma, Viral pneumonia |
nasopharyngeal Covid-19 RT-PCR alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Universitaire D Amiens |
Central Hospital, Nancy, France, Centre Hospitalien Sud Francilien, Centre Hospitalier Intercommunal Creteil, Centre Hospitalier Regional Universitaire de Lille, Centre Hospitalier Universitaire De Nice, Centre Hospitalier Universitaire De Poitiers Etablissement D’Hospitalisation, Centre Hospitalier Universitaire de Toulouse, Hospices Civils De Lyon, Hospital Boisguillaume, Hôpital Paul Brousse, Jean Verdier Hospital, Rennes University Hospital, University Hospital, Bordeaux, University Hospital, Grenoble, University Hospital, Montpellier |
France |
2020-04-27 |
2020-10-31 |
COVID19-CHIEF, NCT04367805, PI2020_843_0042 |
Phase Not Applicable |
Recruiting |
1 |
6 Months |
50 |
Aurore BARON, MD, Christine SILVAIN, Pr, Eric ASSENAT, Pr, Eric NGUYEN KHAC, Pr, Giuliana AMADDEO, MD, Jean Pierre BRONOWICKI, Pr, Jean-Frédéric BLANC, MD, Jean-Marie PERON, Pr, Julien EDELINE, MD, Mohamed BOUATTOUR, MD, Nathalie GANNE-CARRIE, Pr, Olivier GANRY, Pr, Olivier Ganry, Pr, Philippe MATHURIN, Pr, Philippe MERLE, Pr, Pierre MICHEL, Pr, Rodolphe ANTY, Pr, Thomas DECAENS, Pr, Éric VIBERT, Pr |
2020-05-01 |
| ColchiVID: Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease |
Coronavirus disease 19 infection, Inflammatory disease |
colchicine (Perrigo) alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Instituto Nacional de Ciencias Medicas y Nutricion |
|
Mexico |
2020-04-27 |
2021-04-27 |
337420-21-1, ColchiVID, NCT04367168 |
Phase 2 Clinical |
Not yet recruiting |
1 |
12 Months |
174 |
Jose J Torres-Ruiz, MD, MSc, Marina Rull-Gabayet, MD |
2020-05-05 |
| Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR |
Coronavirus disease 19 infection |
Dry flocked nasopharyngeal Swab alone, Flocked nasopharyngeal eSwab alone, Flocked oropharynx eSwab alone |
|
Healthy volunteers accepted |
Jessa Hospital |
|
Belgium |
2020-04-20 |
2020-05-20 |
20.43, NCT04361448 |
Phase Not Applicable |
Not yet recruiting |
1 |
1 Month |
30 |
Koen Magerman, Reinoud Cartuyvels |
2020-05-04 |
| COHORT: Covid-19 Hospitalized Patients Registry |
Coronavirus disease 19 infection |
|
|
|
University Hospital Halle |
|
Germany |
2020-05-03 |
|
2020-039, COHORT, DRKS00021575 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
750 |
Daniel Sedding |
2020-05-01 |
| COVBIO: Thrombosis and Covid-19 |
Coronavirus disease 19 infection, Thrombosis |
thromboelastometry alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hospices Civils De Lyon |
|
France |
2020-05-01 |
2020-12-31 |
69HCL20_0401 - COVBIO, COVBIO, ID-RCB, NCT04366778 |
Phase Not Applicable |
Recruiting |
1 |
8 Months |
300 |
Yesim DARGAUD, Pr, Yseim DARGAUD, Pf |
2020-05-07 |
| Social Media and COVID-19 |
Acute stress disorder, Anxiety disorder, Coronavirus disease 19 infection, Depression |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Yale-NUS College |
|
Singapore |
2020-03-08 |
2020-05-31 |
2020-CERC-001B, NCT04367363 |
Phase Not Applicable |
Recruiting |
1 |
2 Months |
150 |
Jean Liu, PhD |
2020-05-01 |
| Cardiac Injury in COVID-19: a Pathology Study |
Coronavirus disease 19 infection, Heart injury, Lung disease, Myocardial infarction, Myocarditis, Pulmonary heart disease |
EKG alone, RNAscope in situ hybridization alone, autopsy alone, cardiac catheterization alone, cardiac sampling alone, dual immunofluorescence alone, echocardiography alone, reverse transcription polymerase chain reaction alone, transmission electron microscopy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Ospedale Papa Giovanni XXIII |
CVPath Institute |
Italy |
2020-04-30 |
2021-03-31 |
56/20, NCT04367792 |
Phase Not Applicable |
Recruiting |
1 |
11 Months |
50 |
Andrea Gianatti, MD, Antonio Bellasi, MD, CTC CLINICAL TRIAL CENTER, Giulio Guagliumi, MD, Lara Faggi, PhD |
2020-05-04 |
| MARCO: A Phase Ib/II, Randomized, Placebo-Controlled, Dose-Finding Study Followed by a Dose Level Expansion to Assess the Safety and Efficacy of NoveCite MSCs in Subjects with Acute Respiratory Distress Syndrome (ARDS) Due to SARS-CoV-2 Disease (COVID-19) |
Coronavirus disease 19 infection, Respiratory distress syndrome |
Allogeneic NoveCite mesenchymal stem cell therapy (acute respiratory distress syndrome/COVID-19), Citius Pharmaceuticals alone |
|
|
Citius Pharmaceuticals Inc |
|
US |
|
|
MARCO |
Phase 1/Phase 2 Clinical |
Planned |
0 |
|
|
|
2020-05-04 |
| X-Covid 19: Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients |
Coronavirus disease 19 infection, Thromboembolism |
enoxaparin sodium alone |
Low molecular weight heparin |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Niguarda Hospital |
|
Italy |
2020-05-31 |
2020-11-30 |
2020-001708-41, NCT04366960, X-Covid 19 |
Phase 3 Clinical |
Not yet recruiting |
1 |
6 Months |
2712 |
Nuccia Morici, MD |
2020-05-02 |
| A double-blinded, randomized and placebo-controlled study of trans sodium crocetinate (intravenous), Diffusion Pharmaceuticals in hospitalized COVID-19 patients who have not yet been admitted to an ICU |
Coronavirus disease 19 infection |
trans sodium crocetinate (intravenous), Diffusion Pharmaceuticals alone |
|
|
Diffusion Pharmaceuticals LLC, West Virginia University Healthcare |
|
US, Eastern Europe |
|
|
|
Phase Not Applicable |
Planned |
0 |
|
|
Dr. Alex Kadl, Dr. Andrew Southerland |
2020-04-30 |
| Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection |
Coronavirus disease 19 infection, Respiratory distress syndrome |
remestemcel-L alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Mesoblast International Sarl |
Mesoblast Ltd |
US |
|
|
MSB-MSC-ARDS001, NCT04366830 |
Phase Not Applicable |
No longer recruiting |
0 |
|
50 |
Mahboob Rahman, MD |
2020-05-02 |
| A phase I/II clinical trial for inactivated novel coronavirus (2019-CoV) vaccine (Vero cells) |
Coronavirus disease 19 infection |
COVID-19 vaccine (inactivated, Vero cells/intramuscular), Beijing Biological Products Institute/National Institute for Viral Disease Control and Prevention of Chinese Center for Disease Control and Prevention alone |
|
Healthy volunteers accepted, Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Beijing Biological Products Institute Co Ltd, China National Pharmaceutical Group Corporation, Henan Center for Disease Control and Prevention |
Ministry of Science and Technology of the People´s Republic of China |
China |
2020-04-28 |
2021-11-28 |
ChiCTR2000032459 |
Phase 1/Phase 2 Clinical |
Recruiting |
1 |
19 Months |
2128 |
Wei Wang, Yanxia Wang |
2020-05-06 |
| LUCID: Lung Ultrasound in Covid-19 Pneumonia |
Coronavirus disease 19 infection, Cough, Dyspnea, Respiratory disease, Viral pneumonia |
computed tomography alone, lung ultrasoound alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Vivantes Humboldt-Klinikum |
|
Germany |
2020-04-24 |
|
DRKS00021585, Eth08-20, LUCID |
Phase Not Applicable |
Recruiting |
1 |
|
220 |
Andreas Umgelter |
2020-05-02 |
| SARS-CoV-2 and Surgery |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Jagiellonian University |
|
Poland |
2020-03-30 |
2020-07-01 |
1072.6120.103.2020, NCT04368026 |
Phase Not Applicable |
Recruiting |
2 |
3 Months |
350 |
Tomasz Stefura, Tomasz Stefura, MD |
2020-05-02 |
| A larger, double-blinded, randomized, placebo-controlled study of trans sodium crocetinate (intravenous) to confirm safety in COVID-19 patients who have been admitted to Intensive Care Units (ICUs) |
Coronavirus disease 19 infection |
trans sodium crocetinate (intravenous), Diffusion Pharmaceuticals alone |
|
|
Diffusion Pharmaceuticals LLC, West Virginia University Healthcare |
|
US |
|
|
|
Phase Not Applicable |
Planned |
0 |
|
|
Dr. Alex Kadl, Dr. Andrew Southerland |
2020-04-30 |
| COR-DIAL-1: Rapid Detection of COVID-19 by Portable and Connected Biosensor |
Coronavirus disease 19 infection |
RT-PCR alone, nasopharyngeal swab sampling alone, viral biosensor alone |
|
|
Centre Hospitalier Regional Universitaire de Lille |
|
France |
2020-05-31 |
2020-09-30 |
2020-A01147-32, 2020_36, COR-DIAL-1, NCT04367142 |
Phase Not Applicable |
Not yet recruiting |
1 |
4 Months |
200 |
David Devos, MD,PhD, Enagnon Kazali ALIDJINOU, MD |
2020-05-02 |
| MolCOVID: Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hospital Boisguillaume |
|
France |
2020-04-30 |
2020-05-31 |
2020/0094/OB, MolCOVID, NCT04367545 |
Phase Not Applicable |
Recruiting |
1 |
1 Month |
50 |
Julien BLOT, Thierry FREBOURG, Pr |
2020-05-01 |
| EVIDENCE: COVID-19 Detection Test in Oncology |
Coronavirus disease 19 infection, Solid tumor |
enzyme-linked immunosorbent assay (ELISA) alone, rapid diagnostic test (RDT) alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
The UNICANCER Group |
|
France |
2020-05-31 |
2021-05-31 |
2020-A01002-37, EVIDENCE, NCT04367870, UC-TRA-2002 |
Phase Not Applicable |
Not yet recruiting |
11 |
12 Months |
2500 |
Alexandra JACQUET, Aurélien NORET, François-Clément BIDARD, Frédéric VIRET, Georges EMILE, Jean-Baptiste BACHET, Jean-Marc FERRERO, Lionel MOREAU, WILLIAM JACOT |
2020-05-03 |
| ScreenNC: A Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19 |
Coronavirus disease 19 infection |
COVID-19 testing alone, PCR test alone, sequencing alone, swab test alone, viral load testing alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of North Carolina |
|
US |
2020-04-28 |
2021-04-30 |
20-0937, NCT04367740, ScreenNC |
Phase Not Applicable |
Recruiting |
0 |
12 Months |
10000 |
David B Peden, MD |
2020-05-01 |
| ACCORD: ACcelerating COVID-19 Research and Development platform |
Coronavirus disease 19 infection |
bemcentinib alone |
Axl tyrosine kinase receptor inhibitor |
|
BerGenBio AS |
Department of Health and Social Care, IQVIA Holdings Inc, United Kingdom Research & Innovation |
UK |
|
|
ACCORD |
Phase 2 Clinical |
Not yet recruiting |
1 |
|
120 |
|
2020-05-05 |
| BACT-ovid: Bacteriotherapy in the Treatment of COVID-19 |
Coronavirus disease 19 infection |
bacteriotherapy alone, Variable regimens including SivoMixx , azithromycin , darunavir , darunavir + cobicistat , hydroxychloroquine , lopinavir + ritonavir , ritonavir |
Cytochrome P450 3A4 inhibitor, HIV protease inhibitor, HIV-1 protease inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universita degli Studi di Roma La Sapienza |
|
Italy |
2020-03-01 |
2020-07-31 |
BACT-ovid, DPHID-UNIROMA05, NCT04368351 |
Phase Not Applicable |
No longer recruiting |
1 |
5 Months |
70 |
Gabriella d'Ettorre, MD, PhD, Giancarlo Ceccarelli |
2020-05-05 |
| Comorbidites among COVID-19 Mortality Cases |
Coronavirus disease 19 infection |
|
|
|
National Institutes of Health Malaysia |
|
Malaysia |
2020-04-30 |
|
54554, NMRR-20-766-54554 |
Phase Not Applicable |
Status not specified |
1 |
|
|
Hamizatul Akmal Binti Abd Hamid, P Robert Lourdes, Tania Gayle |
2020-05-01 |
| Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection |
Coronavirus disease 19 infection |
angiotensin converting enzyme inhibitor therapy alone, angiotensin-receptor blocker therapy alone, influenza vaccine alone |
|
Healthy volunteers accepted |
Consorci Sanitari de Terrassa |
Catalan Health Service, Jordi Gol i Gurina Foundation |
Spain |
2020-03-01 |
2023-08-31 |
02-20-161-021, NCT04367883 |
Phase Not Applicable |
Recruiting |
1 |
42 Months |
2574 |
Anna Puigdellívol-Sánchez, Ph D, Anna Puigdellívol-Sánchez, Ph.D., Mar Muñoz |
2020-05-02 |
| Health Behavior Change During COVID-19 Pandemic |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
SWPS University of Social Sciences and Humanities |
|
Poland, Singapore, France, Italy, Portugal, Gambia, Canada, China, Switzerland, Germany, Israel, Australia, Malaysia, Romania |
2020-03-25 |
2021-03-24 |
3228-1BPSYPSBEH-30, NCT04367337 |
Phase Not Applicable |
Recruiting |
14 |
12 Months |
5600 |
Adriana Baban, PhD, Aleksandra Luszczynska, PhD, Bruno Quintard, PhD, Charles Abraham, PhD, Jan Keller, PhD, Karen Morgan, PhD, Katarzyna Byrka, PhD, Konstadina Griva, PhD, Konstantin Schenkel, MA, Margarida Gaspar de Matos, PhD, Martyna Kuszneruk, MA, Michelle Jongenelis, PhD, Nina Knoll, PhD, Noa Vilchinsky, PhD, Sabrina Cipolletta, PhD, Stephan Dombrowski, PhD, Urte Scholz, PhD, Vishna Shah, PhD, Yiquin Gan, PhD, Yiqun Gan, PhD, Zofia Szczuka, MA |
2020-05-02 |
| Stigmatization of Covid-19 patients |
Coronavirus disease 19 infection |
|
|
|
Hospital Raja Permaisuri Bainun |
|
Malaysia |
2020-06-01 |
|
54697, NMRR-20-777-54697 |
Phase Not Applicable |
Status not specified |
1 |
|
|
Chang Chee Tao, Ms. Chew Chii Chii |
2020-05-02 |
| Psychological Impairment Due to Covid-19 |
Anxiety disorder, Coronavirus disease 19 infection, Depression, Psychiatric disorder |
|
|
Healthy volunteers accepted |
Universitatsklinikum Essen |
|
|
2020-05-06 |
2020-05-30 |
NCT04368312, TEMP553914-BO |
Phase Not Applicable |
Not yet recruiting |
0 |
|
100 |
Johannes Siebermair, MD |
2020-05-02 |
| COVIVA: COVID-19 Survival |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital Basel |
|
Switzerland |
2020-03-19 |
2021-06-30 |
COVIVA, NCT04366765, UHOSPITAL SWITZ |
Phase Not Applicable |
Recruiting |
2 |
15 Months |
1500 |
Christian Mueller, MD, Christian Nickel, MD, Gabriela Kuster Pfister, MD, Hans Pargger, MD, Katharina Rentsch-Savoca, MD, Martin Siegemund, MD, Mirjam Christ Crain, MD, Raphael Twerenbold, MD, Roland Bingisser, MD, Sarah Tschudin-Sutter, MD, Stefan Osswald, MD, Stefano Bassetti, MD |
2020-05-05 |
| SAVIOR: Study Assessing Vagus Nerve Stimulation in COVID-19 Respiratory Symptoms |
Coronavirus disease 19 infection, Respiratory disease |
GammaCore alone, vagus nerve stimulation alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Valencia |
|
Spain |
2020-04-20 |
2020-07-31 |
NCT04368156, SAVIOR, SAVIOR |
Phase Not Applicable |
Recruiting |
1 |
3 Months |
90 |
Carlos Tornero, Carlos Tornero, PhD, Natividad Pozo, PhD |
2020-05-01 |
| IMPROVE: Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 |
Coronavirus disease 19 infection, Thromboembolism |
enoxaparin sodium alone, unfractionated heparin alone |
Low molecular weight heparin |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Columbia University |
|
US |
2020-05-31 |
2021-04-30 |
AAAS8980, IMPROVE, NCT04367831 |
Phase 4 Clinical |
Not yet recruiting |
0 |
11 Months |
100 |
Ajay Kirtane, MD, Kate Dalton, Sahil A. Parikh, Sahil Parikh, MD |
2020-05-04 |
| Registry to Study Factors That May Impact COVID-19 Occurrence and Severity |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
IQVIA RDS Pty Ltd |
|
US |
2020-04-02 |
2022-06-01 |
IQVIA-COVIDREGISTRY-2020, NCT04368065 |
Phase Not Applicable |
Recruiting |
0 |
26 Months |
100000 |
Barbara Arone, MS, Nancy Dreyer, PhD, MPH |
2020-05-01 |
| Use of Convalescent Plasma in the treatment of COVID-19 |
Coronavirus disease 19 infection |
convalescent plasma alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
HILTON PHARMA (PVT) LTD, National Institute of Blood Disease Center |
|
Iran |
2020-04-14 |
|
4-87/NBC-COVID19-/20/03, IRCT20200414047072N1 |
Phase 2 Clinical |
Recruiting |
1 |
|
357 |
Dr. Arshi Naz, Dr. Neeta Maheshwary, Professor Dr. Tahir S Shamsi, Saba Fatima |
2020-05-01 |
| ATTRACT: A phase II, randomized, double-blind, placebo-controlled clinical trial of VP-01 for the tretment of patients with COVID-19, SARS CoV-2 infection |
Coronavirus disease 19 infection, Respiratory failure |
VP-01 alone |
Angiotensin II AT-2 receptor agonist |
|
Vicore Pharma AB |
|
UK |
|
|
ATTRACT |
Phase 2 Clinical |
Not yet recruiting |
1 |
|
100 |
Professor Joanna Porter |
2020-04-30 |
| Chula Covid-19 Rapid Test for Pandemic Control |
Coronavirus disease 19 infection |
RT-PCR alone |
|
Healthy volunteers accepted |
Burapha University, Chaophraya Yommaraj Hospital, Chulalongkorn University, H.R.H. Maha Chakri Sirindhorn Medical Center, King Chulalongkorn Memorial Hospital, Lampang Hospital, Nan Hospital, National Cancer Institute, Thailand, Paholpolpayuhasena Hospital, Police General Hospital, Samitivej Sukhumvit Hospital, Samut Sakhon Hospital, Sikhio Hospital, Songkhla Hospital |
|
Thailand |
2020-03-20 |
|
TCTR20200426002 |
Phase Not Applicable |
Recruiting |
1 |
|
200 |
Krit Pongpirul, Narin Hiransuthikul |
2020-05-05 |
| Intravascular Access in Suspected/Confirmed COVID-19 Patient |
Cardiac arrest, Coronavirus disease 19 infection |
NIO needle set alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Lazarski University |
Medical University of Bialystok, Poznan University of Medical Sciences, Wroclaw Medical University |
Poland |
2020-04-14 |
2020-05-20 |
IO_PPE_1, NCT04366947 |
Phase Not Applicable |
No longer recruiting |
1 |
1 Month |
60 |
Lukasz Szarpak, Lukasz Szarpak, PhD |
2020-05-01 |
| COVID-19BRAIN: Neuroradiolological Analysis of COVID-19 Patients |
Brain disease, Coronavirus disease 19 infection |
neurological examination alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hopitaux Universitaires de Strasbourg |
|
France |
2020-04-03 |
2021-04-30 |
7759, COVID-19BRAIN, NCT04368390 |
Phase Not Applicable |
Recruiting |
1 |
12 Months |
100 |
Saïd CHAYER, PhD, HDR, Stephane Kremer, MD, PhD, Stéphane KREMER, MD, PhD |
2020-05-01 |
| A clinical trial of recombinant protein vaccine for the prevention of COVID-19 infection |
Coronavirus disease 19 infection |
recombinant protein vaccine (COVID-19), UMN Pharma Inc alone |
|
|
Shionogi & Co Ltd |
|
Japan |
|
|
|
Phase Not Applicable |
Planned |
1 |
|
|
|
2020-04-30 |
| Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic |
Coronavirus disease 19 infection |
injection molded polypropylene flocked nylon nasopharyngeal swab alone |
|
Healthy volunteers accepted, Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Virginia |
|
US |
2020-04-24 |
2020-07-31 |
HSR200127, NCT04368260 |
Phase Not Applicable |
Recruiting |
0 |
3 Months |
40 |
Amy Mathers, MD, Limor Steinberg |
2020-05-01 |
| COVIDSMELL: Study of the Pathogenesis of Olfactory Disorders in COVID-19 |
Coronavirus disease 19 infection, Dysomia |
nasal swab sampling alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Institut Pasteur |
Assistance Publique Hopitaux de Paris |
France |
2020-05-04 |
2022-09-15 |
2020-021, COVIDSMELL, NCT04366934 |
Phase Not Applicable |
Recruiting |
2 |
28 Months |
24 |
Benjamin VERILLAUD, MD, Carolina APARICIO, MD, Caroline APARICIO, MD, Charlotte HAUTEFORT, MD, Françoise LAZARINI, PhD |
2020-05-08 |
| RESCUE 1-19: Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 |
Coronavirus disease 19 infection, Edema, Viral pneumonia |
low dose radiation therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Emory University |
National Cancer Institute |
US |
2020-04-23 |
2020-07-01 |
NCI-2020-02676, NCT04366791, P30CA138292, RAD5002-20, RESCUE 1-19, STUDY00000476 |
Phase 1/Phase 2 Clinical |
Recruiting |
0 |
2 Months |
10 |
Autumn Lunceford, Clayton B Hess, MD, MPH, Clayton B. Hess, Clayton B. Hess, MD MPH, Clayton Hess, MD, MPH, Mohammad K Khan, MD, PhD, Mohammad K. Khan, MD PhD |
2020-05-02 |
| Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement |
Coronavirus disease 19 infection |
electromyography alone, electroneurography alone, muscle ultrasound alone, transthoracic echocardiography alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital Tubingen |
|
Germany |
2020-03-20 |
2022-03-31 |
246/2020BO2, NCT04367350 |
Phase Not Applicable |
Recruiting |
1 |
24 Months |
500 |
Alexander Grimm, MD, Helene Häberle, MD, Markus Krumbholz, MD, Sophia Willikens, MD, Sven Poli, MD |
2020-05-01 |
| African Covid-19 Critical Care Outcomes Study |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Cape Town |
University Of Kwazulu-Natal |
South Africa |
2020-05-01 |
2020-12-31 |
ACCCOS, NCT04367207 |
Phase Not Applicable |
Not yet recruiting |
1 |
8 Months |
2000 |
Bruce Biccard, Bruce M Biccard |
2020-05-08 |
| DEPRECOVID: Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women's Depression |
Anxiety disorder, Coronavirus disease 19 infection, Depression, Gynecological disorder |
|
|
Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Universitaire De Poitiers Etablissement D’Hospitalisation |
|
France |
2020-05-31 |
2020-12-31 |
2020-A01065-34, DEPRECOVID, NCT04368208 |
Phase Not Applicable |
Not yet recruiting |
1 |
7 Months |
900 |
bertarnd GACHON, MD, PhD student |
2020-05-04 |
| IRCEP: International Registry of Coronavirus (COVID-19) Exposure in Pregnancy |
Coronavirus disease 19 infection |
|
|
Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Pregistry |
Harvard TH Chan School of Public Health |
US |
2020-05-01 |
2024-04-30 |
0001, IRCEP, NCT04366986 |
Phase Not Applicable |
Not yet recruiting |
0 |
48 Months |
25000 |
Diego Wyszynski, MD, MHS, PhD, Sonia Hernandez-Diaz, MD, DrPH |
2020-05-01 |
| reCoVery: Repurposing of Chlorpromazine in Covid-19 Treatment |
Coronavirus disease 19 infection |
chlorpromazine alone, standard of care alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Sainte Anne |
Hôpital Cochin |
France |
2020-04-29 |
2020-09-30 |
D20-P016, NCT04366739, reCoVery |
Phase 3 Clinical |
Not yet recruiting |
1 |
5 Months |
40 |
Marion Plaze, MD, PHD, Raphaël Gaillard, MD, PHD |
2020-05-01 |
| COVCKD: Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19 |
Coronavirus disease 19 infection, Kidney dialysis |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Region Midtjylland |
Aalborg Hospital, Aarhus University Hospital, Central Jutland Regional Hospital |
Denmark |
2020-03-15 |
2021-12-01 |
COVCKD, FHM-1-2020, NCT04367714 |
Phase Not Applicable |
Recruiting |
1 |
20 Months |
300 |
Frank Mose, Frank Mose, MD |
2020-05-01 |
| MY-CO-VID: Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU |
Aspergillus infection, Coronavirus disease 19 infection, Mucor infection, Pneumocystis carinii infection |
biological sampling alone, polymerase chain reaction alone, real-time polymerase chain reaction alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Rennes University Hospital |
|
France |
2020-04-30 |
2021-05-31 |
35RC20_8885_MY_CO_VID, MY-CO-VID, NCT04368221 |
Phase Not Applicable |
Not yet recruiting |
15 |
13 Months |
250 |
Achille Kouatchet, Alain Mercat, Anna Novara, Antoine Berry, Beatrice Riu-Poulenc, Carole Schwebel, Christophe Hennequin, Cécile Aubron, Daniele Monbon, Emmanuel Canet, Eric Dannaoui, Feraht Meziani, Florence Persat, Florence Robert-Gangneux, Florent Morio, Francoise Botterel, Frederic Dalle, Frédéric Dalle, Gilles Nevez, Gilles Nevez Nevez, Guillaume Desoubeaux, Jean Christophe Richard, Jean-Francois Timsit, Jean-Marc Tadié, Jean-Philippe Bouchara, Jean-Pierre GANGNEUX, MD, PhD, Jean-Pierre Gangneux, Keyvan Razazi, Laurent Argaud, Marie LE NAOU, Martine Wallon, Muriel Cornet, Muriel Sarrah Fartoukh, Nicolas Terzi, Nicolas de Prost, Patrice Le Pape, Pierre-Francois Dequin, Pierre-François Dequin, Sandrine Houzé, Sophie Brun, Stephane Gaudry, Stéphane Gaudry, Valerie Letcher-Bru, Valérie Letcher-Bru, Xavier Iriart, Yves Cohen, Yves Le Tulzo, cecile Aubron, cécile Aubron |
2020-05-07 |
| THROMBOCOVID: Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy |
Coronavirus disease 19 infection, Lung disease, Thromboembolism, Viral pneumonia |
venous ultrasound alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Universitaire D Amiens |
|
France |
2020-04-22 |
2020-09-22 |
NCT04366752, PI2020_843_0036, THROMBOCOVID |
Phase Not Applicable |
Recruiting |
1 |
5 Months |
100 |
Clement Brault, MD, Julien Maizel, Pr, Michel Slama, Pr, Simon Soudet, MD, Yoann Zerbib, MD |
2020-05-01 |
| IMSEQ: COVID-19 Immune Repertoire Sequencing |
Coronavirus disease 19 infection |
blood sampling alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Institute of Tropical Medicine, Belgium |
Antwerp University Hospital |
Belgium |
2020-04-01 |
2020-12-31 |
IMSEQ, IMSEQ, NCT04368143 |
Phase Not Applicable |
Recruiting |
1 |
9 Months |
100 |
Koen Vercauteren |
2020-05-01 |
| The effect of NBS powder in treatment of patients with COVID-19 |
Coronavirus disease 19 infection |
NBS powder alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hamadan University of Medical Sciences |
|
Iran |
2020-05-09 |
|
IR.UMSHA.REC.1399.046, IRCT20200426047206N1 |
Phase 3 Clinical |
Not yet recruiting |
1 |
|
46 |
Farid Azizi Jalilian |
2020-05-04 |
| PIC-19: Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 |
Coronavirus disease 19 infection, Respiratory failure, Viral pneumonia |
Variable regimens including acetylsalicylic acid , clopidogrel , fondaparinux sodium , tirofiban |
Factor Xa antagonist, GP IIb IIIa antagonist, P2Y12 purinoceptor antagonist |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universita degli Studi di Milano |
Fondazione Un Cuore per Milano |
Italy |
2020-04-06 |
2020-04-23 |
18275/2020, NCT04368377, PIC-19 |
Phase 2b Clinical |
Completed |
1 |
|
5 |
Pierachille Santus |
2020-05-02 |
| Effect of natural from Tahini oil product on corona |
Coronavirus disease 19 infection |
Tahini oil alone |
|
Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Gonabad University of Medical Sciences |
|
Iran |
2020-04-30 |
|
IR.GMU.REC.1399.014, IRCT20140407017169N2 |
Phase 0 Clinical |
Recruiting |
1 |
|
100 |
Ahmadi Reza, Hossein Mohammadzadeh- Moghadam, Hossein Mohammadzadeh-moghadam |
2020-05-05 |
| BEVACOR: Pilot study of bevacizumab as a treatment for respiratory distress in patients with COVID-19 |
Coronavirus disease 19 infection, Respiratory distress syndrome |
bevacizumab alone |
VEGF ligand inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Fundación Para La Investigación Biomédica De Córdoba |
|
Spain |
2020-04-24 |
|
2020-001541-39, BEVACOR, BEVACOR |
Phase 2 Clinical |
Recruiting |
1 |
|
22 |
Antonio Luque |
2020-05-01 |
| Is there a benefit in treating novel corona virus (Sars-CoV2) infections with the established antihypertensive valsartan? |
Coronavirus disease 19 infection |
valsartan alone |
Angiotensin I receptor antagonist, Angiotensin II receptor antagonist |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Klinikum St Georg |
|
Germany |
2020-04-22 |
|
2020-001431-27, CovidVal01 |
Phase 2 Clinical |
No longer recruiting |
1 |
|
300 |
Geschäftsführung |
2020-05-04 |
| Telemedicine in the Covid-19 pandemic in Brazil in a medical clinic in the supplementary health sector in São Paulo, Brazil |
Coronavirus disease 19 infection |
telemedicine alone, azithromycin plus hydroxychloroquine |
|
|
Centro Medico Mazzei |
|
Brazil |
2020-04-01 |
|
3.947.259, 30246520.0.0000.0069, A36899523876, RBR-658khm |
Phase 2 Clinical |
Recruiting |
1 |
|
90 |
Michelle Chechter |
2020-05-01 |
| SIDIACO: The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients |
Coronavirus disease 19 infection, Non-insulin dependent diabetes, Respiratory failure, Viral pneumonia |
nutrition intake alone, sitagliptin alone, standard of care alone, insulin plus sitagliptin |
Dipeptidyl peptidase IV inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universita degli Studi di Milano |
|
Italy |
2020-04-30 |
2020-12-30 |
FBF SACCO, NCT04365517, SIDIACO |
Phase 3 Clinical |
Not yet recruiting |
1 |
8 Months |
170 |
Paolo Fiorina, MD, PhD, Teresa Letizia, Dr. |
2020-05-02 |
| MERMAIDS 2: European Study of Major Infectious Disease Syndromes Related to COVID-19 |
Coronavirus disease 19 infection, Respiratory disease, Respiratory tract infection |
biological sampling alone |
|
|
Universitair Medisch Centrum Utrecht |
|
Netherlands |
2020-05-01 |
2022-04-30 |
MERMAIDS 2, NCT04364711, RECOVER - MERMAIDS 2.0 |
Phase Not Applicable |
Not yet recruiting |
1 |
24 Months |
2000 |
MJM Bonten |
2020-05-07 |
| Intravascular Access of COVID-19 Patient Under Personal Protective Equipment |
Coronavirus disease 19 infection |
NIO alone, Standard intravenous cannula alone, intraosseous access alone, intravenous access alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Lazarski University |
Medical University of Bialystok, Poznan University of Medical Sciences, Wroclaw Medical University |
Poland |
2020-01-12 |
2020-02-25 |
IO_PPE_MS_1, NCT04366297 |
Phase Not Applicable |
Completed |
1 |
1 Month |
41 |
Jacek Smereka, PhD, Łukasz Szarpak, Assoc Prof PhD |
2020-04-30 |
| PROBIOZOVID: Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora |
Coronavirus disease 19 infection |
oxygen-ozone therapy alone, standard of care alone, Variable regimens including Ozone , SivoMixx , azithromycin , darunavir , darunavir + cobicistat , hydroxychloroquine , lopinavir + ritonavir , ritonavir |
Cytochrome P450 3A4 inhibitor, HIV protease inhibitor, HIV-1 protease inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Azienda Policlinico Umberto I |
|
Italy |
2020-03-26 |
2020-12-31 |
110/2020, NCT04366089, PROBIOZOVID |
Phase 2 Clinical |
Recruiting |
1 |
9 Months |
152 |
Andrea Calò, MD, Carmela Imperiale, MD, Claudio M Mastroianni, MD PhD, Fabio Araimo, MD, Francesco Pugliese, MD PhD, Francesco Pugliese, MD, PhD, Gabriella d'Ettorre, MD PhD, Giancarlo Ceccarelli, MD PhD MSc, Gregorio Egidio Recchia, MD, Paolo Tordiglione, MD PhD, Roberto Poscia MD, Serena Zancla, MD, Vera MAuro, MD |
2020-05-01 |
| The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial |
Coronavirus disease 19 infection |
hydroxychloroquine alone, standard preventive measures alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
University of the Philippines |
|
Philippines |
2020-05-31 |
2021-05-31 |
NCT04364815, RGAO-2020-0339 |
Phase 3 Clinical |
Not yet recruiting |
1 |
12 Months |
960 |
Belen L Dofitas, MD |
2020-05-06 |
| COVID-19 Seremban 3MCO |
Coronavirus disease 19 infection |
|
|
|
Pejabat Kesihatan Daerah Seremban |
|
Malaysia |
2020-04-29 |
2020-09-01 |
54671, NMRR-20-786-54671 |
Phase Not Applicable |
Recruiting |
1 |
4 Months |
|
Dr MOHD 'AMMAR IHSAN BIN AHMAD ZAMZURI |
2020-05-06 |
| COVID-T: COVID-19 Search in Conjunctival Cells |
Coronavirus disease 19 infection, Lung disease |
computed tomography alone, conjunctival swab alone, nasopharyngeal swab alone, real time-PCR alone, x-ray alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Policlinico Universitario Agostino Gemelli |
|
Italy |
2020-03-26 |
2020-05-30 |
0013008/20, COVID-T, NCT04364594 |
Phase Not Applicable |
No longer recruiting |
1 |
2 Months |
50 |
|
2020-04-30 |
| PRON-COVID: The Prone Position in Covid-19 Affected Patients |
Coronavirus disease 19 infection, Respiratory distress syndrome, Viral pneumonia |
continuous positive airway pressure therapy alone, oxygen therapy alone, prone positioning alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
University of Milano-Bicocca |
|
Italy |
2020-03-20 |
2020-05-31 |
NCT04365959, PRON-COVID, PRON-COVID |
Phase Not Applicable |
No longer recruiting |
1 |
2 Months |
56 |
Giuseppe Foti, Prof. |
2020-05-01 |
| To study the effectiveness of Ivermectin with standard of care treatment versus standard of care treatment for COVID-19 cases. A Pilot Study |
Coronavirus disease 19 infection |
ivermectin alone |
Chloride channel modulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Max Super Speciality Hospital |
|
India |
2020-04-25 |
|
CTRI/2020/04/024858 |
Phase 2 Clinical |
Not yet recruiting |
1 |
|
50 |
Dr Ram Shankar Mishra, Dr Sandeep Budhiraja, Rajesh Saxena |
2020-04-29 |
| Bid data analytic COVID-19 |
Coronavirus disease 19 infection |
predictive visual analytic method alone |
|
|
National Institutes of Health Malaysia |
|
Malaysia |
2020-04-30 |
2020-08-31 |
54648, NMRR-20-790-54648 |
Phase Not Applicable |
Not yet recruiting |
1 |
4 Months |
|
Dr Mohd Azahadi Omar, Encik MOHAMAD FUAD BIN MOHAMAD ANUAR |
2020-04-29 |
| RNA-based vaccine for COVID-19 |
Coronavirus disease 19 infection |
RNA-based vaccine alone |
|
|
Institute For Medical Research (Inc In Malaysia) |
|
Malaysia |
2020-06-01 |
2022-12-31 |
54569, NMRR-20-764-54569 |
Phase Not Applicable |
Status not specified |
1 |
31 Months |
|
Dr MASITA BINTI ARIP, Ms Ching Yee Ming |
2020-04-30 |
| COVID-19 NGS: NGS Diagnostic in COVID-19 Hosts: Genetic Cause Relating to the Course of Disease Progression |
Coronavirus disease 19 infection |
DNA methylation analysis alone, T-cell receptor repertoire sequencing alone, methylation beadchip (EPIC) array alone, next generation sequencing alone, whole genome sequencing alone, whole transcriptome sequencing alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital Tubingen |
|
Germany |
2020-04-30 |
2021-08-31 |
COVID-19 NGS, COVID-19 NGS, NCT04364828 |
Phase Not Applicable |
Not yet recruiting |
1 |
16 Months |
1000 |
Michael Bitzer, Prof. Dr., Olaf Rieß, Prof. Dr. |
2020-05-04 |
| COVID-19: investigation into biochemical and hematological parameters in clinical laboratory |
Coronavirus disease 19 infection |
|
|
|
UNIVERSITI INDUSTRI SELANGOR (UNISEL) - SHAH ALAM CAMPUS |
|
Malaysia |
2020-04-29 |
2020-05-29 |
54641, NMRR-20-760-54641 |
Phase Not Applicable |
Status not specified |
1 |
1 Month |
|
CHIA ZHEN ZHAN |
2020-04-29 |
| Lung Recruitment Device for COVID-19 |
Coronavirus disease 19 infection |
Chest physiotherapy alone |
|
|
CHU de Quebec-Universite Laval |
Dymedso Inc, Fonds de la Recherche en Sante du Quebec |
|
2020-05-01 |
2020-12-31 |
MP-21-2020-2871, NCT04361435 |
Phase Not Applicable |
Not yet recruiting |
0 |
8 Months |
50 |
Atsushi Kawaguchi, MD PhD, Philippe Jouvet, MD PhD MBA, Saly Salti, MSc |
2020-05-08 |
| LAPTRANSCOV: Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients |
Coronavirus disease 19 infection |
RT-PCR alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier René-Dubos |
|
France |
2020-05-31 |
2020-10-31 |
CHRD 0420, LAPTRANSCOV, NCT04361396 |
Phase Not Applicable |
Recruiting |
2 |
5 Months |
40 |
Christophe Poncelet, Maryline Delattre, Nelson Trelles, Veronique Da Costa |
2020-05-01 |
| Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology |
Anxiety disorder, Coronavirus disease 19 infection, Depression, Psychiatric disorder |
non-pharmacological intervention treatment alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Modum Bad |
University of Oslo |
Norway |
2020-03-31 |
2020-04-07 |
NCT04365881, REK12345 |
Phase Not Applicable |
Completed |
1 |
|
10084 |
Asle Hoffart, PhD, Omid V. E. Ebrahimi, Cand Psychol, Sverre Urnes Johnson, PhD |
2020-05-01 |
| NutriCovid30: Nutritional Evaluation for Covid-19 Infection at D30 |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital, Grenoble |
Universite Grenoble Alpes |
France |
2020-05-31 |
2020-11-30 |
2020-A01120-39, NCT04365816, NutriCovid30 |
Phase Not Applicable |
Not yet recruiting |
1 |
6 Months |
600 |
Marie-France VAILLANT, PhD |
2020-05-04 |
| AIC: Azithromycin in Hospitalized COVID-19 Patients |
Coronavirus disease 19 infection |
azithromycin alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Shaheed Beheshti Medical University |
|
Iran |
2020-04-20 |
2020-05-05 |
AIC, AZITHROMYCIN IN COVID-19, NCT04359316 |
Phase 4 Clinical |
Not yet recruiting |
1 |
|
40 |
Mehran Lack, MD, Mohammad Fathi, MD, Nader Markazi, MD, Nasser Malekpour Alamdari, MD, Sanaz Zargar Balaye Jam, MD, Sasan Tavana, MD, Seyed Sina Naghibi Irvani, MD, MPH, MBA |
2020-04-29 |
| An International, multicenter clinical study to evaluate the efficacy and safety of Polyoxidonium in hospitalized COVID-19 patients |
Coronavirus disease 19 infection |
Polyoxidonium alone |
|
|
NPO Petrovax Pharm LLC |
|
Russian Federation |
|
|
|
Phase Not Applicable |
Not yet recruiting |
1 |
|
|
|
2020-04-29 |
| CYNK001COVID: Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 |
Coronavirus disease 19 infection, Lower respiratory tract infection |
CYNK-001 alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Celularity Inc, Sorrento Therapeutics Inc |
Infectious Disease Research Institute, Lung Biotechnology Inc |
US |
2020-04-30 |
2021-11-30 |
CYNK-001-COVID-19, CYNK001COVID, NCT04365101 |
Phase 1/Phase 2 Clinical |
Not yet recruiting |
0 |
19 Months |
86 |
Corey Casper, MD MPH, Erica Rave, MS, IDRI |
2020-04-29 |
| OzonoCOVID19: Indirect Endovenous Systemic Ozone for New Coronavirus Disease (COVID 19) in Non-intubated Patients |
Coronavirus disease 19 infection |
Base WHO recommended treatment. alone, Systemic indirect endovenous ozone therapy alone, ozone alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universidad Católica San Antonio de Murcia |
Sociedad Española de Ozonoterapia |
Spain |
2020-04-30 |
2020-06-30 |
NCT04359303, OzonoCOVID19, P.INV. OZONO-COVID19 VER.1.2 |
Phase 3 Clinical |
Not yet recruiting |
1 |
2 Months |
50 |
Francisco J Hidalgo Tallón, MD, PhD, Jose Baeza Noci, MD, PhD |
2020-04-30 |
| COVIDHIV: Clinical Characterization Protocol for COVID-19 in People Living With HIV |
Coronavirus disease 19 infection, HIV infection |
auto-questionnaires alone, biological collection alone, qualitative interviews alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Assistance Publique Hopitaux de Paris |
|
France |
2020-04-30 |
2020-10-31 |
2020-A00984-35, COVIDHIV, NCT04361604 |
Phase Not Applicable |
Not yet recruiting |
1 |
6 Months |
270 |
Antoine Chéret, Dr |
2020-04-29 |
| A Single-center, Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients |
Coronavirus disease 19 infection, Diabetes mellitus, Viral pneumonia |
multivariate analysis alone, real-time RT-PCR test alone, univariate analysis alone |
|
|
Tongji Hospital |
|
China |
2020-02-02 |
2020-04-01 |
NCT04365634, TJ20200202 |
Phase Not Applicable |
Completed |
1 |
2 Months |
306 |
Meifang Han, Professor, Qin Ning |
2020-05-02 |
| Metabolon Study to Provide Better Understanding of COVID-19 |
Coronavirus disease 19 infection |
|
|
|
Institute For Systems Biology, Metabolon Inc |
|
US |
|
|
|
Phase Not Applicable |
Status not specified |
0 |
|
|
James R. Heath, Ph.D, Jason Goldman, M.D |
2020-04-29 |
| HASCOPT: Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial |
Coronavirus disease 19 infection, Respiratory failure |
azithromycin plus hydroxychloroquine |
|
Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hospital St. Joseph, Marseille, France |
|
France |
2020-04-30 |
2021-01-31 |
HASCOPT, HASCOPT2020, NCT04365231 |
Phase 3 Clinical |
Not yet recruiting |
1 |
9 Months |
50 |
Laurence CUREL, Maria mg Gackiere, Raoul RD Desbriere, MD, Xavier-Côme xcd Donato |
2020-04-29 |
| The Effect of RBT-9(Stannous Protoporphyrin [SnPP]) on Progression of COVID-19 Infection in High-Risk Individuals |
Coronavirus disease 19 infection |
RBT-9 alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Renibus Therapeutics Inc |
|
|
2020-06-01 |
2021-12-31 |
NCT04364763, REN-005 |
Phase 2 Clinical |
Not yet recruiting |
0 |
19 Months |
252 |
Austin Keyser, PharmD |
2020-05-08 |
| A study to assess the efficacy of tocilizumab in severe patients with Corona Virus Disease19 (COVID-19) |
Coronavirus disease 19 infection |
routine therapy alone, tocilizumab (intravenous), Roche/Chugai alone |
IL-6 receptor antagonist, IL-6 receptor modulator |
|
2nd People's Hospital of Fuyang City, Anhui Provincial Hospital |
China National Center For Biotechnology Development, Department of Science and Technology of Anhui Province |
China |
|
|
|
Phase Not Applicable |
Status not specified |
2 |
|
21 |
|
2020-04-29 |
| COVID-RPC: Observational, Cohort of COVID-19 Patients at Raymond-Poincare |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Assistance Publique Hopitaux de Paris |
|
France |
2020-04-30 |
2020-05-31 |
20SBS-COVID-RPC, COVID-RPC, NCT04364698 |
Phase Not Applicable |
Not yet recruiting |
1 |
1 Month |
500 |
Aurelien Dinh, MD, Simon Bessis, MD |
2020-04-29 |
| Convalescent Plasma for COVID-19 |
Coronavirus disease 19 infection, Viral pneumonia |
convalescent plasma alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Ente Ospedaliero Cantonale, |
|
Switzerland |
2020-04-27 |
2020-06-30 |
2020-00895, NCT04365439 |
Phase 2 Clinical |
Not yet recruiting |
2 |
2 Months |
10 |
Beatrice Bernasconi, Enos Bernasconi, Enos Bernasconi, M.D., Stefano Fontana, M.D. |
2020-04-29 |
| Covid-19 Associated Coagulopathy |
Blood clotting disorder, Coronavirus disease 19 infection |
enoxaparin sodium alone |
Low molecular weight heparin |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Iowa |
|
US |
2020-05-06 |
2021-04-16 |
202004235, NCT04360824 |
Phase 4 Clinical |
Not yet recruiting |
0 |
11 Months |
170 |
Usha Perepu |
2020-05-08 |
| Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection |
Coronavirus disease 19 infection |
convalescent plasma alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Andalusian Network for Design and Translation of Advanced Therapies |
|
Spain |
2020-04-30 |
2021-12-31 |
NCT04366245, PC/COVID-19 |
Phase 1/Phase 2 Clinical |
Recruiting |
1 |
20 Months |
72 |
Ana Cardesa Gil |
2020-04-29 |
| Proving the efficacy of Homeopathic treatment in prevention and cure of COVID-19 |
Coronavirus disease 19 infection |
Variable regimens including Ars Alb , Bryonia Alba , Camphora , Helleborus niger , Justicia Adhatoda |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Welling Healthcare Private Limited |
|
India |
2020-05-04 |
|
CTRI/2020/04/024857 |
Phase 1/Phase 2 Clinical |
Not yet recruiting |
1 |
|
100 |
Angelo Smith, Dr Sourabh R Welling |
2020-04-29 |
| HIGH-PRONE-COVID-19: Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 |
Coronavirus disease 19 infection, Respiratory distress syndrome, Viral pneumonia |
prone decubitus alone, usual care alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital, Tours |
|
France |
2020-04-27 |
2020-11-24 |
2020-A01121-38, DR200125, HIGH-PRONE-COVID-19, HIGH-PRONE-COVID-19, NCT04358939 |
Phase Not Applicable |
Recruiting |
13 |
6 Months |
248 |
Agathe DELBOVE, MD, Anne-Charlotte TELLIER, MD, Arnaud THILLE, MD-PhD, Christophe GUITTON, MD, Damien ROUX, MD-PhD, Erwan L'HER, MD-PhD, Gaetan PLANTEFEVE, MD, Guillaume VOIRIOT, MD, Jean DELLAMONICA, MD-PhD, Jean REIGNIER, MD-PhD, Mai-Anh NAY, MD, Saadalla NSEIR, MD, Stephan EHRMANN, MD-PhD, Yoanatan PEREZ, MD, Yonatan PEREZ, MD |
2020-04-30 |
| COVID-19 CAir: SARS-CoV-2 Associated Respiratory Failure Recovery |
Coronavirus disease 19 infection, Respiratory failure |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Zurich |
|
Switzerland |
2020-05-31 |
2020-12-31 |
2020-00745, COVID-19 CAir, NCT04365595 |
Phase Not Applicable |
Recruiting |
1 |
7 Months |
200 |
Christian F Clarenbach, MD, Dario Kohlbrenner, MSc |
2020-05-05 |
| COP-COVID-19: Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia |
Coronavirus disease 19 infection, Viral pneumonia |
convalescent plasma alone, supportive management alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hospital Universitario Dr. Jose E. Gonzalez |
|
Mexico |
2020-04-27 |
2021-05-30 |
COP-COVID-19, IF20-00002, NCT04358783 |
Phase 2 Clinical |
Not yet recruiting |
1 |
13 Months |
30 |
Adrian Camacho-Ortiz, MD, Eduardo Pérez Alba, MD, Laura Marina Nuzzolo Shihadeh, MD |
2020-04-30 |
| COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box |
Coronavirus disease 19 infection |
COVID-19 barrier box alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of British Columbia |
|
Canada |
2020-05-31 |
2021-04-30 |
H20-01270, NCT04366141 |
Phase Not Applicable |
Not yet recruiting |
1 |
11 Months |
120 |
Anton Chau, MD, Tim Jen, MD |
2020-05-05 |
| A Proof of Concept study of Nu.Q COVID-19 Triage Test in COVID-19 patients |
Coronavirus disease 19 infection, Respiratory distress syndrome, Viral pneumonia |
Volition’s Nu.QTM nucleosome assays alone |
|
|
VolitionRX Ltd |
|
|
|
|
|
Phase Not Applicable |
Planned |
0 |
|
|
|
2020-04-29 |
| REP-COVID: Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial |
Coronavirus disease 19 infection |
Variable regimens including anakinra , azithromycin , enoxaparin sodium , hydroxychloroquine , lopinavir + ritonavir , methylprednisolone , plasma exchange , polyclonal immunoglobulin , serum albumin , tocilizumab |
HIV protease inhibitor, Low molecular weight heparin, Type I IL-1 receptor antagonist |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Fundació Clínic Per A La Recerca Biomèdica |
Instituto de Salud Carlos III |
Spain |
2020-04-23 |
2021-08-29 |
2020-001722-66, NCT04374539, REP-COVID, REP_COVID |
Phase 2 Clinical |
Recruiting |
2 |
16 Months |
116 |
Anna Cruceta, Anna Cruceta, MD, CTU, Fundacio Hospital Clinic |
2020-05-06 |
| JAKINKOV: Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation |
Coronavirus disease 19 infection, Inflammatory disease, Respiratory distress syndrome, Viral pneumonia |
anakinra alone, Jakavi plus Kineret |
Type I IL-1 receptor antagonist |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer |
Assistance Publique Hopitaux De Marseille |
France |
2020-05-01 |
2020-08-31 |
2020-001963-10, 2020-CHITS-003, JAKINKOV, NCT04366232 |
Phase 2 Clinical |
Not yet recruiting |
3 |
4 Months |
50 |
David DELARBRE, MD, Gilles HITTINGER, MD, Gilles KAPLANSKI, MD, Jean-Philippe Suppini, PhD |
2020-04-30 |
| A study to track coronavirus (COVID-19) in the general population |
Coronavirus disease 19 infection |
|
|
|
University of Oxford |
|
UK |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
300000 |
Department for Health and Social Care, Office for National Statistics |
2020-04-29 |
| ESCAPE: Study to evaluate the efficacy and tolerability of treatment with vafidemstat in combination with standard of care treatment to prevent Acute Respiratory Distress Syndrome in adult severely ill patients with COVID-19 |
Coronavirus disease 19 infection, Respiratory distress syndrome |
standard of care alone, Variable regimens including azithromycin , hydroxihidroxichloroquine , lopinavir + ritonavir , vafidemstat |
HIV protease inhibitor, Lysine specific histone demethylase 1 inhibitor, MAO B inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Oryzon Genomics SA |
|
Spain |
2020-04-24 |
|
2020-001618-39, CL08-ORY-2001_COVID-19, ESCAPE |
Phase 2 Clinical |
No longer recruiting |
1 |
|
40 |
Sonia Gutiérrez |
2020-05-07 |
| AUTONOMIC: Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic |
Anxiety disorder, Coronavirus disease 19 infection, Post traumatic stress disorder |
electrocardiography alone, electrodermal test alone, emotional stimulation test alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Direction Centrale du Service de Sante des Armees |
Institut de Recherche Biomedicale des Armees |
France |
2020-04-30 |
2020-06-30 |
2020-COVID19-11, AUTONOMIC, NCT04365335 |
Phase Not Applicable |
Recruiting |
2 |
2 Months |
60 |
Damien CLAVERIE, MD, PhD |
2020-05-04 |
| SINK COVID-19: Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 |
Coronavirus disease 19 infection |
Ketalar alone, naltrexone (once-monthly controlled-release, Medisorb), Alkermes alone, Ketalar plus naltrexone (once-monthly controlled-release, Medisorb), Alkermes |
Opioid receptor antagonist, Opioid receptor mu antagonist |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
William Beaumont Hospitals |
|
US |
2020-04-29 |
2020-08-31 |
2020-097, NCT04365985, SINK COVID-19 |
Phase 2 Clinical |
Recruiting |
0 |
4 Months |
500 |
Matthew Sims, MD, Matthew Sims, MD PhD, Maureen Cooney, RN, BSN |
2020-05-08 |
| Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients |
Coronavirus disease 19 infection, Respiratory disease |
anti-SARS-CoV-2 convalescent plasma alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
NYU Langone Health |
Albert Einstein College of Medicine |
US |
2020-04-17 |
2023-04-30 |
20-00541, 2020-11467, NCT04364737 |
Phase 2 Clinical |
Recruiting |
0 |
36 Months |
300 |
Michelle Chang, Mila B Ortigoza, MD, PhD, Mila Ortigoza, MD, Mila Ortigoza, MD, PhD |
2020-05-08 |
| COVIDIOL: Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome |
Coronavirus disease 19 infection |
Hidroferol alone, best available therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Fundación Para La Investigación Biomédica De Córdoba, Maimonides Biomedical Research Institute of Cordoba |
Consejeria de Salud. Junta de Andalucia, Dynamic Solutions Inc, FAES Farma SA |
Spain |
2020-04-28 |
2020-08-28 |
2020-001717-20, COVIDIOL, COVIDIOL, NCT04366908 |
Phase 2 Clinical |
Not yet recruiting |
1 |
4 Months |
1008 |
Antonio Luque, Antonio Luque, MsC, José López Miranda, MD, José Manuel Quesada Gómez, MD |
2020-05-01 |
| MESCEL-COVID19: Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19 |
Coronavirus disease 19 infection |
umbilical cord tissue derived undifferentiated allogeneic mesenchymal cells alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hospital Infantil Universitario Nino Jesus |
Apices Soluciones, S.L. |
Spain |
2020-04-24 |
2021-05-31 |
2020-001450-22, MESCEL-COVID19, MESCEL-COVID19, NCT04366271 |
Phase 2 Clinical |
Not yet recruiting |
6 |
13 Months |
106 |
Clara I Rodriguez, MD, Francisco García-Rio, MD, Jose A Lorente Balanza, MD, Julio Ancochea, MD, Luis Madero, MD, Luis Madero, PhD, Maria J del Cerro Marin, MD, Mrs. Laura Aranzasti, Sergio Serrano, MD, Teresa de Rojas, PhD |
2020-05-07 |
| REMDECO-19: Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections |
Coronavirus disease 19 infection |
remdesivir alone |
Coronavirus non structural protein 8 modulator, RNA polymerase modulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Assistance Publique Hopitaux de Paris |
|
France |
2020-04-30 |
2020-05-31 |
APHP200522, NCT04365725, REMDECO-19 |
Phase Not Applicable |
Not yet recruiting |
1 |
1 Month |
200 |
Jeremie ZERBIT, PharmaD, Jérémie ZERBIT, PharmaD |
2020-04-30 |
| RAMIC: Ramipril for the Treatment of COVID-19 |
Coronavirus disease 19 infection |
ramipril alone |
ACE inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of California San Diego |
Pfizer Inc |
US |
2020-04-30 |
2021-04-30 |
NCT04366050, RAMIC, RAMIC TRIAL |
Phase 2 Clinical |
Not yet recruiting |
0 |
12 Months |
560 |
Archana Bhatt, Len Lazaro, Rohit Loomba |
2020-05-02 |
| Progesterone for the Treatment of COVID-19 in Hospitalized Men |
Coronavirus disease 19 infection |
progesterone (sc, in vitro fertlilization), Institut Biochimique alone, standard of care alone |
Progesterone receptor agonist |
Male, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Cedars-Sinai Medical Center |
IBSA Institut Biochimique SA |
US |
2020-04-27 |
2021-04-17 |
NCT04365127, STUDY00000611 |
Phase 1 Clinical |
Recruiting |
0 |
11 Months |
40 |
Sara Ghandehari, MD, Vanessa Vasco |
2020-04-30 |
| COVIDMES: Efficacy and safety evaluation of umbilical cord mesenchymal stem cells for the treatment of patients with respiratory failure due to coronavirus (COVID-19) |
Coronavirus disease 19 infection, Respiratory distress syndrome |
umbilical cord mesenchymal stem cells alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Banc De Sang I Teixits |
|
Spain |
2020-04-23 |
|
2020-001505-22, BST-COVID-01, COVIDMES |
Phase 1/Phase 2 Clinical |
No longer recruiting |
1 |
|
30 |
Banc de Sang i Teixits |
2020-04-30 |
| BIRCOV: ARB, ACEi, DRi in COVID-19 |
Coronavirus disease 19 infection, Hypertension |
angiotensin converting enzyme inhibitor (ACEi) therapy alone, angiotensin receptor blocker (ARB) therapy alone, dopamine reuptake inhibitor (DRI) therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Medical Practice Prof D. Ivanov |
|
Ukraine |
2020-04-01 |
2021-08-01 |
BIRCOV, COVID20, NCT04364984 |
Phase Not Applicable |
Recruiting |
1 |
16 Months |
10 |
Dmytro Ivanov, MD, Prof, Mariia Ivanova, MD, PhD |
2020-04-30 |
| DURO-SIN: COVID-19 in an academic teaching hospital in Konstanz/Germany - evaluation of the 'double rule out - single rule in' concept |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Klinikum Konstanz, II. Medizin |
|
Germany |
2020-04-27 |
|
81/2020, DRKS00021605, DURO-SIN, U1111-1251-0310 |
Phase Not Applicable |
Recruiting |
1 |
|
200 |
Stephan Walterspacher |
2020-04-30 |